Document:

SECURITY AGREEMENT

 

SECURITY AGREEMENT
(this “Agreement”), dated as of March 5, 2012, by and among Global Investor Services, Inc., a Nevada corporation
(“Parent”), Razor Data, LLC, a Utah limited liability company, and Investment Tools and Training, LLC, a Utah
limited liability company (collectively, the “Subsidiaries”) (hereinafter the Parent and the Subsidiaries shall
collectively be referred to as the “Company”) and the secured parties signatory hereto and their respective
endorsees, transferees and assigns (collectively, the “Secured Party”).

 

WITNESSETH:

 

WHEREAS, pursuant to
a Subscription Agreement, dated the date hereof, between Parent and the Secured Party (the “Purchase Agreement”),
Parent has agreed to issue to the Secured Party and the Secured Party has agreed to purchase from Parent certain of Parent’s
8% Secured Convertible Promissory Notes, due three years from the date of issue (the “Notes”), which are convertible
into shares of Company’s Common Stock, par value $0.01 per share (the “Common Stock”) and such Notes are
issued as part of a series of Notes issued in accordance with the terms of the Purchase Agreement; and

 

WHEREAS, the Subsidiaries
constitutes all of the subsidiaries of the Parent and it is in the best interest of the Subsidiaries as subsidiaries of the Parent
and the indirect beneficiaries of the Purchase Agreement and Notes, that the Secured Party enter into the Purchase Agreement and
purchase the Notes to the Company; and

 

WHEREAS, in order to
induce the Secured Party to purchase the Notes, Company has agreed to execute and deliver to the Secured Party this Agreement for
the benefit of the Secured Party and to grant to it a first priority security interest in certain property of Company to secure
the prompt payment, performance and discharge in full of all of Company’s obligations under the Notes and exercise and discharge
in full of Company’s obligations under the Warrants; and

 

WHEREAS, in light of
the foregoing, the Company expects to derive substantial benefit from the Purchase Agreement and sale of the Notes and the transactions
contemplated thereby and, in furtherance thereof, has agreed to execute and deliver this.

 

NOW, THEREFORE, in
consideration of the agreements herein contained and for other good and valuable consideration, the receipt and sufficiency of
which is hereby acknowledged, the parties hereto hereby agree as follows:

 

1.          Certain
Definitions. As used in this Agreement, the following terms shall have the meanings set forth in this Section 1. Terms used
but not otherwise defined in this Agreement that are defined in Article 9 of the UCC (such as “general intangibles”
and “proceeds”) shall have the respective meanings given such terms in Article 9 of the UCC.

 

(a)          “Collateral”
means the collateral in which the Secured Party is granted a security interest by this Agreement and which shall include the following,
whether presently owned or existing or hereafter acquired or coming into existence, and all additions and accessions thereto and
all substitutions and replacements thereof, and all proceeds, products and accounts thereof, including, without limitation, all
proceeds from the sale or transfer of the Collateral and of insurance covering the same and of any tort claims in connection therewith:

 

    	 

    	 

    

 

(i)          All
Goods of the Company, including, without limitations, all machinery, equipment, computers, motor vehicles, trucks, tanks, boats,
ships, appliances, furniture, special and general tools, fixtures, test and quality control devices and other equipment of every
kind and nature and wherever situated, together with all documents of title and documents representing the same, all additions
and accessions thereto, replacements therefor, all parts therefor, and all substitutes for any of the foregoing and all other items
used and useful in connection with the Company’s businesses and all improvements thereto (collectively, the “Equipment”);
and

 

(ii)         All
Inventory of the Company; and

 

(iii)        All
of the Company’s contract rights and general intangibles, including, without limitation, all partnership interests, stock
or other securities, licenses, distribution and other agreements, computer software development rights, leases, franchises, customer
lists, quality control procedures, grants and rights, goodwill, trademarks, service marks, trade styles, trade names, patents,
patent applications, copyrights, deposit accounts, and income tax refunds (collectively, the “General Intangibles”);
and

 

(iv)        All
Receivables of the Company including all insurance proceeds, and rights to refunds or indemnification whatsoever owing, together
with all instruments, all documents of title representing any of the foregoing, all rights in any merchandising, goods, equipment,
motor vehicles and trucks which any of the same may represent, and all right, title, security and guaranties with respect to each
Receivable, including any right of stoppage in transit; and

 

(v)         All
of the Company’s documents, instruments and chattel paper, files, records, books of account, business papers, computer programs
and the products and proceeds of all of the foregoing Collateral set forth in clauses (i)-(iv) above.

 

(b)          “Company”
shall mean, collectively, Company and all of the subsidiaries of Company, a list of which is contained in Schedule A, attached
hereto.

 

(c)          “Obligations”
means all of the Company’s obligations under this Agreement and the Notes, in each case, whether now or hereafter existing,
voluntary or involuntary, direct or indirect, absolute or contingent, liquidated or unliquidated, whether or not jointly owed with
others, and whether or not from time to time decreased or extinguished and later decreased, created or incurred, and all or any
portion of such obligations or liabilities that are paid, to the extent all or any part of such payment is avoided or recovered
directly or indirectly from the Secured Party as a preference, fraudulent transfer or otherwise as such obligations may be amended,
supplemented, converted, extended or modified from time to time.

 

    	2

    	 

    

 

(d)          “UCC”
means the Uniform Commercial Code, as currently in effect in the State of Nevada.

 

2.          Grant
of Security Interest. As an inducement for the Secured Party to purchase the Notes and to secure the complete and timely payment,
performance and discharge in full, as the case may be, of all of the Obligations, the Company hereby, unconditionally and irrevocably,
pledges, grants and hypothecates to the Secured Party, a continuing security interest in, a continuing first lien upon, an unqualified
right to possession and disposition of and a right of set-off against, in each case to the fullest extent permitted by law, all
of the Company’s right, title and interest of whatsoever kind and nature in and to the Collateral (the “Security
Interest”).

 

3.          Representations,
Warranties, Covenants and Agreements of the Company. The Company represents and warrants to, and covenants and agrees with,
the Secured Party as follows:

 

(a)          The
Company has the requisite corporate power and authority to enter into this Agreement and otherwise to carry out its obligations
thereunder. The execution, delivery and performance by the Company of this Agreement and the filings contemplated therein have
been duly authorized by all necessary action on the part of the Company and no further action is required by the Company. This
Agreement constitutes a legal, valid and binding obligation of the Company enforceable in accordance with its terms, except as
enforceability may be limited by bankruptcy, insolvency, reorganization, moratorium or similar laws affecting the enforcement of
creditor’s rights generally.

 

(b)          The
Company represents and warrants that it has no place of business or offices where its respective books of account and records are
kept (other than temporarily at the offices of its attorneys or accountants) or places where Collateral is stored or located, except
as set forth on Schedule A attached hereto;

 

(c)          The
Company is the sole owner of the Collateral (except for non-exclusive licenses granted by the Company in the ordinary course of
business), free and clear of any liens, security interests, encumbrances, rights or claims, and is fully authorized to grant the
Security Interest in and to pledge the Collateral. There is not on file in any governmental or regulatory authority, agency or
recording office an effective financing statement, security agreement, license or transfer or any notice of any of the foregoing
(other than those that have been filed in favor of the Secured Party pursuant to this Agreement) covering or affecting any of the
Collateral. So long as this Agreement shall be in effect, the Company shall not execute and shall not knowingly permit to be on
file in any such office or agency any such financing statement or other document or instrument (except to the extent filed or recorded
in favor of the Secured Party pursuant to the terms of this Agreement).

 

(d)          No
part of the Collateral has been judged invalid or unenforceable. No written claim has been received that any Collateral or the
Company’s use of any Collateral violates the rights of any third party. There has been no adverse decision to the Company’s
claim of ownership rights in or exclusive rights to use the Collateral in any jurisdiction or to the Company’s right to keep
and maintain such Collateral in full force and effect, and there is no proceeding involving said rights pending or, to the best
knowledge of the Company, threatened before any court, judicial body, administrative or regulatory agency, arbitrator or other
governmental authority.

 

    	3

    	 

    

 

(e)          The
Company shall at all times maintain its books of account and records relating to the Collateral at its principal place of business
and its Collateral at the locations set forth on Schedule A attached hereto and may not relocate such books of account and
records or tangible Collateral unless it delivers to the Secured Party at least 30 days prior to such relocation (i) written notice
of such relocation and the new location thereof (which must be within the United States) and (ii) evidence that appropriate
financing statements and other necessary documents have been filed and recorded and other steps have been taken to perfect the
Security Interest to create in favor of the Secured Party valid, perfected and continuing first priority liens in the Collateral.

 

(f)          This
Agreement creates in favor of the Secured Party a valid security interest in the Collateral securing the payment and performance
of the Obligations and, upon making the filings described in the immediately following sentence, a perfected first priority security
interest in such Collateral. Except for the filing of financing statements on Form-1 under the UCC with the jurisdictions indicated
on Schedule B, attached hereto, no authorization or approval of or filing with or notice to any governmental authority or
regulatory body is required either (i) for the grant by the Company of, or the effectiveness of, the Security Interest granted
hereby or for the execution, delivery and performance of this Agreement by the Company or (ii) for the perfection of or exercise
by the Secured Party of its rights and remedies hereunder.

 

(g)          On
the date of execution of this Agreement, the Company will deliver to the Secured Party one or more executed UCC financing statements
on Form-1 with respect to the Security Interest for filing with the jurisdictions indicated on Schedule B, attached hereto
and in such other jurisdictions as may be requested by the Secured Party.

 

(h)          The
execution, delivery and performance of this Agreement does not conflict with or cause a breach or default, or an event that with
or without the passage of time or notice, shall constitute a breach or default, under any agreement to which the Company is a party
or by which the Company is bound. No consent (including, without limitation, from stock holders or creditors of the Company) is
required for the Company to enter into and perform its obligations hereunder.

 

(i)          The
Company shall at all times maintain the liens and Security Interest provided for hereunder as valid and perfected first priority
liens and security interests in the Collateral in favor of the Secured Party until this Agreement and the Security Interest hereunder
shall terminate pursuant to Section 11. The Company hereby agrees to defend the same against any and all persons. The Company shall
safeguard and protect all Collateral for the account of the Secured Party. At the request of the Secured Party, the Company will
sign and deliver to the Secured Party at any time or from time to time one or more financing statements pursuant to the UCC (or
any other applicable statute) in form reasonably satisfactory to the Secured Party and will pay the cost of filing the same in
all public offices wherever filing is, or is deemed by the Secured Party to be, necessary or desirable to effect the rights and
obligations provided for herein. Without limiting the generality of the foregoing, the Company shall pay all fees, taxes and other
amounts necessary to maintain the Collateral and the Security Interest hereunder, and the Company shall obtain and furnish to the
Secured Party from time to time, upon demand, such releases and/or subordinations of claims and liens which may be required to
maintain the priority of the Security Interest hereunder.

 

    	4

    	 

    

 

(j)          The
Company will not transfer, pledge, hypothecate, encumber, license (except for non-exclusive licenses granted by the Company in
the ordinary course of business), sell or otherwise dispose of any of the Collateral without the prior written consent of the Secured
Party.

 

(k)          The
Company shall keep and preserve its Equipment, Inventory and other tangible Collateral in good condition, repair and order and
shall not operate or locate any such Collateral (or cause to be operated or located) in any area excluded from insurance coverage.

 

(l)          The
Company shall, within ten (10) days of obtaining knowledge thereof, advise the Secured Party promptly, in sufficient detail, of
any substantial change in the Collateral, and of the occurrence of any event which would have a material adverse effect on the
value of the Collateral or on the Secured Party’s security interest therein.

 

(m)          The
Company shall promptly execute and deliver to the Secured Party such further deeds, mortgages, assignments, security agreements,
financing statements or other instruments, documents, certificates and assurances and take such further action as the Secured Party
may from time to time request and may in its sole discretion deem necessary to perfect, protect or enforce its security interest
in the Collateral including, without limitation, the execution and delivery of a separate security agreement with respect to the
Company’s intellectual property (“Intellectual Property Security Agreement”) in which the Secured Party
has been granted a security interest hereunder, substantially in a form acceptable to the Secured Party, which Intellectual Property
Security Agreement, other than as stated therein, shall be subject to all of the terms and conditions hereof.

 

(n)          The
Company shall permit the Secured Party and its representatives and agents to inspect the Collateral at any time, and to make copies
of records pertaining to the Collateral as may be requested by the Secured Party from time to time.

 

(o)          The
Company will take all steps reasonably necessary to diligently pursue and seek to preserve, enforce and collect any rights, claims,
causes of action and accounts receivable in respect of the Collateral.

 

(p)          The
Company shall promptly notify the Secured Party in sufficient detail upon becoming aware of any attachment, garnishment, execution
or other legal process levied against any Collateral and of any other information received by the Company that may materially affect
the value of the Collateral, the Security Interest or the rights and remedies of the Secured Party hereunder.

 

(q)          All
information heretofore, herein or hereafter supplied to the Secured Party by or on behalf of the Company with respect to the Collateral
is accurate and complete in all material respects as of the date furnished.

 

    	5

    	 

    

 

(r)          Schedule
A attached hereto contains a list of all of the subsidiaries of Company.

 

4.          Defaults.
The following events shall be “Events of Default”:

 

(a)          The
occurrence of an Event of Default (as defined in the Notes) under the Notes;

 

(b)          Any
representation or warranty of the Company in this Agreement or in the Intellectual Property Security Agreement shall prove to have
been incorrect in any material respect when made;

 

(c)          The
failure by the Company to observe or perform any of its obligations hereunder or in the Intellectual Property Security Agreement
for ten (10) days after receipt by the Company of notice of such failure from the Secured Party; and

 

(d)          Any
breach of, or default under, the Warrants.

 

5.          Duty
To Hold In Trust. Upon the occurrence of any Event of Default and at any time thereafter, the Company shall, upon receipt by
it of any revenue, income or other sums subject to the Security Interest, whether payable pursuant to the Notes or otherwise, or
of any check, draft, note, trade acceptance or other instrument evidencing an obligation to pay any such sum, hold the same in
trust for the Secured Party and shall forthwith endorse and transfer any such sums or instruments, or both, to the Secured Party
for application to the satisfaction of the Obligations.

 

6.          Rights
and Remedies Upon Default. Upon occurrence of any Event of Default and at any time thereafter, the Secured Party shall have
the right to exercise all of the remedies conferred hereunder and under the Notes, and the Secured Party shall have all the rights
and remedies of a secured party under the UCC and/or any other applicable law (including the Uniform Commercial Code of any jurisdiction
in which any Collateral is then located). Without limitation, the Secured Party shall have the following rights and powers:

 

(a)          The
Secured Party shall have the right to take possession of the Collateral and, for that purpose, enter, with the aid and assistance
of any person, any premises where the Collateral, or any part thereof, is or may be placed and remove the same, and the Company
shall assemble the Collateral and make it available to the Secured Party at places which the Secured Party shall reasonably select,
whether at the Company’s premises or elsewhere, and make available to the Secured Party, without rent, all of the Company’s
respective premises and facilities for the purpose of the Secured Party taking possession of, removing or putting the Collateral
in saleable or disposable form.

 

    	6

    	 

    

 

(b)          The
Secured Party shall have the right to operate the business of the Company using the Collateral and shall have the right to assign,
sell, lease or otherwise dispose of and deliver all or any part of the Collateral, at public or private sale or otherwise, either
with or without special conditions or stipulations, for cash or on credit or for future delivery, in such parcel or parcels and
at such time or times and at such place or places, and upon such terms and conditions as the Secured Party may deem commercially
reasonable, all without (except as shall be required by applicable statute and cannot be waived) advertisement or demand upon or
notice to the Company or right of redemption of the Company, which are hereby expressly waived. Upon each such sale, lease, assignment
or other transfer of Collateral, the Secured Party may, unless prohibited by applicable law which cannot be waived, purchase all
or any part of the Collateral being sold, free from and discharged of all trusts, claims, right of redemption and equities of the
Company, which are hereby waived and released.

 

7.          Applications
of Proceeds. The proceeds of any such sale, lease or other disposition of the Collateral hereunder shall be applied first,
to the expenses of retaking, holding, storing, processing and preparing for sale, selling, and the like (including, without limitation,
any taxes, fees and other costs incurred in connection therewith) of the Collateral, to the reasonable attorneys’ fees and
expenses incurred by the Secured Party in enforcing its rights hereunder and in connection with collecting, storing and disposing
of the Collateral, and then to satisfaction of the Obligations, and to the payment of any other amounts required by applicable
law, after which the Secured Party shall pay to the Company any surplus proceeds. If, upon the sale, license or other disposition
of the Collateral, the proceeds thereof are insufficient to pay all amounts to which the Secured Party is legally entitled, the
Company will be liable for the deficiency, together with interest thereon, at the rate of 15% per annum (the “Default
Rate”), and the reasonable fees of any attorneys employed by the Secured Party to collect such deficiency. To the extent
permitted by applicable law, the Company waives all claims, damages and demands against the Secured Party arising out of the repossession,
removal, retention or sale of the Collateral, unless due to the gross negligence or willful misconduct of the Secured Party.

 

8.          Costs
and Expenses. The Company agrees to pay all out-of-pocket fees, costs and expenses incurred in connection with any filing required
hereunder, including without limitation, any financing statements, continuation statements, partial releases and/or termination
statements related thereto or any expenses of any searches reasonably required by the Secured Party. The Company shall also pay
all other claims and charges which in the reasonable opinion of the Secured Party might prejudice, imperil or otherwise affect
the Collateral or the Security Interest therein. The Company will also, upon demand, pay to the Secured Party the amount of any
and all reasonable expenses, including the reasonable fees and expenses of its counsel and of any experts and agents, which the
Secured Party may incur in connection with (i) the enforcement of this Agreement, (ii) the custody or preservation of,
or the sale of, collection from, or other realization upon, any of the Collateral, or (iii) the exercise or enforcement of
any of the rights of the Secured Party under the Notes. Until so paid, any fees payable hereunder shall be added to the principal
amount of the Notes and shall bear interest at the Default Rate.

 

9.          Responsibility
for Collateral. The Company assumes all liabilities and responsibility in connection with all Collateral, and the obligations
of the Company hereunder or under the Notes and the Warrants shall in no way be affected or diminished by reason of the loss, destruction,
damage or theft of any of the Collateral or its unavailability for any reason.

 

    	7

    	 

    

 

10.         Security
Interest Absolute. All rights of the Secured Party and all Obligations of the Company hereunder, shall be absolute and unconditional,
irrespective of: (a) any lack of validity or enforceability of this Agreement, the Notes, the Warrants or any agreement entered
into in connection with the foregoing, or any portion hereof or thereof; (b) any change in the time, manner or place of payment
or performance of, or in any other term of, all or any of the Obligations, or any other amendment or waiver of or any consent to
any departure from the Notes, the Warrants or any other agreement entered into in connection with the foregoing; (c)  any
exchange, release or nonperfection of any of the Collateral, or any release or amendment or waiver of or consent to departure from
any other collateral for, or any guaranty, or any other security, for all or any of the Obligations; (d) any action by the
Secured Party to obtain, adjust, settle and cancel in its sole discretion any insurance claims or matters made or arising in connection
with the Collateral; or (e) any other circumstance which might otherwise constitute any legal or equitable defense available
to the Company, or a discharge of all or any part of the Security Interest granted hereby. Until the Obligations shall have been
paid and performed in full, the rights of the Secured Party shall continue even if the Obligations are barred for any reason, including,
without limitation, the running of the statute of limitations or bankruptcy. The Company expressly waives presentment, protest,
notice of protest, demand, notice of nonpayment and demand for performance. In the event that at any time any transfer of any Collateral
or any payment received by the Secured Party hereunder shall be deemed by final order of a court of competent jurisdiction to have
been a voidable preference or fraudulent conveyance under the bankruptcy or insolvency laws of the United States, or shall be deemed
to be otherwise due to any party other than the Secured Party, then, in any such event, the Company’s obligations hereunder
shall survive cancellation of this Agreement, and shall not be discharged or satisfied by any prior payment thereof and/or cancellation
of this Agreement, but shall remain a valid and binding obligation enforceable in accordance with the terms and provisions hereof.
The Company waives all right to require the Secured Party to proceed against any other person or to apply any Collateral which
the Secured Party may hold at any time, or to marshal assets, or to pursue any other remedy. The Company waives any defense arising
by reason of the application of the statute of limitations to any obligation secured hereby.

 

11.         Term
of Agreement. This Agreement and the Security Interest shall terminate on the date on which all payments under the Notes have
been made in full and all other Obligations have been paid or discharged. Upon such termination, the Secured Party, at the request
and at the expense of the Company, will join in executing any termination statement with respect to any financing statement executed
and filed pursuant to this Agreement.

 

12.         Power
of Attorney; Further Assurances.

 

(a)          The
Company authorizes the Secured Party, and does hereby make, constitute and appoint it, and its respective officers, agents, successors
or assigns with full power of substitution, as the Company’s true and lawful attorney-in-fact, with power, in its own name
or in the name of the Company, to, after the occurrence and during the continuance of an Event of Default, (i) endorse any
notes, checks, drafts, money orders, or other instruments of payment (including payments payable under or in respect of any policy
of insurance) in respect of the Collateral that may come into possession of the Secured Party; (ii) to sign and endorse any
UCC financing statement or any invoice, freight or express bill, bill of lading, storage or warehouse receipts, drafts against
debtors, assignments, verifications and notices in connection with accounts, and other documents relating to the Collateral; (iii) to
pay or discharge taxes, liens, security interests or other encumbrances at any time levied or placed on or threatened against the
Collateral; (iv) to demand, collect, receipt for, compromise, settle and sue for monies due in respect of the Collateral;
and (v) generally, to do, at the option of the Secured Party, and at the Company’s expense, at any time, or from time
to time, all acts and things which the Secured Party deems necessary to protect, preserve and realize upon the Collateral and the
Security Interest granted therein in order to effect the intent of this Agreement, the Notes and the Warrants, all as fully and
effectually as the Company might or could do; and the Company hereby ratifies all that said attorney shall lawfully do or cause
to be done by virtue hereof. This power of attorney is coupled with an interest and shall be irrevocable for the term of this Agreement
and thereafter as long as any of the Obligations shall be outstanding.

 

    	8

    	 

    

 

(b)          On
a continuing basis, the Company will make, execute, acknowledge, deliver, file and record, as the case may be, in the proper filing
and recording places in any jurisdiction, including, without limitation, the jurisdictions indicated on Schedule B, attached
hereto, all such instruments, and take all such action as may reasonably be deemed necessary or advisable, or as reasonably requested
by the Secured Party, to perfect the Security Interest granted hereunder and otherwise to carry out the intent and purposes of
this Agreement, or for assuring and confirming to the Secured Party the grant or perfection of a security interest in all the Collateral.

 

(c)          The
Company hereby irrevocably appoints the Secured Party as the Company’s attorney-in-fact, with full authority in the place
and stead of the Company and in the name of the Company, from time to time in the Secured Party’s discretion, to take any
action and to execute any instrument which the Secured Party may deem necessary or advisable to accomplish the purposes of this
Agreement, including the filing, in its sole discretion, of one or more financing or continuation statements and amendments thereto,
relative to any of the Collateral without the signature of the Company where permitted by law.

 

13.         Notices.
All notices, requests, demands and other communications hereunder shall be in writing, with copies to all the other parties hereto,
and shall be deemed to have been duly given when (i) if delivered by hand, upon receipt, (ii) if sent by facsimile, upon
receipt of proof of sending thereof, (iii) if sent by nationally recognized overnight delivery service (receipt requested),
the next business day or (iv) if mailed by first-class registered or certified mail, return receipt requested, postage prepaid,
four days after posting in the U.S. mails, in each case if delivered to the following addresses:

 

	If to the Company, to:	Global Investor Services, Inc.
	 	287 East 950 South 
	 	 
	 	Orem, Utah, 84058
	 	Attention: William Kosoff, Acting CFO

 

	With a copy to:	
        Fleming PLLC

        Attn: Stephen Fleming

	 	
        49 Front Street, Suite 206

        Rockville Centre, NY 11570

	 	Telephone: (516) 833-5034
	 	Facsimile: (516) 977-1029

 

    	9

    	 

    

  

If to the Secured Party, then the address set forth in the Purchase
Agreement.

 

14.         Other
Security. To the extent that the Obligations are now or hereafter secured by property other than the Collateral or by the guarantee,
endorsement or property of any other person, firm, corporation or other entity, then the Secured Party shall have the right, in
its sole discretion, to pursue, relinquish, subordinate, modify or take any other action with respect thereto, without in any way
modifying or affecting any of the Secured Party’s rights and remedies hereunder.

 

15.         Miscellaneous.

 

(a)          No
course of dealing between the Company and the Secured Party, nor any failure to exercise, nor any delay in exercising, on the part
of the Secured Party, any right, power or privilege hereunder or under the Notes shall operate as a waiver thereof; nor shall any
single or partial exercise of any right, power or privilege hereunder or thereunder preclude any other or further exercise thereof
or the exercise of any other right, power or privilege.

 

(b)          All
of the rights and remedies of the Secured Party with respect to the Collateral, whether established hereby or by the Notes or by
any other agreements, instruments or documents or by law shall be cumulative and may be exercised singly or concurrently.

 

(c)          This
Agreement constitutes the entire agreement of the parties with respect to the subject matter hereof and is intended to supersede
all prior negotiations, understandings and agreements with respect thereto. Except as specifically set forth in this Agreement,
no provision of this Agreement may be modified or amended except by a written agreement specifically referring to this Agreement
and signed by the parties hereto.

 

(d)          In
the event that any provision of this Agreement is held to be invalid, prohibited or unenforceable in any jurisdiction for any reason,
unless such provision is narrowed by judicial construction, this Agreement shall, as to such jurisdiction, be construed as if such
invalid, prohibited or unenforceable provision had been more narrowly drawn so as not to be invalid, prohibited or unenforceable.
If, notwithstanding the foregoing, any provision of this Agreement is held to be invalid, prohibited or unenforceable in any jurisdiction,
such provision, as to such jurisdiction, shall be ineffective to the extent of such invalidity, prohibition or unenforceability
without invalidating the remaining portion of such provision or the other provisions of this Agreement and without affecting the
validity or enforceability of such provision or the other provisions of this Agreement in any other jurisdiction.

 

(e)          No
waiver of any breach or default or any right under this Agreement shall be considered valid unless in writing and signed by the
party giving such waiver, and no such waiver shall be deemed a waiver of any subsequent breach or default or right, whether of
the same or similar nature or otherwise.

 

(f)          This
Agreement shall be binding upon and inure to the benefit of each party hereto and its successors and assigns.

 

    	10

    	 

    

 

(g)          Each
party shall take such further action and execute and deliver such further documents as may be necessary or appropriate in order
to carry out the provisions and purposes of this Agreement.

 

(h)          This
Agreement shall be construed in accordance with the laws of the State of Nevada, except to the extent the validity, perfection
or enforcement of a security interest hereunder in respect of any particular Collateral which are governed by a jurisdiction other
than the State of Nevada in which case such law shall govern. Each of the parties hereto irrevocably submit to the exclusive jurisdiction
of any New York State or United States Federal court sitting in Sarasota county over any action or proceeding arising out of or
relating to this Agreement, and the parties hereto hereby irrevocably agree that all claims in respect of such action or proceeding
may be heard and determined in such New York State or Federal court. The parties hereto agree that a final judgment in any such
action or proceeding shall be conclusive and may be enforced in other jurisdictions by suit on the judgment or in any other manner
provided by law. The parties hereto further waive any objection to venue in the State of New York and any objection to an action
or proceeding in the State of New York on the basis of forum non conveniens.

 

(i)          EACH
PARTY HERETO HEREBY AGREES TO WAIVE ITS RESPECTIVE RIGHTS TO A JURY TRIAL OF ANY CLAIM OR CAUSE OF ACTION BASED UPON OR ARISING
OUT OF THIS AGREEMENT. THE SCOPE OF THIS WAIVER IS INTENDED TO BE ALL ENCOMPASSING OF ANY DISPUTES THAT MAY BE FILED IN ANY COURT
AND THAT RELATE TO THE SUBJECT MATER OF THIS AGREEMENT, INCLUDING WITHOUT LIMITATION CONTRACT CLAIMS, TORT CLAIMS, BREACH OF DUTY
CLAIMS AND ALL OTHER COMMON LAW AND STATUTORY CLAIMS. EACH PARTY HERETO ACKNOWLEDGES THAT THIS WAIVER IS A MATERIAL INDUCEMENT
FOR EACH PARTY TO ENTER INTO A BUSINESS RELATIONSHIP, THAT EACH PARTY HAS ALREADY RELIED ON THIS WAIVER IN ENTERING INTO THIS AGREEMENT
AND THAT EACH PARTY WILL CONTINUE TO RELY ON THIS WAIVER IN THEIR RELATED FUTURE DEALINGS. EACH PARTY FURTHER WARRANTS AND REPRESENTS
THAT IT HAS REVIEWED THIS WAIVER WITH ITS LEGAL COUNSEL, AND THAT SUCH PARTY HAS KNOWINGLY AND VOLUNTARILY WAIVES ITS RIGHTS TO
A JURY TRIAL FOLLOWING SUCH CONSULTATION. THIS WAIVER IS IRREVOCABLE, MEANING THAT, NOTWITHSTANDING ANYTHING HEREIN TO THE CONTRARY,
IT MAY NOT BE MODIFIED EITHER ORALLY OR IN WRITING, AND THIS WAIVER SHALL APPLY TO ANY SUBSEQUENT AMENDMENTS, RENEWALS AND SUPPLEMENTS
OR MODIFICATIONS TO THIS AGREEMENT. IN THE EVENT OF A LITIGATION, THIS AGREEMENT MAY BE FILED AS A WRITTEN CONSENT TO A TRIAL BY
THE COURT.

 

(j)          This
Agreement may be executed in any number of counterparts, each of which when so executed shall be deemed to be an original and,
all of which taken together shall constitute one and the same Agreement. In the event that any signature is delivered by facsimile
transmission, such signature shall create a valid binding obligation of the party executing (or on whose behalf such signature
is executed) the same with the same force and effect as if such facsimile signature were the original thereof.

 

[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]

 

    	11

    	 

    

 

IN WITNESS WHEREOF,
the parties hereto have caused this to be duly executed on the day and year first above written.

 

	 	COMPANY
	 	 
	 	GLOBAL INVESTOR SERVICES, INC.
	 	 	 
	 	By:	/s/William Kosoff
	 	 	 
	 	Name: 	William Kosoff
	 	Title:	Acting Chief Financial Officer
	 	 	 
	 	Razor Data, LLC
	 	 	 
	 	By:	/s/William Kosoff
	 	Name: 	William Kosoff
	 	Title:	Acting Chief Financial Officer
	 	 	 
	 	Investment Tools and Training, LLC
	 	 	 
	 	By:	/s/William Kosoff
	 	Name: 	William Kosoff
	 	Title:	Acting Chief Financial Officer

 

	 	Secured PartY:	 
	 	 	 
	 	/s/Francis Herrbold	 

 

    	 

    	 

    

 

Schedule A

 

Subsidiaries:

 

Razor Data, LLC, a Utah limited liability
company

 

Investment Tools and Training, LLC, a Utah
limited liability company

 

Location of Collateral

 

Utah

 

    	2

    	 

    

  

Schedule B

 

UCC -1 Financing

 

Nevada

 

Utah

 

    	3Execution Copy

 

 

 

 

SHARE
pURCHASE AGREEMENT

 

 

BY
AND AMONG

 

 

SAPIENS
INTERNATIONAL CORPORATION N.V., 

 

 

sapieNs
Technologies (1982) Ltd.,

 

 

IDIT
I.D.I. TECHNOLOGIES Ltd., 

 

 

THE
shareholders of IDIT I.D.I. TECHNOLOGIES LTD.,

 

 

MR.
Amit Ben Yehuda, as THE IDIT I.D.I. TECHNOLOGIES Ltd. SHAREHOLDERS REPRESENTATIVE, 

 

 

FIS
SOFTWARE LTD.,

 

 

THE
shareholders of FIS SOFTWARE LTD.

 

 

and

 

 

MR.
Dani goldSTEIN as THE FIS SOFTWARE LTD. SHAREHOLDERS REPRESENTATIVE

 

 

July 21, 2011

 

 

    	 

    	 

    

 

Execution Copy 

 

	Table of Contents	 
	 	 	 
	Article I Definitions	 	10
	Section 1.01	Certain Definitions.	10
	Section 1.02	Additional Definitions	18
	Section 1.03	Definitional and Interpretative Provisions.	21
	Article II Purchase of Companies shares	21
	Section 2.01	Purchase and Sale of Companies Shares.	21
	Section 2.02	Consideration.	22
	Section 2.03	Payment Schedule	23
	Section 2.04	Companies Options.	24
	Section 2.05	Escrow Fund.	28
	Section 2.06	Other Shareholders.	28
	Section 2.07	Section 341 Action.	28
	Section 2.08	Withholding Tax.	30
	Section 2.09	Legend Requirement.	30
	Section 2.10	IDIT Closing.	31
	Section 2.11	FIS Closing.	32
	Section 2.12	Closing of One Transaction.	33
	Article III Representations and Warranties of the COMPANY	33
	Section 3.01	Corporate Existence and Power.	34
	Section 3.02	Corporate Authorization.	34
	Section 3.03	Compliance with Applicable Law.	35
	Section 3.04	Governmental Authorizations; Governmental Grants.	35
	Section 3.05	Non-Contravention.	36
	Section 3.06	Capitalization.	37
	Section 3.07	Products.	38
	Section 3.08	Financial Statements.	38
	Section 3.09	Notes and Accounts Receivable.	39
	Section 3.10	Deleted	39
	Section 3.11	Absence of Certain Changes.	39
	Section 3.12	No Undisclosed Liabilities.	41

 

    	 

    	 

    
Execution Copy

 

 

	Section 3.13	Material Contracts.	42
	Section 3.14	Restrictions on Business Activities.	44
	Section 3.15	Litigation.	44
	Section 3.16	Properties.	45
	Section 3.17	Customers and Suppliers.	45
	Section 3.18	Intellectual Property.	46
	Section 3.19	Insurance Coverage.	49
	Section 3.20	Tax Matters.	50
	Section 3.21	Employees; Contractors and Benefit Plans	51
	Section 3.22	Affiliate Transactions.	53
	Section 3.23	Finder's Fees.	53
	Section 3.24	Bank Accounts.	53
	Article IV Representations and Warranties of the Selling Shareholders	53
	Section 4.01	Title to Company Shares.	54
	Section 4.02	Authority; Binding Effect.	54
	Section 4.03	Non-Contravention; Consents.	55
	Section 4.04	Capacity of Selling Shareholder.	55
	Section 4.05	Tax Withholding Information.	56
	Section 4.06	Finder’s Fees.	56
	Section 4.07	Company Group Assets.	56
	Section 4.08	Securities Laws.	56
	Section 4.09	Selling Shareholders Status.	58
	Article V Representations and Warranties of Purchaser and parent	58
	Section 5.01	Corporate Existence and Power.	58
	Section 5.02	Corporate Authorization.	59
	Section 5.03	Compliance with Applicable Law.	59
	Section 5.04	Governmental Authorizations; Governmental Grants.	60
	Section 5.05	Non Contravention.	60
	Section 5.06	Capitalization of Parent Group.	61
	Section 5.07	Products.	61
	Section 5.08	Valid Issuance of Consideration Shares and Warrants Shares.	62
	Section 5.09	Financial Statements.	62
	Section 5.10	Notes and Accounts Receivable.	63

 

    	3

    	 

    
Execution Copy

 

 

	Section 5.11	Absence of Certain Changes.	63
	Section 5.12	No Undisclosed Liabilities.	65
	Section 5.13	Material Contracts.	65
	Section 5.14	Restrictions on Business Activities.	68
	Section 5.15	Litigation.	68
	Section 5.16	Properties.	68
	Section 5.17	Customers and Suppliers.	69
	Section 5.18	Parent Intellectual Property	69
	Section 5.19	Insurance Coverage.	72
	Section 5.20	Tax Matters.	72
	Section 5.21	Employees; Contractors and Benefit Plans	73
	Section 5.22	Affiliate Transactions.	75
	Section 5.23	Finder’s Fees.	75
	Section 5.24	Investment Company.	75
	Section 5.25	Private Placement; Securities Law.	75
	Article VI PRE CLOSING Covenants	76
	Section 6.01	Conduct of Business.	76
	Section 6.02	No Solicitation; Other Offers.	78
	Section 6.03	Access to Information.	79
	Section 6.04	Notices of Certain Events.	79
	Section 6.05	Restriction on Transfer.	80
	Section 6.06	Filings.	80
	Section 6.07	Adoption of New Parent Option Plan.	81
	Section 6.08	Israeli Tax Ruling.	81
	Section 6.09	FIS Shareholders Meeting.	82
	Section 6.10	Transactions in Parent's Shares.	83
	Article VII Additional agreements	83
	Section 7.01	Public Announcements.	83
	Section 7.02	Commercially Reasonable Efforts.	83
	Section 7.03	Litigation Support	84
	Section 7.04	Tax Matters.	84
	Section 7.05	Confidentiality.	84
	Section 7.06	Appointment of Board Member.	84

 

    	4

    	 

    
Execution Copy

 

 

	Section 7.07	Waiver of Claims.	84
	Section 7.08	Further Actions	85
	Section 7.09	D&O Insurance	85
	Section 7.10	Registration Statement on Form S-8	85
	Section 7.11	Form D	86
	Article VIII Conditions to the transactions	86
	Section 8.01	Conditions to the Obligations of the Parties to the FIS Transaction.	86
	Section 8.02	Conditions to the Obligations of the Parties to the IDIT Transaction	86
	Section 8.03	Conditions to the Obligations of Purchaser and Parent to Consummate the FIS Transaction	87
	Section 8.04	Conditions to the Obligations of Purchaser and Parent to Consummate the IDIT Transaction	89
	Section 8.05	Conditions to the Obligations of the FIS Selling Shareholders.	92
	Section 8.06	Conditions to the Obligations of the IDIT Selling Shareholders.	93
	Article IX Termination	95
	Section 9.01	Termination of FIS Transactions.	95
	Section 9.02	Effect of Termination of FIS Transaction.	96
	Section 9.03	Termination of IDIT Transactions.	96
	Section 9.04	Effect of Termination of IDIT Transaction.	97
	Article X Indemnification	97
	Section 10.01	Survival of Representations.	97
	Section 10.02	Indemnification by Selling Shareholders.	98
	Section 10.03	Indemnification by Purchaser.	100
	Section 10.04	Claims and Procedures.	102
	Section 10.05	Defense of Third-Party Claims.	105
	Section 10.06	No Contribution.	106
	Section 10.07	Tax Impact.	106
	Section 10.08	Additional Provisions.	106
	Article XI Shareholders Representative	106
	Section 11.01	Appointment of Shareholders Representatives; Power and Authority.	106
	Section 11.02	Reimbursement.	107
	Section 11.03	Release from Liability; Indemnification.	107
	Article XII Miscellaneous	108
	Section 12.01	Entire Agreement.	108

 

    	5

    	 

    
Execution Copy

 

 

	Section 12.02	Amendments and Waivers.	108
	Section 12.03	Binding Effect; Benefit; Assignment.	109
	Section 12.04	Construction.	109
	Section 12.05	Headings.	109
	Section 12.06	Governing Law.	109
	Section 12.07	Jurisdiction.	109
	Section 12.08	Notices.	110
	Section 12.09	Severability.	112
	Section 12.10	Specific Performance.	113
	Section 12.11	Expenses.	113
	Section 12.12	Disclosure Schedule References.	113
	Section 12.13	Counterparts; Effectiveness.	113

 

    	6

    	 

    
Execution Copy

 

 

	Exhibits	 
	Exhibit A	Form of FIS Escrow Agreement
	Exhibit B	Form of IDIT Escrow Agreement
	Exhibit C	IDIT Purchase Price Allocation
	Exhibit D	FIS Purchase Price Allocation
	Exhibit E1	Form of IDIT Spousal Consent
	Exhibit E2	Form of FIS Spousal Consent
	Exhibit F1	Form of FIS TEA Agreement
	Exhibit F2	Form of IDIT TEA Agreement
	Exhibit G	Form of Consideration Warrant
	Exhibit H	Irrevocable Instructions to Transfer Agent Re Transfer of IDIT Purchase Price to Escrow Agent
	Exhibit I	Irrevocable Instructions to Transfer Agent Re Transfer of IDIT Purchase Price to IDIT Selling Shareholders
	Exhibit J	Irrevocable Instructions to Transfer Agent Re Transfer of FIS Purchase Price to Escrow Agent
	Exhibit K	Irrevocable Instructions to Transfer Agent Re Transfer of FIS Purchase Price to FIS Selling Shareholders
	Exhibit L	List of Non-Executing Shareholders
	Exhibit M1	Form of New Option Plan
	Exhibit M2	Form of Option Agreement
	Exhibit N	Form of FIS Closing Certificate
	Exhibit O	Form of FIS Selling Shareholder Closing Certificate
	Exhibit P	Form of Resignation Letters of FIS' Directors
	Exhibit Q	Form of Formula and Kardan Side Letter
	Exhibit R	Form of Registration Rights Agreement
	Exhibit S	Form of Affidavit of Lost FIS Certificates
	Exhibit T	Form of FIS Share Transfer Deed
	Exhibit U	Form of IDIT Closing Certificate
	Exhibit V	Form of IDIT Selling Shareholder Closing Certificate
	Exhibit W	Form of Resignation Letters of IDIT's Directors
	Exhibit X	Form of Affidavit of Lost IDIT Certificates
	Exhibit Y	Form of IDIT Share Transfer Deed
	Exhibit Z1	Form of Purchaser FIS Closing Certificate
	Exhibit Z2	Form of Purchaser IDIT Closing Certificate
	Exhibit Z3	Form of Parent FIS Closing Certificate
	Exhibit Z4	Form of Parent IDIT Closing Certificate
	Exhibit 6.09	Form of EGM Notice
	 	 
	 	 
	Schedules	 
	Schedule A	FIS Options
	Schedule B	IDIT Options
	Schedule C	Antitrust Approvals
	Schedule D	Transaction Expenses

  

FIS Disclosure
Schedule

 

    	7

    	 

    
Execution Copy

 

 

IDIT Disclosure
Schedule

FIS Selling
Shareholders Disclosure Schedule

IDIT Selling
Shareholders Disclosure Schedule

Purchaser
Disclosure Schedule

 

    	8

    	 

    
Execution Copy

 

 

SHARE PURCHASE AGREEMENT

 

THIS SHARE PURCHASE
AGREEMENT (this "Agreement"), dated as of July 21, 2011, is entered into by and among (i) IDIT I.D.I. Technologies
Ltd. ("IDIT"), (ii) FIS Software Ltd. ("FIS", and together with IDIT, the
"Companies" and each, a "Company"), (iii) Sapiens International Corporation N.V. (the
"Parent"), (iv) Sapiens Technologies (1982) Ltd. (the "Purchaser"), (v) the shareholders
of IDIT whose names appear on the signature page of this Agreement or that otherwise become parties to this Agreement under Section
2.06 and Section 2.07 hereof (each an "IDIT Selling Shareholder" and together,
the "IDIT Selling Shareholders"), (vi) Mr. Amit Ben Yehuda in
his capacity as representative of the IDIT Selling Shareholders ("IDIT Shareholders Representative"), (vii) the
shareholders of FIS whose names appear on the signature page of this Agreement or that otherwise become parties to this Agreement
under Section 2.06and Section 2.07 hereof (each an "FIS Selling Shareholder"
and together, the "FIS Selling Shareholders" and together with IDIT Selling Shareholders, the "Selling
Shareholders") and (viii) Mr. Dani Goldstein in his capacity as representative of the FIS Selling Shareholders
("FIS Shareholders Representative" and together with IDIT Shareholders Representative, the "Shareholders
Representatives").

 

RECITALS

 

WHEREAS,
the Companies engage in the business of developing and marketing software products for insurance companies and services and maintenance
therefor; and

 

WHEREAS,
the IDIT Selling Shareholders executing this Agreement on the date hereof own of record and beneficially more than 95% of the issued
and outstanding share capital of IDIT as of the date hereof; and

 

WHEREAS,
the FIS Selling Shareholders executing this Agreement on the date hereof own of record and beneficially more than 95% of the issued
and outstanding share capital of FIS as of the date hereof; and

 

WHEREAS,
the parties intend that, subject to the terms and conditions herein, the Purchaser shall acquire from the FIS Selling Shareholders
(including the Non Executing Shareholders of FIS), and the FIS Selling Shareholders (including the Non Executing Shareholders of
FIS) shall sell to the Purchaser all of the FIS Shares, on the terms and conditions set forth herein; and

 

WHEREAS,
the parties intend that, subject to the terms and conditions herein, the Purchaser shall acquire from the IDIT Selling Shareholders
(including the Non Executing Shareholders of IDIT), and the IDIT Selling Shareholders (including the Non Executing Shareholders
of IDIT) shall sell to the Purchaser all of the IDIT Shares, on the terms and conditions set forth herein.

 

NOW, THEREFORE, in
consideration of the mutual representations, warranties, promises, covenants and agreements contained herein and for other good
and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto, intending to be legally
bound, hereby agree as follows:

 

    	9

    	 

    
  Execution Copy

 

 

Article
I

Definitions

 

Section
1.01Certain Definitions.

 

As used in this Agreement, the following
terms have the following meanings:

 

"Acquisition
Proposal" means, any offer, proposal or inquiry relating to, or any Person’s indication of interest in, an Acquisition
Transaction.

 

"Acquisition
Transaction" means, with respect to each of the Companies or the Parent, any transaction or series of transactions, which
is not in the ordinary course of business, involving the sale, license or disposition of all or a material portion of their or
their Subsidiaries' business or assets and the issuance, disposition or acquisition of: (i) any of their or their Subsidiaries'
share capital or other equity security (other than issuance of shares upon exercise of Options outstanding on the date hereof);
(ii) any Option, call, warrant or right (whether or not immediately exercisable) to acquire any of their share capital, unit or
other equity security; or (iii) any security, instrument or obligation that is or may become convertible into or exchangeable for
any of their share capital.

 

"Affiliate"
means, with respect to any Person, any other Person directly or indirectly controlling, controlled by, or under common control
with such Person. For purposes of this definition, "control," when used with respect to any specified Person, means the
power to direct or cause the direction of the management and policies of such Person, directly or indirectly, whether through ownership
of voting securities or by contract or otherwise, and the terms "controlling" and "controlled by" have correlative
meanings to the foregoing.

 

"Applicable
Law" means, with respect to any Person, any federal, state, local, municipal, or other law (including common law), statutes,
regulations, directives, constitution, treaty, convention, ordinance, code, rule, order, injunction, judgment, decree, request
or other similar requirement enacted, adopted, promulgated or applied by a Governmental Authority that is binding upon or applicable
to such Person.

 

"Assets and
Properties" of any Person shall mean all assets and properties of any kind (whether real, personal or mixed, whether tangible
or intangible, and wherever situated), including the goodwill related thereto, operated, owned or leased by such Person.

 

"Business Day"
means a day, other than Friday, Saturday or other day on which commercial banks in Tel Aviv, Israel are authorized or required
by Applicable Law to close.

 

"Companies
Law" means the Israeli Companies Law-1999.

 

"Companies
Option Plans" means IDIT Option Plans and FIS Option Plans.

 

"Companies
Options" means the IDIT Options and the FIS Options.

 

"Company Products"
means, with respect to each Company or any of its Subsidiaries, all products or services produced, marketed, licensed, sold, distributed
or performed by or on behalf of such Company or any of its Subsidiaries and all products or services currently under development
by such Company or any of its Subsidiaries.

 

    	10

    	 

    
Execution Copy

 

 

"Companies
Shares" means the IDIT Shares and the FIS Shares.

 

"Company Debt"
means with respect to each of the Companies and each of its respective Subsidiaries, at any specified time, any Indebtedness of
any of such Company or any of its Subsidiaries (including, without limitation, any and all principal, accrued and unpaid interest,
expenses or fees).

 

"Company Disclosure
Schedule" means, with respect to each Company, the disclosure schedule dated as of the date of this Agreement relating
to the representations and warranties of such Company made in this Agreement.

 

"Company Group"
means collectively and individually, the respective Company and its Subsidiaries.

 

"Consent"
means any approval, consent, license, authorization, franchise, ratification or permission.

 

"Contract"
means any oral or written contract, agreement, understanding, arrangement, undertaking, indenture, note, or bond.

 

"Consideration
Shares" mean the IDIT Consideration Shares and FIS Consideration Shares.

 

"Escrow Agent"
means ESOP Management & Trust Company Ltd., as Escrow Agent under the FIS Escrow Agreement and the IDIT Escrow Agreement.

 

"Escrow Agreement"
means the FIS Escrow Agreement or the IDIT Escrow Agreement, as applicable.

 

"Escrowed Funds"
means the FIS Escrowed Funds or the IDIT Escrowed Funds, as applicable.

 

"FIS 102 Trustee"
means Schwartz, Lerner, Duvshani, Trustees (2003) Ltd.

 

"FIS Aggregate
Transaction Value" means (i) the Cash Consideration, plus (ii) the number of FIS Consideration Shares multiplied by the
Parent Share Value.

 

"FIS Escrow
Agreement" means an Escrow Agreement in the form of Exhibit A hereto to be entered into on the FIS Closing Date by the
Purchaser, the Parent, the FIS Shareholders Representative (on behalf of the FIS Selling Shareholders) and the Escrow Agent.

 

"FIS Escrow
Deposit" an amount of common shares of the Parent equal to 10% of the FIS Consideration Shares plus an amount of common
shares of the Parent equal to 10% of the Cash Consideration divided by US$4.00, to be held in escrow by the Escrow Agent pursuant
to the FIS Escrow Agreement, which deposited shares may at any time following the FIS Closing be replaced pursuant to the terms
of the FIS Escrow Agreement by the FIS Selling Shareholder on whose benefit such shares were deposited in escrow with such amount
in cash equal to the number of such common shares of the Parent so replaced multiplied by the Parent Share Value.

 

"FIS Escrowed
Funds" shall mean the Parent shares and (if applicable) cash held from time to time in escrow by the Escrow Agent in the
FIS Escrow Deposit pursuant to the terms of the FIS Escrow Agreement.

 

    	11

    	 

    
Execution Copy

 

 

"FIS Extra
Consideration Shares" means such number of additional common shares of Parent equal to the product of the number of new
FIS Shares issued by FIS between the date of this Agreement and the FIS Closing, due to exercise of FIS Options, multiplied by
the FIS Conversion Ratio.

 

"FIS Option
Plans" means FIS Management and Employees Option Plan dated March 31, 2001 and FIS 2003 Share Option Plan.

 

"FIS Options"
means any outstanding Options to purchase FIS Ordinary Shares that have been granted (both vested and unvested) under or subject
to the terms of the FIS Option Plans, details of which are set forth in Schedule A attached hereto.

 

"FIS Ordinary
Shares" mean the ordinary shares, par value NIS 1.00 each, of FIS.

 

"FIS Preferred
Shares" means Series A Preferred Shares and Series A-1 Preferred Shares of FIS, par value NIS 1.00 each, issued and outstanding
as of the date hereof and/or as of the date of the FIS Closing.

 

"FIS Shares"
mean FIS Ordinary Shares issued and outstanding as of the date hereof and/or as of the date of the FIS Closing and the FIS Preferred
Shares.

 

"FIS TEA Agreement"
means the escrow agreement in the form of Exhibit F1.

 

"FIS Transaction"
means the purchase of the FIS Shares by Purchaser and all other transactions contemplated by this Agreement and the other Transaction
Documents in connection with such purchase.

 

"FIS Unvested
Option" means each FIS Option that is outstanding and unvested on the FIS Closing Date.

 

"FIS Vested
Option" means each FIS Option that is outstanding and vested on the FIS Closing Date.

 

"Governmental
Authority" means any: (a) province, region, state, county, city, town, village, district or other jurisdiction; (b) federal,
provincial, regional, state, local, municipal, foreign or other government; (c) governmental or quasi governmental authority
of any nature (including any governmental agency, branch, bureau, department or other entity and any court or other tribunal);
(d) multinational organization; (e) body exercising, or entitled to exercise any administrative, executive, judicial,
legislative, police, regulatory or taxing authority or power of any nature; (f) Taxing Authority; or (g) official of any of
the foregoing.

 

"Governmental
Authorization" means any: permit, license, certificate, franchise, permission, clearance, registration, qualification
or authorization issued, granted, given or otherwise made available by or under the authority of any Governmental Authority or
pursuant to any Applicable Law.

 

"Governmental
Grant" means any grant, incentive, subsidy, award, participation, exemption, status, cost sharing arrangement, reimbursement
arrangement or other benefit, relief or privilege provided or made available by or on behalf of or under the authority of the OCS,
the Investment Center, the BIRD Foundation or any other bi/multi-national grant programs for research and development, the European
Union, the Fund for Encouragement of Marketing Activities of the Israeli Government or any other Governmental Authority.

 

    	12

    	 

    
Execution Copy

 

 

"IDIT 102 Trustee"
means Fahn Kanne Trust Ltd.

 

"IDIT Aggregate
Transaction Value" means the number of IDIT Consideration Shares multiplied by the Parent Share Value.

 

"IDIT Escrow
Agreement" means an Escrow Agreement in the form of Exhibit B hereto to be entered into on the IDIT Closing Date by the
Purchaser, the Parent, the IDIT Shareholders Representative (on behalf of the IDIT Selling Shareholders) and the Escrow Agent.

 

"IDIT Escrow
Deposit" means an amount of common shares of the Parent equal to 10% of the aggregate IDIT Consideration Shares, to be
held in escrow by the Escrow Agent pursuant to the IDIT Escrow Agreement, which deposited shares may at any time following the
IDIT Closing be replaced pursuant to the terms of the IDIT Escrow Agreement by the IDIT Selling Shareholder on whose benefit such
shares were deposited in escrow with such amount in cash equal to the number of such common shares of the Parent so replaced multiplied
by the Parent Share Value.

 

"IDIT Escrowed
Funds" mean the Parent shares and (if applicable) cash held from time to time in escrow by the Escrow Agent in the IDIT
Escrow Deposit pursuant to the terms of the IDIT Escrow Agreement.

 

"IDIT Extra
Consideration Shares" means such number of additional common shares of Parent equal to the product of the number of new
IDIT Shares issued by IDIT between the date of this Agreement and the Closing, due to exercise of IDIT Options, multiplied by the
IDIT Conversion Ratio.

 

"IDIT Option
Plans" mean 2001 Plan of Allocation of Options for IDIT's Employees and 2004 Israeli Option Plan for Allocation of Options.

 

"IDIT Options"
mean any outstanding Options to purchase IDIT Ordinary Shares that have been granted (both vested and unvested) under or subject
to the terms of the IDIT Option Plans, details of which are set forth in Schedule B attached hereto.

 

"IDIT Ordinary
Shares" mean the ordinary shares, par value NIS 1.00 each, of IDIT.

 

"IDIT Shares"
mean IDIT Ordinary Shares, Series A-1 Preferred Shares and Series A-2 Preferred Shares par value NIS 1.00 each of IDIT issued and
outstanding as of the date hereof and/or as of the date of IDIT Closing.

 

"IDIT TEA Agreement"
means the escrow agreement in the form of Exhibit F2.

 

"IDIT Transaction"
means the purchase of the IDIT Shares by Purchaser and all other transactions contemplated by this Agreement and the other Transaction
Documents in connection with such purchase.

 

"IDIT Unvested
Options" means each IDIT Option that is outstanding and unvested immediately prior to the IDIT Closing Date.

 

"IDIT Vested
Options" means each IDIT Option that is outstanding and vested on the IDIT Closing Date.

 

    	13

    	 

    
Execution Copy

 

 

"IFRS"
International Financial Reporting Standard, consistently applied throughout the respective periods covered.

 

"Indebtedness"
shall mean, with respect to any Person, (i) indebtedness for borrowed money or in respect of overdrafts, loans or advances
or indebtedness issued or incurred in substitution or exchange for indebtedness for borrowed money, overdrafts, loans or advances,
(ii) any obligations as lessee under any lease or similar arrangement required to be recorded as a capital lease in accordance
with IFRS or US GAAP (with respect to Parent), (iii) all liabilities under or in connection with bankers’ acceptances, performance
bonds, sureties or similar obligations that have been drawn down, in each case, to the extent of such draw, (iv) all liabilities
under conditional sale or other title retention agreements, (v) amounts owing as deferred purchase price for property goods or
services, (vi) indebtedness evidenced by any note, bond, debenture, mortgage, debt factoring, invoice or trade bills, discounting,
letters or credits, guarantees, undertakings and indemnities in respect of third party borrowings and the mark to market value
of any derivate instruments, any contingent liabilities under acceptance credits or other debt instrument or debt security, (vii)
commitments or obligations by which such Person assures a creditor against Loss (including contingent reimbursement obligations
with respect to letters of credit), (viii) indebtedness secured by a Lien on any Assets and Properties of such Person, (ix) obligations
or commitments to repay deposits or other amounts advanced by and owing to third parties, (x) all obligations under any interest
rate, currency swap arrangement or other hedging agreement or other arrangements designed to provide protection against fluctuation
in interest or currency rates, (xi) any deficit on the reserve for the severance fund for employees or (viii) guarantees or other
contingent liabilities with respect to any indebtedness, obligation, claim or liability of any other Person of a type described
in clauses (i) through (vii) above.

 

"ITA"
means the Israel Tax Authority.

 

"Investment
Center" means the Investment Center of the Israeli Ministry of Industry, Trade and Labor established under the Israel
Law for the Encouragement of Capital Investments-1959.

 

"Israeli Securities
Law" means the Israeli Securities Law, 1968.

 

“Knowledge”
or "best of Knowledge" shall be defined as follows: Each Person shall be deemed to have “Knowledge”
of a particular fact or matter if such Person (and, if such Person is a corporation, partnership or other corporate entity, then
the reference shall be to the chief executive officer, chief financial officer and internal general counsel, and (with respect
to the Companies and Parent) in relation to the technical and intellectual property issues, also its chief technology officer,
or any other persons carrying responsibilities similar to those of the forgoing office holders) is actually aware of such fact.

 

"Liability"
means any liability, debt, obligation, deficiency, interest, Tax, penalty, fine, judgment or any other loss, including reasonable
costs and expenses incurred in connection with such liabilities.

 

"Lien"
means, with respect to any security, property or asset, as the case may be, any mortgage, lien, pledge, charge, security interest,
encumbrance, hypothecation, Options, proxies, right of first refusal, preemptive right or restriction or rights of third parties
of any nature (including any spousal community property rights, any restriction on the voting, transfer, receipt of any income
derived from, the possession of any security, or the exercise or transfer of any other attribute of ownership of a security) or
other adverse claim of any kind in respect of such property or asset. For purposes of this Agreement, a Person shall be deemed
to own subject to a Lien any property or asset that it has acquired or holds subject to the interest of a vendor or lessor under
any conditional sale agreement, capital lease or other title retention agreement relating to such property or asset.

 

    	14

    	 

    
Execution Copy

 

 

"Losses"
mean any and all losses, liabilities, actions, causes of action, costs, damages (excluding consequential damages, special damages
and incidental damages) or expenses, whether or not arising from or in connection with any third-party claims (including, without
limitation, interest, penalties, reasonable attorneys’, consultants’ and experts’ fees and expenses and all amounts
paid in investigation, defense or settlement of any of the foregoing) or any other claim, default or assessment (including any
claim asserting or disputing any right under this Agreement or any Transaction Document against any party hereto or otherwise),
plus any interest that may accrue on any of the foregoing from the date of incurrence.

 

"Material Adverse
Effect" when used in connection with a Person means any event, change, development, occurrence, circumstance or effect
(other than changes in general economic conditions to the extent such changes do not have a disproportionate effect on such Person
and its subsidiaries, taken as a whole ("Disproportionally Exception")) that, when taken individually or together with
any or all other events, changes, developments, occurrences, circumstances or effects, is or is reasonably likely to be materially
adverse, to the business, Assets and Properties, liabilities, affairs, results of operations, or condition (financial or otherwise)
of such Person and its Subsidiaries, taken as a whole, but shall not include adverse effect resulting primarily from, arising in
connection with or relating to (i) events, changes, developments, occurrences, circumstances or effects generally affecting the
industry, markets or general political or economic environment in which such Person operates (subject to the Disproportionally
Exception), or (ii) the announcement of the Transactions; or (iii) any change in Applicable Laws or accounting principles (subject
to the Disproportionally Exception), or (iv) compliance with the terms of, or taking any action required by, this Agreement.

 

"Nasdaq"
means Nasdaq Capital Market.

 

"OCS"
means the Office of the Chief Scientist of the Israeli Ministry of Industry, Trade and Labor.

 

"Option"
means, with respect to any Person, any security, right, subscription, warrant, option, "phantom" stock right or other
Contract that gives the right to (i) purchase or otherwise receive or be issued any shares of such Person or any security of any
kind convertible into or exchangeable or exercisable for any shares of such Person or (ii) receive or exercise any benefits or
rights similar to any rights enjoyed by or accruing to the holder of shares of such Person, including any rights to participate
in the equity or income of such Person or to participate in or direct the election of any directors or officers of such Person
or the manner in which any shares of such Person are voted.

 

"Parent Debt"
means with respect to the Parent and each of its respective Subsidiaries, at any specified time, any Indebtedness of the Parent
or any of its Subsidiaries (including, without limitation, any and all principal, accrued and unpaid interest, expenses or fees).

 

"Parent Group"
means collectively and individually, the Parent and its Subsidiaries.

 

"Parent Products"
means, with respect to the Parent or any of its Subsidiaries, all products or services produced, marketed, licensed, sold, distributed
or performed by or on behalf of the Parent or any of its Subsidiaries and all products or services currently under development
by the Parent or any of its Subsidiaries.

 

    	15

    	 

    
Execution Copy

 

 

"Parent Share
Value" means the average of the closing prices of a common share of Parent as reported on the Nasdaq over the 60-day period
ending on, and including, the third Business Day prior to the respective Closing Date.

 

"Participation
Portion" means, with respect to each Selling Shareholder, the percentage of IDIT Purchase Price or FIS Purchase Price,
as the case may be, appearing opposite the name of such Selling Shareholder, in Exhibit C and Exhibit D in the columns
entitled Participation Portion which shall include, with respect to FIS, different columns for the Cash Consideration and the FIS
Consideration Shares.

 

"Person"
means an individual, corporation, partnership, limited liability company, association, trust or other entity or organization, including
a Governmental Authority.

 

"Post-Closing
Tax Period" means any Tax period beginning after the respective Closing Date.

 

"Pre-Closing
Tax Period" means any Tax period ending on (and including) or prior to the respective Closing Date.

 

"Proceeding"
means any action, suit, litigation, arbitration, proceeding (including any civil, criminal, administrative, investigative or appellate
proceeding), hearing, inquiry, audit, examination or investigation commenced, brought, conducted or heard by or before, or otherwise
involving, any court or other Governmental Authority or any arbitrator or arbitration panel.

 

"Purchaser
Disclosure Schedule" means the disclosure schedule dated as of the date of this Agreement relating to the representations
and warranties of the Purchaser and the Parent made in this Agreement.

 

"Representative"
means a Person’s officers, directors, employees, agents, attorneys, accountants, advisors, investment bankers and other representatives
(and in case of a partnership, also its general partner).

 

"Rule 144"
means Rule 144 promulgated by the SEC pursuant to the Securities Act, as such Rule may be amended or interpreted from time to time,
or any similar rule or regulation hereafter adopted by the SEC having substantially the same purpose and effect as such Rule.

 

"SEC"
means the United States Securities and Exchange Commission.

 

"Securities
Act" means the United States Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.

 

"Selling Shareholder
Disclosure Schedule" means, with respect to each Selling Shareholder, the disclosure schedule dated as of the date of
this Agreement relating to the representations and warranties of such Selling Shareholder made in this Agreement.

 

"Spousal Consent"
means the consent of the spouse of any Selling Shareholder that is married in the forms attached hereto as Exhibit E1 and E2.

 

"Straddle Period"
means any Tax period beginning on or before and ending after the respective Closing Date.

 

    	16

    	 

    
Execution Copy

 

 

"Subsidiary"
means, with respect to any Person, any entity of which securities or other ownership interests having ordinary voting power to
elect a majority of the board of directors or other persons performing similar functions are at any time directly or indirectly
owned by such Person.

 

"Super Majority"
means, with respect to FIS, approval of the holders of 70% of the voting rights and with respect to, IDIT approval of the holders
of 90% of the voting rights.

 

"TASE"
means the Tel Aviv Stock Exchange.

 

“Tax”
(and, with correlative meaning, “Taxes”) means (i) any tax on net income, alternative or add-on minimum, gross income,
gross receipts, sales, use, value-added, ad valorem, transfer, franchise, profits, license, withholding, payroll, employment, excise,
severance, stamp, occupation, premium, property, environmental or windfall profit tax, custom duty and import and export taxes,
provincial health insurance plan premiums, employer health tax, United States or other government pension plan contributions, employment
insurance premiums, workman’s compensation, national insurance, national health insurance and other payroll taxes, deductions
at source, non-resident withholding, social service provincial sales and goods and services taxes, including estimated taxes, countervail
and anti-dumping fees and taxes, all licenses and registration fees, escheat, any related penalties, or other tax, governmental
fee or other like assessment, reassessment or charge, duties, impositions and liabilities of any kind whatsoever, together with
any interest, linkages differences or any penalty, addition to tax or additional amount imposed by any Governmental Authority responsible
for the imposition of any such tax, (ii) any Liability for the payment of any amounts of the type described in clause (i) of this
sentence as a result of being a member of an affiliated, consolidated, combined, unitary or aggregate group for any taxable period,
and (iii) any Liability for the payment of any amounts of the type described in clause (i) or (ii) of this sentence as a result
of being a transferee of or successor to any Person or as a result of any express or implied obligation to indemnify any other
Person.

 

"Tax Escrow
Agent" means ESOP Management & Trust Company Ltd. as escrow agent under the FIS TEA Agreement and the IDIT TEA Agreement.

 

"Tax Ordinance"
means the Israeli Income Tax Ordinance [New Version], 1961.

 

"Tax Return"
means any return, report, declaration, claim for refund, information return (including schedules thereto, other attachments thereto,
amendments thereof) filed or required to be filed with any Taxing Authority in connection with the determination, assessment or
collection of any Tax, or the administration of any laws, regulations or administrative requirements relating to any Tax.

 

"Taxing Authority"
means any governmental agency, board, bureau, body, department or authority of any Israeli jurisdiction or any foreign jurisdiction,
having or purporting to exercise jurisdiction with respect to any Tax.

 

"TEA Agreement"
means the FIS TEA Agreement or the IDIT TEA Agreement, as applicable.

 

"Transaction
Documents" means this Agreement and any and all other Contracts, certificates and documents contemplated to be delivered
or executed in connection with this Agreement and the transactions contemplated hereby, and each reference to the term "Transaction
Documents" shall be deemed a reference to the foregoing documents as applicable to the FIS Transaction or the IDIT Transaction,
as applicable.

 

    	17

    	 

    
Execution Copy

 

 

"Transactions"
means the purchase of the Companies Shares by Purchaser and all other transactions contemplated by this Agreement and the other
Transaction Documents, and each reference to the term "Transactions" shall be deemed a reference to the FIS Transaction
or the IDIT Transaction, as applicable.

 

"Transfer Agent"
means American Stock Transfer & Trust Company.

 

"US GAAP"
means generally accepted accounting principles in the United States of America, consistently applied throughout the respective
periods covered.

 

Additional Definitions.

 

	Term	Section  
	ACT	
        Section 2.09(a) 

	Addressee	
        Section 10.04(a) 

	Agreed Amount	
        Section 10.04(b) 

	Antitrust Approvals	
        Section 6.06(d) 

	Antitrust Laws	
        Section 6.06(d) 

	Arbitration Law	
        Section 10.04(e) 

	Arbitrator	
        Section 10.04(e) 

	Assets	
        Section 3.16(b) 

	Assumption Date	
        Section 2.04(c) 

	Assumed Options	
        Section 2.04(b)(i) 

	Balance Sheet Date	
        Section 3.08(a) 

	Sellers Basket Amount	
        Section 10.02(d) 

	Benefit Plans	
        Section 3.21(b) 

	Bring-Along Notice	
        Section 2.07(c) 

	Charter Documents	
        Section 3.01(c) 

	Claimed Amount	
        Section 10.04(a)(ii) 

	Closing	
        Section 2.11(a) 

	Closing Date	
        Section 2.11(a) 

	Company IP Rights	
        Section 3.18(a)(2) 

	Company IP Rights Agreements	
        Section 3.18(h) 

	Company Leased Real Property	
        Section 3.16(a) 

	Company Material Contract	
        Section 3.13(a) 

	Company-Owned IP Rights 	
        Section 3.18(a)(3) 

	Company's Financial Statements	
        Section 3.08(a) 

	Company Significant Customer	
        Section 3.17 

	Company Significant Supplier	
        Section 3.17 

	Company Source Code	
        Section 3.18(a)(5) 

	Compensation Package	
        Section 3.21(a) 

	Delivering Party	
        Section 10.04(a) 

	Confidential Information	
        Section 3.18(p) 

	Consideration Warrants	
        Section 2.02(c)(iii) 

	Consideration Securities	
        Section 4.08(a) 

	Contested Amount	
        Section 10.04(b) 

	Dispute Period	
        Section 10.04(b) 

 

    	18

    	 

    
Execution Copy

 

 

	EGM Notice	
        Section 6.09 

	Electing Holder	
        Section 6.08(a)(ii) 

	Exchange Act	
        Section 5.25(g) 

	Executing Shareholders 	
        Section 2.07(a) 

	Expected Revenues	
        Section 5.09(f) 

	Financial Statements Date	
        Section 5.09(b) 

	FIS Articles	
        Section 2.07(a) 

	FIS Assumed Options	
        Section 2.04(b)(i) 

	FIS Closing	
        Section 2.11(a) 

	FIS Closing Certificate	
        Section 8.03(d)(i) 

	FIS Closing Date	
        Section 2.11(a) 

	FIS Consideration Shares	
        Section 2.02(c)(ii) 

	FIS Conversion Ratio	
        Section 2.04(a)(i) 

	FIS End Date	
        Section 9.01(b) 

	FIS Executing Shareholders	
        Section 2.07(a) 

	FIS Selling Shareholder Closing Certificate	
        Section 8.03(d)(ii) 

	Formula and Kardan Side Letter	
        Section 8.03(d)(v) 

	Formula Systems	
        Section 8.03(d)(vi)

	Formula Vision	
        Section 8.03(d)(v)

	IDIT Articles	
        Section 2.07(a) 

	IDIT Assumed Options	
        Section 2.04(a)(i) 

	IDIT Closing	
        Section 2.10(a) 

	IDIT Closing Certificate	
        Section 8.04(d)(i) 

	IDIT Closing Date	
        Section 2.10(a) 

	IDIT Consideration Shares	
        Section 2.02(b) 

	IDIT Conversion Ratio	
        Section 2.04(a)(i) 

	IDIT Executing Shareholders	
        Section 2.07(a) 

	IDIT Purchase Price	
        Section 2.02(b) 

	IDIT Selling Shareholder Closing Certificate	
        Section 8.04(d)(ii) 

	Indemnified Party	
        Section 10.03(a) 

	Indemnifying Party	
        Section 10.04(a) 

	Insider Receivables	
        Section 3.08(e) 

	Intellectual Property	
        Section 3.18(a)(1) 

	IRA	
        Section 8.03(d)(vi) 

	ISA	
        Section 5.01(a) 

	Israeli 104(h) Tax Ruling	
        Section 6.08(a)(ii) 

	Israeli Options Tax Ruling	
        Section 6.08(a)(i) 

	Israeli Securities Exemption	
        Section 6.06(b) 

	Kardan	
        Section 7.06 

	Leased Assets	
        Section 3.16(c) 

	Leased Contracts	
        Section 3.16(c) 

	Malicious Code	
        Section 3.18(s) 

	Material Contract	
        Section 5.13(a) 

	Menora Revenues	
        Section 5.09(f) 

	Non Executing Shareholders	
        Section 2.06 

	Nondisclosure Agreement	
        Section 7.05 

	Offering	
        Section 5.25(a)

	Officer’s Claim Certificate	
        Section 10.04(a)

	Open Source Materials	
        Section 3.18(q)

         

 

    	19

    	 

    
Execution Copy

 

 

	Other Interested Party	
        Section 6.02 

	Parent Assets	
        Section 5.16(b) 

	Parent Benefit Plans	
        Section 5.21(b) 

	Parent Confidential Information	
        Section 5.18(n) 

	Parent's Financial Statements	
        Section 5.09(a) 

	Parent FIS Closing Certificate	
        Section 8.05(d)(i) 

	Parent Foreign Filings	
        Section 5.01(a) 

	Purchaser Basket Amount	
        Section 10.03(c) 

	Purchaser Indemnified Parties	
        Section 10.02(a) 

	Purchaser Fundamental Representations	
        Section 10.01(c) 

	Purchaser IDIT Closing Certificate	
        Section 8.06(d)(i) 

	Purchaser Survival Date	
        Section 10.01(c) 

	Parent IP Rights	
        Section 5.18(a)(1) 

	Parent IP Rights Agreements	
        Section 5.18(f) 

	Parent Leased Assets	
        Section 5.16(c) 

	Parent Leased Contracts	
        Section 5.16(c) 

	Parent Leased Real Property	
        Section 5.16(a) 

	Parent-Owned IP Rights	
        Section 5.18(a)(1) 

	Parent Material Contract	
        Section 5.13(a) 

	Parent Real Property Lease	
        Section 5.16(a) 

	Parent Related Person	
        Section 5.22 

	Parent SEC Documents	
        Section 5.01(a) 

	Parent Significant Customer	
        Section 5.17 

	Parent Significant Supplier	
        Section 5.17 

	Parent Source Code	
        Section 5.18(a)(3) 

	Payment Day	
        Section 2.08(b) 

	Purchaser FIS Closing Certificate	
        Section 8.05(d)(i) 

	Purchaser IDIT Closing Certificate	
        Section 8.06(d)(i) 

	Purchaser Indemnified Parties	
        Section 10.02(a) 

	Real Property Lease	
        Section 3.16(a) 

	Rep Letters	
        Section 8.03(m) 

	Registrar	
        Section 8.03(l) 

	Regulation D Investor	
        Section 4.08(b) 

	Regulation S Investor	
        Section 4.08(b) 

	Related Person	
        Section 3.22 

	Releasee and Releasees	
        Section 7.07 

	Response Notice	
        Section 10.04(b) 

	Restricted Parties	
        Section 6.10 

	Section 102	
        Section 3.21(b) 

	Section 401(a)	
        Section 3.21(b) 

	Sellers Fundamental Representations	
        Section 10.01(a) 

	Selling Shareholders Indemnified Parties	
        Section 10.03(a) 

	Stipulated Amount	
        Section 10.04(d) 

	Sellers Survival Date	
        Section 10.01(a) 

	TASE Approval	
        Section 6.06(c) 

	TASE Certificate	
        Section 8.05(j) 

	Tax Certificate	
        Section 2.08(b) 

	Third Party Intellectual Property Rights	
        Section 3.18(a)(4) 

	Transfer Taxes	
        Section 7.04(b) 

 

    	20

    	 

    
Execution Copy

 

 

Section
1.03Definitional and Interpretative Provisions.

 

(a)The
words "hereof," "herein" and "hereunder" and words of like import used in this Agreement shall refer
to this Agreement as a whole and not to any particular provision of this Agreement.

 

(b)The
captions herein are included for convenience of reference only and shall be ignored in the construction or interpretation hereof.
References to Articles, Sections, Exhibits and Schedules are to Articles, Sections, Exhibits and Schedules of this Agreement, unless
otherwise specified.

 

(c)All
Exhibits and Schedules annexed hereto or referred to herein are hereby incorporated in and made a part of this Agreement as if
set forth in full herein. Any capitalized terms used in any Exhibit or Schedule but not otherwise defined therein, shall have the
meaning as defined in this Agreement.

 

(d)Any
singular term in this Agreement shall be deemed to include the plural, and any plural term the singular.

 

(e)Whenever
the words "include," "includes" or "including" are used in this Agreement, they shall be deemed to
be followed by the words "without limitation," whether or not they are in fact followed by those words or words of like
import.

 

(f)All
references to time shall refer to Israel time. The word "extent" in the phrase "to the extent" means the degree
to which a subject or other thing extends, and such phrase shall not mean simply "if".

 

(g)The
use of the word "or" shall not, necessarily, be exclusive.

 

(h)Any
rule of construction to the effect that ambiguities are to be resolved against the drafting party shall not be applied in the construction
or interpretation of this Agreement.

 

(i)Any
agreement or instrument defined or referred to herein, or in any agreement or instrument that is referred to herein, means such
agreement or instrument as from time to time amended, modified or supplemented. Other terms may be defined elsewhere in the text
of this Agreement and shall have the meaning indicated throughout this Agreement.

 

(j)The
term "foreign" when used with respect to Applicable Law or a Governmental Authority shall refer to all jurisdictions
other than Israel.

 

(k)The
term "Dollar", "$", or US$ shall refer to the currency of the United States of America.

 

Article
II

purchase of Companies shares

 

Section
2.01Purchase and Sale of Companies Shares.

 

    	21

    	 

    

Execution Copy

 

 

(a)Subject
to the terms and conditions set forth in this Agreement, and in reliance on the representations, warranties and covenants of IDIT
and the IDIT Selling Shareholders contained herein, at the IDIT Closing (i) the IDIT Selling Shareholders (including the Non Executing
Shareholders of IDIT) shall sell, assign, transfer and deliver, to the Purchaser, all of the IDIT Shares; (ii) the Purchaser shall
purchase, acquire and accept from each IDIT Selling Shareholder (including the Non Executing Shareholders of IDIT) all of the
IDIT Shares transferred by such IDIT Selling Shareholder (including the Non Executing Shareholders of IDIT), in each of (i) and
(ii), free and clear of any and all Liens; and (iii) the Parent shall, subject to Section 2.04(a)(ii), replace the IDIT Vested
Options and the IDIT Unvested Options pursuant to Section 2.04 below. At the IDIT Closing, the Purchaser shall purchase all (and
not less than all) of the IDIT Shares which constitut

e the entire issued and outstanding share capital of IDIT, assuming replacement
of the IDIT Options pursuant to Section 2.04below and cancellation, conversion and/or exercise of any and all other securities
and other rights that are exercisable or convertible into IDIT Shares, subject to Section 2.04(a)(ii)

.

 

(b)Subject
to the terms and conditions set forth in this Agreement, and in reliance on the representations, warranties and covenants of FIS
and the FIS Selling Shareholders contained herein, at the FIS Closing (i) the FIS Selling Shareholders (including the Non Executing
Shareholders of FIS) shall sell, assign, transfer and deliver, to the Purchaser, all of the FIS Shares; (ii) the Purchaser shall
purchase, acquire and accept from each FIS Selling Shareholder (including the Non Executing Shareholders of FIS) all of the FIS
Shares transferred by such FIS Selling Shareholder (including the Non Executing Shareholders of FIS), in each of (i) and (ii),
free and clear of any and all Liens; and (iii) the Parent shall, subject to Section 2.04(b)(ii)

, replace the FIS Vested Options and the FIS Unvested Options pursuant to Section 2.04

below. At the FIS Closing, the Purchaser shall purchase all (and not less than all) of the FIS Shares
which constitute the entire issued and outstanding share capital of FIS, assuming assumption of the FIS Options pursuant to Section
2.04

below and cancellation, conversion and/or exercise of any and all other securities and other rights that
are exercisable or convertible into FIS Shares, subject to Section 2.04(b)(ii)

.

 

Section
2.02Consideration.

 

(a)General.

 

(i)As
consideration for the sale, assignment, transfer and delivery of all of the IDIT Shares to the Purchaser, the Purchaser will pay
the IDIT Selling Shareholders, under the terms and conditions of this Agreement, the IDIT Purchase Price, at the times and according
to the allocation and other terms set forth in Section 2.03(a)

and in accordance with this Section 2.02

. The allocation of the IDIT Purchase Price among the IDIT Selling Shareholders shall be as set forth
in Exhibit C (as may be amended no later than two (2) Business Days prior to the IDIT Closing Date to reflect any changes
in IDIT's share capital). The Purchaser is permitted to rely on the allocation set forth in Exhibit C with respect to the
payment of the IDIT Purchase Price and shall have no responsibility or liability with respect to such allocation.

 

(ii)As
consideration for the sale, assignment, transfer and delivery of all of the FIS Shares to the Purchaser, the Purchaser will pay
the FIS Selling Shareholders, under the terms and conditions of this Agreement, the FIS Purchase Price, at the times and according
to the allocation and other terms set forth in Section 2.03(b)

and in accordance with this Section 2.02. The allocation of the FIS Purchase Price among the FIS Selling
Shareholders shall be as set forth in Exhibit D (as may be amended no later than two (2) Business Days prior to the FIS
Closing Date to reflect any changes in FIS' share capital). The Purchaser is permitted to rely on the allocation set forth in
Exhibit D with respect to the payment of the FIS Purchase Price and shall have no responsibility or liability with respect
to such allocation.

 

    	22

    	 

    
Execution Copy

 

 

(iii)Any
cash payment of any portion of the FIS Purchase Price shall be made in US Dollars. In the event that any date on which payment
is due hereunder is not a Business Day, then payment shall be due on the first Business Day thereafter.

 

(b)IDIT
Purchase Price. Subject to the fulfillment of all respective conditions included herein, the total aggregate consideration
for all of the IDIT Shares (the "IDIT Purchase Price") shall be 7,483,125 newly issued common shares of Parent
plus the IDIT Extra Consideration Shares, if any (the "IDIT Consideration Shares").

 

(c)FIS
Purchase Price. Subject to the fulfillment of all respective conditions included herein, the total aggregate consideration
for all of the FIS Shares shall consist of the following payments by the Purchaser (the "FIS Purchase Price"):

 

(i)Cash
Consideration. An amount in United States Dollars equal to US$6,750,000 (the "Cash Consideration"), which
will be allocated as set forth in Exhibit D;

 

(ii)Share
Consideration. 10,016,875 common shares of Parent plus the FIS Extra Consideration Shares, if any (the "FIS Consideration
Shares") which shall be allocated as set forth in Exhibit D; and

 

(iii)Warrant
Consideration. Warrants in the form attached hereto as Exhibit G (the "Consideration Warrants") to purchase
an aggregate of 1,000,000 common shares of Parent (the "Warrants Shares") which shall be allocated as set forth
in Exhibit D.

 

Section
2.03Payment Schedule 

 

(a)The
IDIT Purchase Price shall be allocated as follows:

 

(i)At
the IDIT Closing, the Parent shall deliver to the Transfer Agent, with a copy to the IDIT Shareholders Representative, irrevocable
written instructions in the form of Exhibit H, to issue in the name of the Escrow Agent, certificate representing the Parent's
shares to be deposited in the IDIT Escrow Deposit and to deliver all such certificate to the Escrow Agent; and

 

(ii)At
the IDIT Closing, the Parent shall deliver to the Transfer Agent, with a copy to the IDIT Shareholders Representative, irrevocable
written instructions in the form of Exhibit I to issue to the IDIT Selling Shareholders, based on their Participation Portions
of the IDIT Purchase Price set forth in Exhibit C (as may be amended no later than two (2) Business Days prior to the IDIT Closing
Date to reflect any changes in IDIT's issued and outstanding share capital), certificates representing the balance of the IDIT
Consideration Shares and to deliver such certificates to the IDIT Selling Shareholders or the IDIT 102 Trustee, as set forth in
Section 2.03(c) hereunder.

 

(b)The
FIS Purchase Price shall be allocated as follows:

 

(i)At
the FIS Closing, the Parent shall deliver to the Transfer Agent, with a copy to the FIS Shareholders Representative, irrevocable
written instructions in the form of Exhibit J to issue in the name of the Escrow Agent, certificate representing the Parent's shares
to be deposited in the FIS Escrow Deposit and to deliver all such certificate to the Escrow Agent;

 

    	23

    	 

    
Execution Copy

 

 

(ii)At
the FIS Closing, the Parent shall deliver to the Transfer Agent, with a copy to the FIS Shareholders Representative, irrevocable
written instructions in the form of Exhibit K to issue to FIS Selling Shareholders, based on their Participation Portions of the
FIS Purchase Price set forth in Exhibit D (as may be amended no later than two (2) Business Days prior to the FIS Closing Date
to reflect any changes in FIS' issued and outstanding share capital), certificates representing the balance of the FIS Consideration
Shares and to deliver such certificates to the FIS Selling Shareholders or to the FIS 102 Trustee, as set forth in Section
2.03(c)

hereunder;

 

(iii)At
the FIS Closing, the Parent shall issue the Consideration Warrants to the FIS Selling Shareholders as set forth in Exhibit D;
and

 

(iv)At
the FIS Closing, the Purchaser shall deliver, by wire transfer of immediately available funds, an amount in United States dollars
equal to the Cash Consideration to the FIS Selling Shareholders as set forth in Exhibit D.

 

(c)Notwithstanding
anything to the contrary in this Agreement, to the extent that any Companies Shares are held in trust pursuant to Section 102 of
the Tax Ordinance, the Parent or Purchaser, as applicable, will make or instruct the Transfer Agent to make, as the case may
be, payment of the consideration that such holder of Companies Shares is entitled to receive under this Agreement directly
to the FIS 102 Trustee or the IDIT 102 Trustee, as applicable, in accordance with the provisions of the Israeli Option Tax Ruling
(as defined below), if obtained.

 

Section
2.04Companies Options. 

 

(a)IDIT
Options Conversion.

 

(i)At
the IDIT Closing, each IDIT Option that is outstanding and unexercised immediately prior to the IDIT Closing, whether or not vested,
shall be replaced with an option to purchase common shares of Parent, subject to the remainder of this Section 2.04(a)(i), having
the same terms set forth in the Parent's 2011 Option Plan and the Parent's Notice of Share Option Grant issued thereunder, copies
of which are attached hereto as Exhibits M1 and Exhibit M2, respectively, except that the Type of Option Award,
the Vesting Commencement Date, the Vesting Schedule and the Expiration Date (as such terms are defined in the Notice of Share
Option Grant attached hereto), shall be the same as such terms were determined with respect to the replaced IDIT Option, subject
to the terms of the Israeli Option Tax Ruling (all IDIT Options that are replaced pursuant to this Section 2.04(a) are hereafter
referred to as "IDIT Assumed Options"). All rights to purchase IDIT Ordinary Shares, as applicable, under IDIT
Assumed Options shall thereupon be converted into rights to purchase common shares of Parent and thereafter there shall be no
options outstanding to purchase IDIT Shares. Accordingly, from and after the IDIT Closing: (A) each IDIT Assumed Option may be
exercised solely for common shares of Parent; (B) the number of common shares of Parent subject to each IDIT Assumed Option shall
be determined by multiplying the number of IDIT Ordinary Shares that were subject to such IDIT Assumed Option immediately prior
to the IDIT Closing, by the IDIT Conversion Ratio (as defined below), and rounding the resulting number up or down to the nearest
whole number of common shares of Parent (with a fraction equal to or greater than 0.50 being rounded up and all other fractions
being rounded down) ; (C) the per share exercise price for the common shares of Parent issuable upon exercise of each IDIT Assumed
Option shall be determined by dividing the per share exercise price of IDIT Ordinary Shares subject to such IDIT Assumed Option,
as in effect immediately prior to the IDIT Closing, by the IDIT Conversion Ratio, and rounding the resulting exercise price up
or down to the nearest whole cent (with a fraction equal to or greater than 0.50 being rounded up and all other fractions being
rounded down); and (D) any restriction on the exercise of any IDIT Assumed Option shall continue in full force and effect; provided,
however, that: (1) each IDIT Assumed Option shall, in accordance with its terms, be subject to further adjustment as appropriate
to reflect any stock split, division or subdivision of shares, stock dividend, issuance of bonus shares, reverse stock split,
consolidation of shares, reclassification, recapitalization or other similar transaction with respect to common shares of Parent
subsequent to the IDIT Closing; and (2) Parent’s board of directors or a committee thereof shall succeed to the authority
and responsibility of IDIT's boards of directors or any committees thereof with respect to each IDIT Assumed Option. For the avoidance
of any doubt, any IDIT Option that is expired or terminated by its terms as a result of the consummation of the IDIT Transaction
shall expire or terminate, as applicable, at the IDIT Closing and shall not be replaced with option to purchase common shares
of Parent as set forth in this Section 2.04(a).

 

    	24

    	 

    
Execution Copy

 

 

For the
purpose of this Section 2.04, the "IDIT Conversion Ratio" shall mean a fraction, (i) the numerator of which is
the number of IDIT Consideration Shares (including such IDIT Consideration Shares to be held in the IDIT Escrow Deposit and the
IDIT Extra Consideration Shares, if any) payable pursuant to this Agreement to the holders of IDIT Ordinary Shares, as set forth
in Exhibit C, and (ii) the denominator of which is the number of IDIT Ordinary Shares held by such holders immediately prior to
the IDIT Closing (after giving effect to the issuance of IDIT Shares pursuant to the exercise of IDIT Options at or prior to Closing),
which fraction is 210.2.

 

(ii)Notwithstanding
Section 2.04(a)(i), in the event that the Israeli Options Tax Ruling will not be obtained prior to the IDIT Closing, the IDIT
Options shall not be replaced by the Parent at the IDIT Closing and shall continue to be exercisable to IDIT Ordinary Shares until
the Israeli Options Tax Ruling is obtained, at which time the IDIT Options shall be replaced pursuant to the terms of Section
2.04(a)(i), mutatis mutandis. Notwithstanding anything to the contrary, in the event that any IDIT Option is exercised
after the IDIT Closing but prior to the replacement of such IDIT Option under Section 2.04(a)(i), then any and all IDIT Shares
issued upon such exercise shall automatically upon such exercise and issuance, and with no further action by the holder of such
IDIT Options, be deemed to be IDIT Shares that shall have been transferred to Purchaser upon issuance under Section 2.01(a) above,
and upon such exercise and issuance, such holder of IDIT Options shall have no rights as a holder of IDIT Shares, rather it shall
only be entitled to receive, as consideration, a number of Parent common shares equal to the number of IDIT Shares issued upon
such exercise multiplied by the IDIT Conversion Ratio, except that such Parent common shares shall be treated as IDIT Consideration
Shares (including allocation to escrow).

 

(iii)Any
certificate representing Parent common shares acquired upon the exercise of IDIT Assumed Options prior to the filing of the registration
statement on Form S-8 referred to in Section 7.10 shall bear the restrictive legend set forth in Section 2.09 hereof. The IDIT
Assumed Options may only be exercised (i) outside the United States in an offshore transaction in accordance with Rule 903 of
Regulation S, or (ii) within the United States pursuant to exemption from the registration requirements of the Securities Act.
Until Parent files the foregoing registration statement on Form S-8, in order to establish the availability of Rule 903, a holder
of IDIT Assumed Options will not be entitled to exercise the IDIT Assumed Options unless at the time of such exercise the holder
of such IDIT Assumed Options makes to the Parent the representations and warranties of a Selling Shareholder set forth in Section
4.08 with respect to its purchase of the relevant Parent common shares.

 

    	25

    	 

    
Execution Copy

 

 

(b)FIS
Options Conversion.

 

(i)At
the FIS Closing, each FIS Option that is outstanding and unexercised immediately prior to the FIS Closing, whether or not
vested, shall be replaced with an option to purchase common shares of Parent, subject to the remainder of this Section
2.04(b)(i), having the same terms set forth in the Parent's 2011 Option Plan and the Parent's Notice of Share Option Grant
issued thereunder, copies of which are attached hereto as Exhibits M1 and Exhibit M2, respectively, except that
the Type of Option Award, the Vesting Commencement Date, the Vesting Schedule and the Expiration Date, shall be the same as
such terms were determined with respect to the replaced FIS Option , subject to the terms of the Israeli Option Tax Ruling
(all FIS Options that are replaced pursuant to this Section 2.04(b) are hereafter referred to as "FIS Assumed
Options", and together with the IDIT Assumed Options, the "Assumed Options"). All rights to
purchase FIS Ordinary Shares, as applicable, under FIS Assumed Options shall thereupon be converted into rights to purchase
common shares of Parent and thereafter there shall be no options outstanding to purchase FIS Shares. Accordingly, from and
after the FIS Closing: (A) each FIS Assumed Option may be exercised solely for common shares of Parent; (B) the number of
common shares of Parent subject to each FIS Assumed Option shall be determined by multiplying the number of FIS Ordinary
Shares that were subject to such FIS Assumed Option immediately prior to the FIS Closing, by the FIS Conversion Ratio (as
defined below), and rounding the resulting number up or down to the nearest whole number of common shares of Parent (with a
fraction equal to or greater than 0.50 being rounded up and all other fractions being rounded down); (C) the per share
exercise price for the common shares of Parent issuable upon exercise of each FIS Assumed Option shall be determined by
dividing the per share exercise price of FIS Ordinary Shares subject to such FIS Assumed Option, as in effect immediately
prior to the FIS Closing, by the FIS Conversion Ratio, and rounding the resulting exercise price up or down to the nearest
whole cent (with a fraction equal to or greater than 0.50 being rounded up and all other fractions being rounded down); and
(D) any restriction on the exercise of any FIS Assumed Option shall continue in full force and effect; provided,
however, that: (1) each FIS Assumed Option shall, in accordance with its terms, be subject to further adjustment as
appropriate to reflect any stock split, division or subdivision of shares, stock dividend, issuance of bonus shares, reverse
stock split, consolidation of shares, reclassification, recapitalization or other similar transaction with respect to common
shares of Parent subsequent to the FIS Closing; and (2) Parent’s board of directors or a committee thereof shall
succeed to the authority and responsibility of FIS' boards of directors or any committees thereof with respect to each FIS
Assumed Option. For the avoidance of any doubt, any FIS Option that is expired or terminated by its terms as a result of the
consummation of the FIS Transaction shall expire or terminate, as applicable, at the FIS Closing and shall not be replaced
with option to purchase common shares of Parent as set forth in this Section 2.04(b)

 

For the purpose
of this Section 2.04, the "FIS Conversion Ratio" shall mean a fraction (i) the numerator of which is the number
of FIS Consideration Shares (including the FIS Consideration Shares to be held in the FIS Deposit and the FIS Extra Consideration
Shares, if any) plus a number of common shares of Parent equal to the quotient resulting from the Cash Consideration divided
by four (4), and (ii) the denominator of which is the number of FIS Shares issued and outstanding immediately prior to the FIS
Closing (after giving effect to the issuance of FIS Options at or prior to Closing) , which fraction is 392.75.

 

(ii)Notwithstanding
Section 2.04(b)(i), in the event that the Israeli Options Tax Ruling will not be obtained prior to the FIS Closing, the FIS Options
shall not be replaced by the Parent at the FIS Closing and shall continue to be exercisable to FIS Ordinary Shares until the Israeli
Options Tax Ruling is obtained, at which time the FIS Options shall be replaced pursuant to the terms of Section 2.04(b)(i), mutatis
mutandis. Notwithstanding anything to the contrary, in the event that any FIS Option is exercised after the FIS Closing but prior
to the replacement of such FIS Option under Section 2.04(b)(i), then any and all FIS Shares issued upon such exercise shall automatically
upon such exercise and issuance, and with no further action by the holder of such FIS Options, be deemed to be FIS Shares that
shall have been transferred to Purchaser upon issuance under Section 2.01(b)

above, and upon such exercise and issuance, such holder of FIS Options shall have no rights as a holder
of FIS Shares, rather it shall only be entitled to receive, as consideration, a number of Parent common shares equal to the number
of FIS Shares issued upon such exercise multiplied by the FIS Conversion Ratio, except that such Parent common shares shall be
treated as FIS Consideration Shares (including allocation to escrow).

 

    	26

    	 

    
Execution Copy

 

 

(iii)Any
certificate representing Parent common shares acquired upon the exercise of FIS Assumed Options prior to the filing of the registration
statement on Form S-8 referred to in Section 7.10

shall bear the restrictive legend set forth in Section 2.09

hereof. The FIS Assumed Options may only be exercised (i) outside the United States in an offshore transaction
in accordance with Rule 903 of Regulation S, or (ii) within the United States pursuant to exemption from the registration requirements
of the Securities Act. Until Parent files the foregoing registration statement on Form S-8, in order to establish the availability
of Rule 903, a holder of FIS Assumed Options will not be entitled to exercise the FIS Assumed Options unless at the time of such
exercise the holder of such FIS Assumed Options makes to the Parent the representations and warranties of a Selling Shareholder
set forth in Section 4.08

with respect to its purchase of the relevant Parent common shares.

 

(c)Discretionary
Assumption of Companies Option Plan. At the date of actual replacement of the Assumed Options pursuant to this Section
2.04 (the "Assumption Date"), Parent may (but shall not be obligated to) assume any or all of the Companies
Option Plans or merge any of such Companies Option Plans into any stock option plan of Parent. If Parent elects to so assume
or merge any Companies Option Plan, then, under such Companies Option Plan, Parent shall be entitled to grant stock awards,
to the extent permissible under Applicable Law, using the share reserves of such Companies Option Plan as of the respective
Assumption Date (including any shares subsequently returned to such share reserves as a result of the termination of Assumed
Options), except that: (i) stock covered by such awards shall be common shares of Parent; (ii) all references in such
Companies Option Plan to a number of IDIT Ordinary Shares or FIS Ordinary Shares shall be deemed amended to refer instead to
a number of common shares of Parent determined by multiplying the number of referenced IDIT Ordinary Shares or FIS Ordinary
Shares, as the case may be, by the IDIT Conversion Ratio or the FIS Conversion Ratio, as applicable, and rounding the
resulting number up or down to the nearest whole number of common shares of Parent (with a fraction equal to or greater than
0.50 being rounded up and all other fractions being rounded down); and (iii) the Parent’s board of directors or a
committee thereof shall succeed to the authority and responsibility of the relevant Company's board of directors or any
committee thereof with respect to the administration of such Companies Option Plan.

 

(d)Prior
to the respective Assumption Date, each Company shall take all action that may be necessary (under the Companies Option Plans
and otherwise) to effectuate the provisions of this Section 2.04 and to ensure that, from and after the respective Assumption
Date, holders of Companies Options have no rights with respect thereto other than those specifically provided in this Section
2.04. 

 

(e)As
soon as practicable following the respective Assumption Date, the Parent shall send each Person holding Assumed Options a notice
with respect to the matters described in this Section 2.04.

 

(f)Each
Assumed Option that has been held for the benefit of Israeli-resident employees or office holders of the Companies by the IDIT
102 Trustee or the FIS 102 Trustee shall continue to be held by such trustees for such period of time and in accordance with the
terms of (i) Section 102 of the Tax Ordinance or any regulations, rules, orders or procedures promulgated thereunder; and (ii)
to the extent obtained by the Companies, the Israeli Option Tax Ruling.

 

    	27

    	 

    
 Execution Copy

 

 

Section
2.05Escrow Fund.

 

(a)Escrow
Deposit. At the respective Closing, Parent shall deliver to the Transfer Agent, with a copy to the respective Shareholders
Representative, irrevocable written instructions pursuant to Section 2.03(a)(i) and Section 2.03(b)(i) to deliver to the Escrow
Agent, as the escrow agent under the respective Escrow Agreement, the IDIT Escrow Deposit and the FIS Escrow Deposit to be held
by the Escrow Agent in accordance with the terms of the respective Escrow Agreement.

 

(b)Payment
of Claimed Amounts. Any amount paid to Purchaser from the IDIT Escrowed Funds or the FIS Escrowed Funds in common shares of
Parent in accordance with Article X, shall be paid assuming a value for each such share equal to the Parent Share Value.

 

(c)Release
of Escrowed Funds. Within two (2) Business Days after the date that is twelve (12) months after the respective Closing Date,
the Escrow Agent will be instructed, pursuant to the respective Escrow Agreement, to deliver to the respective Selling Shareholders,
the respective Escrowed Funds (including, pursuant to the terms of the respective Escrow Agreement, any interest accrued on any
cash held in escrow on behalf of such respective Selling Shareholders, if applicable) less an amount in cash or in Parent's common
shares based on the Parent Share Value (at the respective Selling Shareholder's discretion) for any unresolved (or resolved in
favor of Purchaser but not distributed) Claimed Amounts which will remain on deposit with the Escrow Agent and will be released
by the Escrow Agent and transferred out of the respective Escrowed Funds by the Escrow Agent only in accordance with the terms
of Article X, and less any Claimed Amounts previously distributed to the Purchaser.

 

Section
2.06Other Shareholders.  

  

Promptly after the
date hereof and as long as this Agreement is not duly terminated, each Company shall take all commercially reasonable action to
obtain from all the shareholders of such Company who did not execute this Agreement on the date hereof and who are listed in Exhibit
L (the "Non Executing Shareholders"), a counter signature on this Agreement under which each such other shareholder
of such Company becomes bound by and subject to the provisions of this Agreement as a "Selling Shareholder" and makes
all the representations and warranties of a "Selling Shareholder" under this Agreement. Any holders of Companies Shares
as of the respective Closing that do not countersign this Agreement shall become Selling Shareholder parties hereto by virtue of
Section 2.07

below.

 

Section
2.07Section 341 Action. 

 

(a)By
executing this Agreement, the IDIT Selling Shareholders executing this Agreement on the date hereof ("IDIT Executing Shareholders"),
who collectively hold more than 95% of the issued and outstanding share capital of IDIT, and the FIS Selling Shareholders executing
this Agreement on the date hereof ("FIS Executing Shareholders", and together with IDIT Executing Shareholders,
the "Executing Shareholders"), who collectively hold more than 95% of the issued and outstanding share capital
of FIS, have, and are deemed to have, accepted an offer by Purchaser to purchase their Companies Shares in accordance with the
terms set forth in this Agreement, in accordance with Section 341 of the Companies Law and Article 40 of IDIT’s Articles
of Association (the "IDIT Articles") or Article 105 of FIS' Articles of Association (the "FIS Articles"),
as applicable.

 

    	28

    	 

    
Execution Copy

 

 

(b)This
Agreement shall be deemed, for the purpose of Section 341(a) of the Companies Law, Article 40 of the IDIT Articles and Article
105 of FIS Articles, to constitute with respect to each Company (i) an offer by Purchaser for the purchase of all issued and outstanding
share capital of such Company which is conditioned upon the sale of all of the outstanding share capital of such Company and (ii)
an acceptance of such offer by all IDIT Executing Shareholders and FIS Executing Shareholders, as the case may be.

 

(c)Within
three (3) Business Days after the date hereof, each Company shall, in accordance with Section 341 of the Companies Law and its
Articles of Association, provide a written notice on behalf of the Purchaser (the "Bring-Along Notice") to each
of its shareholders who is a Non Executing Shareholder, setting forth the information required by Section 341(a) of the Companies
Law and its Articles of Association and offering such Non Executing Shareholder to sell all of its Companies Shares to the Purchaser
under the terms and conditions of this Agreement and become a Selling Shareholder party to this Agreement. The Purchaser and each
Company shall fully coordinate any correspondence to which each may be a party which concerns the Bring-Along Notice. Purchaser
and each Company shall take such other actions as may be commercially reasonably appropriate in order to complete the transfer
of all Company Shares under Section 341 of the Companies Law and its Articles of Association under the terms and conditions of
this Agreement including in making all reasonable filings and taking such other reasonable action which is necessary or desirable
to effect the Transactions with respect to all the securities of such Company outstanding as of the respective Closing in compliance
with Section 341 of the Companies Law and such Company’s Articles of Association. After satisfactory completion of
the necessary procedures under Section 341 of the Companies Law and such Company's Articles of Associations and provided that
no injunction against the Transactions is issued by a competent court and is not removed, at the respective Closing each Company
shall register the transfer of all the respective Companies Shares held by all of its Non Executing Shareholders as of the respective
Closing to the Purchaser and all consideration payable under this Agreement with respect to such Companies Shares transferred
by such Non Executing Shareholders shall be deposited at respective Closing with such Company in accordance with Section 341 of
the Companies Law, for distribution to the Non Executing Shareholders, provided, however that the pro rata share out of such consideration
which is payable to the Escrow Agent in respect of the Companies Shares held by the Non Executing Shareholders, shall be included
in the amounts delivered to the Escrow Agent at the respective Closing and upon distribution of any amounts from the Escrow Agent,
shall be transferred by the Escrow Agent to the Purchaser or its designee for further distribution to the Non Executing Shareholders
in accordance with Section 341 of the Companies Law. The Non Executing Shareholders shall only be entitled to receive the consideration
payable thereto hereunder after they comply with all conditions to receive such consideration set forth in this Agreement (including
delivering all documents under Article VIII).

 

(d)Subject
to the terms of this Agreement, following the execution of this Agreement and prior to the respective Closing Date, if any of the
Companies shall issue any shares pursuant to the exercise of any IDIT Options or FIS Options, as applicable, then such Company
shall promptly: (i) inform Purchaser of such an issuance, and (ii) amend Exhibit L so that the Person exercising such Options
will be deemed, for purposes of this Agreement, a Non-Executing Shareholder with respect to the shares issued upon such exercise
of Options.

 

(e)For
purposes of this Agreement, the terms "IDIT Selling Shareholders", "FIS Selling Shareholder" and "Selling
Shareholder" shall include all respective Non-Executing Shareholders and each such Non-Executing Shareholder shall be deemed
to be subject to the terms and conditions of this Agreement, except to the extent that doing so would be inconsistent with the
provisions of Section 341 of the Companies Law.

 

    	29

    	 

    
Execution Copy

 

 

Section
2.08Withholding Tax.

 

(a)Right
to Withhold. The Escrow Agent, the Parent and the Purchaser shall be entitled to deduct and withhold from any consideration
payable or otherwise deliverable to any Person pursuant to this Agreement such amounts as the Escrow Agent, the Parent and/or the
Purchaser determines to be required to be deducted or withheld therefrom under any Applicable Law, including, without limitation,
to withhold from the Cash Consideration payable to any FIS Selling Shareholders any amount required to be deducted or withheld
therefrom under any Applicable Law with respect to the FIS Consideration Shares payable to such FIS Selling Shareholder. Any withholding
made in NIS with respect to payments made hereunder in US dollars shall be calculated in such manner as the Escrow Agent, the Parent
and/or the Purchaser determines to be in compliance with Applicable Law. To the extent that such amounts are so withheld by the
Escrow Agent, the Parent and/or the Purchaser, such withheld amounts shall be treated for all purposes of this Agreement as having
been paid to the Person to whom such amounts would otherwise have been paid in respect of whom such deduction and withholding was
made. All withheld amounts shall be promptly remitted to the appropriate Governmental Authority by the Escrow Agent, the Parent
or the Purchaser, as applicable.

 

(b)Withholding
Certificates. Without derogating from the foregoing, Purchaser and Parent agree that no withholding or reduced withholding
under Applicable Law will be made from any payment payable hereunder to a Person to the extent that such Person has provided Purchaser
and Parent with an appropriate and applicable valid exemption or confirmation of exemption from withholding or a reduced withholding
rate (as applicable) or other written instructions issued by the applicable Taxing Authority with respect to such Person in form
and substance satisfactory to Purchaser and Parent (each a "Tax Certificate"), at least two (2) Business Days
prior to the day any amounts withheld with respect to such consideration must be transferred to the ITA (the "Payment Day").

 

(c)Notwithstanding
the above, with respect to any consideration payable or otherwise deliverable pursuant to this Agreement to any Selling Shareholder
by the Parent or the Escrow Agent, other than in cash, in the event that such Selling Shareholder does not provide to the Parent
or the Escrow Agent, as applicable, a Tax Certificate applicable to such Selling Shareholder which exempts the Parent or the Escrow
Agent, as applicable, from any obligation to withhold Israeli Tax at source from such consideration, not later than two (2) Business
Days prior to the Payment Day, then subject to the signature of such Selling Shareholder on the respective TEA Agreement, such
consideration shall be paid and/or delivered to the Tax Escrow Agent to be handled by it in accordance with the respective TEA
Agreement.

 

(d)Notwithstanding
anything to the contrary in this Section 2.08, any tax withholding made by the Escrow Agent or the Tax Escrow Agent shall be subject
to the tax withholding provisions set forth in the respective Escrow Agreement or the respective TEA Agreement, as applicable.

 

Section
2.09Legend Requirement.

 

(a)Securities
Act. Each Consideration Warrant and each certificate representing Consideration Shares or Warrants Shares shall (unless otherwise
permitted by the provisions of this Agreement) be imprinted with a legend substantially similar to the following (in addition to
any legend required under applicable securities laws or as provided elsewhere in this Agreement):

 

 

    	30

    	 

    
 

Execution Copy

 

 

"THE SECURITIES
REPRESENTED HEREBY HAVE BEEN ACQUIRED PURSUANT TO [REGULATION D] [REGULATION S] OF THE SECURITIES ACT OF 1933, AS AMENDED (THE
"ACT"), AND MAY NOT BE SOLD, MORTGAGED, PLEDGED, HYPOTHECATED OR OTHERWISE TRANSFERRED EXCEPT IN ACCORDANCE THEREWITH,
PURSUANT TO A REGISTRATION UNDER THE ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM REGISTRATION. THE ISSUER OF THESE SECURITIES
MAY REQUIRE AN OPINION OF COUNSEL IN FORM AND SUBSTANCE SATISFACTORY TO THE ISSUER TO THE EFFECT THAT ANY PROPOSED TRANSFER OR
RESALE IS IN COMPLIANCE WITH THE ACT AND ANY APPLICABLE STATE SECURITIES LAWS. IN ADDITION, NO HEDGING TRANSACTION MAY BE CONDUCTED
WITH RESPECT TO THESE SECURITIES UNLESS SUCH TRANSACTIONS ARE IN COMPLIANCE WITH THE ACT."

 

(b)The
Consideration Warrants, the Warrant Shares and certificates evidencing the Consideration Shares and the Warrants Shares shall
not contain any legend (including the legend set forth in Section 2.09(a) hereof), (i) commencing 40 days after the FIS Closing
or IDIT Closing, as applicable, with respect to Consideration Shares, Consideration Warrants and Warrants Shares held by any Regulation
S Investor (as defined in Section 4.08(b)) which is not an "affiliate" of Parent (within the meaning of Rule 144), (ii)
while a registration statement covering the resale of such security is effective under the Securities Act, (iii) following any
sale of such Consideration Shares, Consideration Warrants or Warrants Shares pursuant to Rule 144, (iv) if such Consideration
Shares, Consideration Warrants or Warrants Shares are eligible for sale under Rule 144, without the requirement for the Parent
to be in compliance with the current public information required under Rule 144 as to such Consideration Shares, Consideration
Warrants or Warrants Shares and without volume or manner-of-sale restrictions, or (v) if such legend is not required under applicable
requirements of the Securities Act (including judicial interpretations and pronouncements issued by the staff of the SEC). The
Parent shall cause its counsel, at its own expense, to issue a legal opinion addressed to the Transfer Agent and the Parent (if
required) promptly to effect the removal of the legend hereunder.  In addition, the Parent shall, for a period of sixty (60)
months as of the first Closing Date: (i) make and keep available adequate current public information with respect to the Parent
within the meaning of Rule 144; and (ii) comply with all other necessary filings and other requirements, in a timely manner, so
as to enable the holders of Consideration Shares and Warrant Shares to sell such securities under Rule 144.

 

(c)Other
Securities Laws. In addition, each Consideration Warrant and each certificate representing Consideration Shares or Warrants
Shares may contain any legend required by the securities laws of any jurisdiction to the extent such laws are applicable to the
sale and issuance of such Consideration Warrants, Warrants Shares or Consideration Shares.

 

Section
2.10IDIT Closing.

 

(a)Time
and Place. The consummation of the respective Transactions between Purchaser, IDIT and the IDIT Selling Shareholders (the
"IDIT Closing") shall take place at the offices of Meitar, Liquornik, Geva & Leshem, Brandwein, Law Offices,
16 Abba Hillel Road, Ramat Gan 52506, Israel at a time and on a date to be specified by the parties, which shall be no later than
the second Business Day after the satisfaction or waiver of all the respective conditions set forth in Article VIII to be satisfied
or waived (other than those respective conditions that by their nature are to be satisfied at the IDIT Closing), or at such other
time, date and location as the Purchaser, IDIT and the IDIT Shareholders Representative agree in writing. The date on which the
IDIT Closing actually takes place is referred to in this Agreement as the "IDIT Closing Date".

 

    	31

    	 

    
Execution Copy

 

 

(b)Transactions
at IDIT Closing. At the IDIT Closing, the following transactions shall occur, which transactions shall be deemed to take place
simultaneously, and no transaction shall be deemed to have been completed or any document delivered until all such transactions
have been completed and all required documents delivered:

 

(i)Subject
to compliance with the conditions set forth in Section 8.04(e), IDIT shall register the transfer of all IDIT Shares to Purchaser
in the register of shareholders of IDIT, and shall provide Purchaser with a true and correct copy of such updated register of
shareholders reflecting such entry, certified by two directors of IDIT and the Purchaser shall acquire good and valid title, free
and clear of any Liens, to all IDIT Shares owned by the IDIT Selling Shareholders, including such IDIT Shares held by Non Executing
Shareholders in accordance with Section 341 of the Companies Law or any other procedures available under the IDIT Articles and
Applicable Law, and as of the IDIT Closing Date, Purchaser will own 100% of the issued and outstanding share capital of IDIT (on
a fully diluted basis).

 

(ii)IDIT
shall issue and deliver to Purchaser validly executed share certificate(s) covering all IDIT Shares, issued in the name of Purchaser.

 

(iii)Unless
otherwise provided for in this Agreement, the Purchaser shall pay the IDIT Purchase Price in accordance with the terms set forth
in Section 2.03(a)

. 

(c)Adjustments.
In the event of any stock split (bonus shares), consolidation, share dividend (including any dividend or distribution of securities
convertible into share capital), reorganization, reclassification, combination, recapitalization or other like change with respect
to any IDIT Shares occurring after the date hereof and prior to the IDIT Closing, all references in this Agreement to numbers of
shares and all calculations provided for that are based upon numbers affected thereby, shall be equitably adjusted to the extent
necessary to provide to the parties the same economic effect as contemplated by this Agreement prior to such event. 

 

Section
2.11FIS Closing. 

 

(a)Time
and Place. The consummation of the respective Transactions between Purchaser, FIS and the FIS Selling Shareholders (the
"FIS Closing", and each of FIS Closing and IDIT Closing may be referred to as the
"Closing") shall take place at the offices of Meitar, Liquornik, Geva & Leshem, Brandwein, Law Offices,
16 Abba Hillel Road, Ramat Gan 52506, Israel at a time and on a date to be specified by the parties, which shall be no later
than the second Business Day after the satisfaction or waiver of all the respective conditions set forth in Article VIII to
be satisfied or waived (other than those respective conditions that by their nature are to be satisfied at the FIS Closing),
or at such other time, date and location as the Purchaser, FIS and the FIS Shareholders Representative agree in writing. The
date on which the FIS Closing actually takes place is referred to in this Agreement as the "FIS Closing
Date" and each of FIS Closing Date and IDIT Closing Date may be referred to as the "Closing
Date".

 

(b)Transactions
at FIS Closing. At the FIS Closing, the following transactions shall occur, which transactions shall be deemed to take place
simultaneously, and no transaction shall be deemed to have been completed or any document delivered until all such transactions
have been completed and all required documents delivered:

 

(i)Subject
to compliance with the conditions set forth in Section 8.04(e), FIS shall register the transfer of all FIS Shares to Purchaser
in the register of shareholders of FIS, and shall provide Purchaser with a true and correct copy of such updated register of shareholders
reflecting such entry, certified by two directors of FIS and the Purchaser shall acquire good and valid title, free and clear
of any Liens, to all FIS Shares owned by the FIS Selling Shareholders, including such FIS Shares held by Non Executing Shareholders
in accordance with Section 341 of the Companies Law or any other procedures available under the FIS Articles and Applicable Law,
and as of the FIS Closing Date, Purchaser will own 100% of the issued and outstanding share capital of FIS (on a fully diluted
basis).

 

    	32

    	 

    
Execution Copy

 

 

(ii)FIS
shall issue and deliver to Purchaser validly executed share certificate(s) covering all FIS Shares, issued in the name of Purchaser.

 

(iii)Unless
otherwise provided for in this Agreement, the Purchaser shall pay the FIS Purchase Price in accordance with the terms set forth
in Section 2.03(b)

.

 

(c)Adjustments.
In the event of any stock split (bonus shares), consolidation, share dividend (including any dividend or distribution of securities
convertible into share capital), reorganization, reclassification, combination, recapitalization or other like change with respect
to any FIS Shares occurring after the date hereof and prior to the FIS Closing, all references in this Agreement to numbers of
shares and all calculations provided for that are based upon numbers affected thereby, shall be equitably adjusted to the extent
necessary to provide to the parties the same economic effect as contemplated by this Agreement prior to such event. 

 

Section
2.12Closing of One Transaction. 

 

Notwithstanding anything
to the contrary in this Agreement, the FIS Closing and the IDIT Closing shall be deemed to be separate closings and each such
closing shall be effected only subject to the fulfillment or waiver of all respective closing conditions applicable to such respective
Closing under Article VIII. Each of the FIS Closing and the IDIT Closing shall not be conditioned upon each other, and may take
place regardless of the other Closing, and even if the other Closing does not or has not occurred, in the event either the FIS
Closing or the IDIT Closing shall not take place, the Closing of the other transaction shall be subject to the approval of each
of the relevant Super Majority and the Purchaser.

 

Article
III

Representations and Warranties of the COMPANY

 

Except as set forth
in each Company Disclosure Schedule, which relates to such Section and to any other Section of such Disclosure Schedule to the
extent that it is reasonably apparent on the face of such disclosure that such disclosure is applicable to such Section, each Company
represents and warrants, with respect to itself and its Company Group (as defined below) only, severally but not jointly with the
other Company, to the Purchaser, that the statements contained in this Article III are true and correct as of the date of
this Agreement and as of the respective Closing Date:

 

    	33

    	 

    
Execution Copy

 

 

Section
3.01Corporate Existence and Power.

 

(a)Such
Company: (i) is a private company limited by shares, duly incorporated and validly existing under the laws of Israel; (ii) is duly
licensed or qualified to do business and, where applicable, is in good standing as a foreign corporation in all jurisdictions in
which the conduct of its business or the activities it is engaged in make such licensing or qualification necessary; and (iii)
has all necessary power and authority: (A) to conduct its business in the manner in which its business is currently being conducted;
(B) to own, use and distribute its assets in the manner in which its assets are currently owned, used and distributed; and (C)
to perform its obligations under all Contracts to which it is a party.

 

(b)Such
Company's Subsidiaries are listed in Section 3.01(b) of its respective Company Disclosure Schedule. Other than those
Subsidiaries listed in Section 3.01(b) of its Company Disclosure Schedule, there are no corporations, limited
liability companies, partnerships, joint ventures, associations or other entities or Persons in which such Company owns, of
record or beneficially, any direct or indirect equity or other interest or any right (contingent or otherwise) to acquire the
same.

 

(c)Such
Company has made available to Purchaser materially accurate and complete copies of (i) the articles of association, or other applicable
organizational documents of any member of its Company Group in effect, including all amendments thereto (the "Charter Documents")
and (ii) save as set forth in Section 3.01(c) of its respective Company Disclosure Schedule, the minutes of the meetings and other
proceedings (including any actions taken by written consent or otherwise without a meeting) of the shareholders and board of directors
and all committees thereof of any member of its Company Group since January 1, 2008; provided, however, that any such minutes that
were not made available to the Purchaser did not include any material resolutions of such Company Group that were not otherwise
disclosed in such Company's Disclosure Schedules. There has not been any violation of any of the provisions of the Charter Documents
of its Company Group since January 1, 2008. No Company Group has taken any action that is materially inconsistent with any
resolution adopted by its shareholders or board of directors (or any committee thereof). The books of accounts, share register,
minute books and other records that are required to be maintained under Applicable Law, of its Company Group are true, up-to-date
and complete in all material respects, and have been maintained in accordance with prudent business practices and all Applicable
Laws.

 

(d)Section
3.01(d) of its Company Disclosure Schedule accurately sets forth with respect to the each Company Group: (i) the names of
the members of the board of directors; (ii) the names of the members of each committee of the board of directors (or similar
body, to the extent applicable); and (iii) the names and titles of its executive officers.

 

(e)No
Company Group member has conducted any business under or has otherwise used, for any purpose or in any jurisdiction, any fictitious
name, assumed name, business name or other name, other than its corporate name as set forth in this Agreement and in Section
3.01(e)

of its Company Disclosure Schedule.

 

Section
3.02Corporate Authorization.

 

Such Company has all
necessary corporate power and authority to enter into and to perform its obligations under this Agreement and the other Transaction
Documents to which it is a party in accordance with the respective terms thereof; and the execution, delivery and performance by
such Company of this Agreement and the other Transaction Documents to which it is a party in accordance with the respective terms
thereof have been duly authorized by all necessary corporate action on the part of such Company. This Agreement constitutes and
any other Transaction Document to which such Company will be a party will constitute upon the execution thereof, the legal, valid
and binding obligation of such Company, and, assuming the due authorization, execution and delivery by the other party thereto,
is enforceable against such Company in accordance with its terms, subject to (i) laws of general application relating to bankruptcy,
insolvency, reorganization, moratorium and the relief of debtors, and (ii) rules of law governing specific performance, injunctive
relief and other equitable remedies. Upon the execution of each of the other Transaction Documents at the respective Closing, each
of such other agreements to which such Company and any of such Company Group members is a party will constitute the legal, valid
and binding obligation of the Company or such member, and will be, assuming the due authorization, execution and delivery by the
other party thereto, enforceable against such Company in accordance with its respective terms, subject to (i) laws of general application
relating to bankruptcy, insolvency, reorganization, moratorium and the relief of debtors, and (ii) rules of law governing specific
performance, injunctive relief and other equitable remedies. Such Company has taken all necessary actions required for the purpose
of enforcing this Agreement and effecting the sale of all Companies Shares hereunder on its respective Non-Executing Shareholders
in accordance with Section 341 of the Companies Law, Article 40 of IDIT Articles of Association or Article 105 of FIS Articles,
as applicable and any other applicable requirements (other than such actions required to be taken following the execution of this
Agreement, with respect to which such Company shall take all such necessary actions by the respective Closing) and the Executing
Shareholders of such Company constitute a sufficient majority in accordance with Section 341 of the Companies Law and Article 40
of IDIT Articles of Association or Article 105 of FIS Articles, as applicable, in order to effect a sale of all the Companies Shares
such that as of the respective Closing Purchaser will acquire good and valid title, free and clear of any Liens, in and to all
outstanding Companies Shares.

 

    	34

    	 

    
Execution Copy

 

 

Section
3.03Compliance with Applicable Law.

 

(a)Each
member of its Company Group is, and has at all times been, in compliance in all material respects with, and has operated its respective
business and maintained its assets and properties in material compliance with, all Applicable Laws. Neither Company Group has been
informed in writing that its operation are under investigation with respect to, given written notice of any violation or possible
violation of, or, to such Company’s Knowledge, is currently threatened to be charged with any violation of, Applicable Law.
To the Knowledge of such Company, no event has occurred, and no condition or circumstance exists, that will or is reasonably expected
to constitute or result in a violation by any member of its Company Group of, or a failure on the part of any member of such Company
Group to comply with or failure of its business and operations to be otherwise in compliance with, any Applicable Law.

 

(b)The
information provided by such Company and its Representatives in connection with the preparation of any filing or submission that
is necessary under the Antitrust Laws, as set forth in Section 6.06(b)

, is true and correct as of the date of this Agreement.

 

Section
3.04Governmental Authorizations; Governmental Grants.

 

(a)Section
3.04(a)

of its Company Disclosure Schedule identifies each Governmental Authorization held by its Company Group
or used in the business of such Company Group, and such Company has made available to Purchaser accurate and complete copies of
all such Governmental Authorizations and any and all correspondence and amendments related thereto. The Governmental Authorizations
identified in Section 3.04(a) of its Company Disclosure Schedule are valid and in full force and effect, and collectively
constitute all Governmental Authorizations necessary to enable the respective Company Group to conduct its business in the manner
in which such business is currently being conducted. Each Company Group member is, and has at all times been, in material compliance
with the terms and requirements of the respective Governmental Authorizations identified in Section 3.04(a) of its Company
Disclosure Schedule. No written notice or other written communication from any Governmental Authority was received by such Company
regarding: (i) any actual or possible violation of or failure to comply with any term or requirement of any Governmental Authorization;
or (ii) any actual or possible revocation, withdrawal, suspension, cancellation, termination or modification of any Governmental
Authorization.

 

    	35

    	 

    
Execution Copy

 

 

(b)Section
3.04

(b)

of its Company Disclosure Schedule identifies all Governmental Grants that have been provided to each
Company Group member. To the Knowledge of such Company, no event has occurred, and no circumstance or condition exists (other than
the intended consummation of the Transactions), that would reasonably be expected to give rise to : (A) the annulment, revocation,
withdrawal, suspension, cancellation, recapture or material adverse modification of any such Governmental Grant; (B) the imposition
of any material limitation on any Governmental Grant or any benefit available in connection with any Governmental Grant; (C) a
requirement that a member of such Company Group return or refund any benefits provided therefor under any Governmental Grant or
(D) the applicability of any Governmental Grant (and any limitation or requirement arising therefrom) to its Company Group, its
business or assets.

 

Section
3.05Non-Contravention.

 

Except as set
forth in Section 3.05 of its Company Disclosure Schedule, neither: (1) the execution, delivery or performance by such
Company of this Agreement or any of the Transaction Documents to which it is a party; nor (2) the consummation by such
Company of the Transactions, will (with or without notice or lapse of time or both):

 

(a)contravene,
conflict with or result in a violation of: (i) any of the provisions of any Charter Document of its Company Group or (ii) any Applicable
Law;

 

(b)give
any Governmental Authority or other Person the right to challenge any of the Transactions or to exercise any remedy or obtain any
relief, under any Applicable Law;

 

(c)contravene,
conflict with or result in a violation of any of the terms or requirements of, or give any Governmental Authority the right to
revoke, withdraw, suspend, cancel, terminate or materially and aversely modify, any Governmental Authorization that is held by
its Company Group or that, to such Company’s Knowledge, otherwise relates to such Company Group's business or to any of the
assets owned or used by such Company Group;

 

(d)contravene,
conflict with or result in a violation or breach of, or result in a default under, any provision of any Company Material Contract
by which its Company Group is bound, or give any Person the right to: (i) declare a default or exercise any remedy under any such
Company Material Contract; (ii) accelerate the maturity or performance of any such Company Material Contract; or (iii) cancel,
terminate or modify any such Company Material Contract; or

 

(e)require
the Company to make any filing with or give any notice to, or to obtain any Consent from, any Person with respect to any Material
Contract or any Governmental Authority in connection with: (x) the execution, delivery or performance of this Agreement or any
of the other Transaction Documents; or (y) the consummation of the Transactions contemplated by this Agreement; or

 

    	36

    	 

    
Execution Copy

 

 

(f)result
in the imposition or creation of any Lien upon or with respect to any asset owned or used by its Company Group.

 

Section
3.06Capitalization.

 

(a)The
authorized share capital of FIS is NIS 59,101, and is divided into 50,401 FIS Ordinary Shares, 6,500 Series A Preferred Shares,
par value NIS 1.00 each and 2,200 A-1 Preferred Shares, par value NIS 1.00 each, out of which 21,378 Ordinary Shares, 6,317 Series
A Preferred Shares and 2,106 Series A-1 Preferred Shares are issued and outstanding. All of the issued and outstanding FIS Shares
are and have been, when issued in accordance with the respective terms thereof, duly authorized and validly issued, fully paid
and nonassessable.

 

(b)The
authorized share capital of IDIT is NIS 53,000, and is divided into 45,000 ordinary shares, nominal value NIS 1.00 per share, 5,000
series A-1 preferred shares, nominal value NIS 1.00 per share and 3,000 series A-2 preferred shares, nominal value NIS 1.00 per
share, out of which 30,691 ordinary shares, nominal value NIS 1.00 per share and 4,911 series A-1 preferred shares are issued and
outstanding. All of the issued and outstanding IDIT Shares are and have been when issued in accordance with the respective terms
thereof, duly authorized and validly issued, fully paid and nonassessable.

 

(c)Section
3.06(c)of its Company Disclosure Schedule sets forth a true and complete list of all outstanding options of such Company and
with respect to each outstanding option, (A) the particular option plan pursuant to which such outstanding option was granted,
(B) the name of the holder thereof, (C) the number and class of shares of the Company issuable thereunder and the number of such
shares with respect to which such outstanding option has vested, (D) the vesting schedule with respect to the unvested outstanding
options, (E) the date on which the outstanding option was granted, and (F) the exercise price thereof. Except as set forth in
Section 3.06(c) of its Company Disclosure Schedule, there are no outstanding (i) shares of each Company Group or (ii) securities,
instruments or obligations of such Company Group that are or may become convertible into or exchangeable for shares or other securities
of such Company Group or conditions or circumstances that may give rise to the assertion of a claim by any Person to the effect
that such Person is entitled to acquire or receive any shares or other securities of any Company Group.

 

(d)Section
3.06(d) of its Company Disclosure Schedule sets forth a complete and accurate list, by name, of such Company’s
shareholders, and the number of Companies Shares owned by such shareholder, identified by class and series. All outstanding
Companies Shares have been issued and granted in compliance with (i) all Applicable Laws; (ii) all requirements set forth in
the Charter Documents of such Company; and (iii) all requirements set forth in applicable Contracts. None of the outstanding
Companies Shares were issued in violation of any preemptive rights or other rights to subscribe for or purchase securities of
the Companies. Section 3.06(d) of its Company Disclosure Schedule accurately identifies each Contract signed by the Company,
relating to any securities of each Company that contains any registration rights, first refusal, tag along or pre-emptive or
first offer rights.

 

(e)Other
than as set forth in Section 3.06(e) of its Company Disclosure Schedule, such Company has never repurchased, redeemed
or otherwise reacquired any of its shares or other securities and there are no outstanding rights or obligations of any
Company to repurchase or redeem any of its securities. All shares repurchased or redeemed by such Company, were repurchased
or redeemed in compliance with: (i) all Applicable Laws; and (ii) all requirements set forth in such Company's Charter
Documents and relevant Contracts.

 

    	37

    	 

    
Execution Copy

 

 

(f)(i)
the allocation of the IDIT Purchase Price or the FIS Purchase Price, as applicable, as set forth in Exhibit C and Exhibit D (as
may be amended no later than two (2) Business Days prior to the respective Closing Date to reflect any changes in such Company's
share capital), shall be complete and accurate as of the respective Closing and shall accurately represent the consideration that
each Selling Shareholder (including Non Executing Shareholders) of such Company is entitled to receive for its/his Companies Shares
out of the IDIT Purchase Price or FIS Purchase Price, as applicable, pursuant to the respective Charter Documents, as may be amended
prior to the respective Closing, and the terms hereof; and (ii) to the Company’s Knowledge, no third party, other than the
Selling Shareholders (including the Non-Executing Shareholders) is entitled to receive any payment from the Purchaser or Parent
in consideration for security of any of the Companies or has merit to challenge or dispute such allocation.

 

Section
3.07Products. 

 

(a)Each
Company Product fits, in all material respects, for the purposes for which it is intended to be used as set out in Contracts under
which such Company sells such Product.

 

(b)Except
as set fort in Section 3.07(b) of its Company Disclosure Schedule, there are no claims pending and submitted to the Company
Group or to the Company's Knowledge threatened against such Company Group member with respect to the quality of or absence of
defects in any Company Products.

 

(c)Other
then as set out in Section 3.07(c) of its Company's Disclosure Schedule, since January 1, 2008, there have been no recalls with
respect to any of the Company Products or any written request to either terminate services provided by any Company Group member
or purchase any of its products, and to the Knowledge of such Company, there are no facts, events or circumstances reasonably
expected to cause the withdrawal or recall of any product sold by any Company Group member.

 

Section
3.08Financial Statements.

 

(a)Such
Company has made available to Purchaser such Company’s audited consolidated balance sheet as of, and the related audited
statements of income, changes in shareholders’ equity and cash flows for the fiscal year ended, December 31, 2010 (the "Balance
Sheet Date") (collectively, the "Company's Financial Statements").

 

(b)The
Company's Financial Statements (i) have been prepared based on the books and records of each Company Group, (ii) comply as to form
with applicable accounting requirements with respect thereto, (iii) have been prepared in accordance with IFRS applied on a consistent
basis throughout the periods indicated (except as may be indicated therein or in the notes thereto) and consistent with each other,
(iv) fairly present the financial condition of the respective Company Group as of the Balance Sheet Date and the consolidated results
of operations and cash flows of such Company Group for the periods therein specified; and (v) accurately reflect all of such Company
Group's guarantees for Liabilities of other Persons.

 

(c)The
books of account of each Company Group have been kept accurate in the ordinary course of business consistent in all material respects
with Applicable Law, the transactions entered therein represent bona fide transactions, and the revenues, expenses, assets and
liabilities of each Company Group have been properly recorded therein. The other financial records of each Company Group have been
kept accurate in the ordinary course of business consistent with Applicable Law, the transactions entered therein represent bona
fide transactions, and the revenues, expenses, assets and liabilities of each Company Group have been properly recorded therein.

 

    	38

    	 

    
Execution Copy

 

 

(d)Neither
Company Group member nor any director or officer or, to the Knowledge of the Company, any employee, auditor, accountant or representative
of such Company Group member, has received any written complaint, allegation, assertion or claim, regarding any material deficiency
in the accounting or auditing practices, procedures, methodologies or methods of the Company Group or its internal accounting controls,
including any complaint, allegation, assertion or claim that such Company Group member has engaged in questionable accounting or
auditing practices.

 

(e)Section
3.08(e) of its Company Disclosure Schedule provides an accurate and complete breakdown of all amounts (including loans,
advances or other Indebtedness) owed to each Company Group by a director, officer, employee or shareholder of such Company
Group (other than travel advances made in the ordinary course of business) (the "Insider Receivables"). All
Insider Receivables (including those receivables reflected in the Company's Financial Statements that have not yet been
collected and those receivables that have arisen since the Balance Sheet Date and have not yet been collected, and which are
in material amount): (i) represent valid obligations arising from bona fide transactions entered into between such Company
Group member and a director, officer, employee or shareholder of such Company Group member in the ordinary course of business
and not in violation of any Applicable Law; and (ii) to the Company's Knowledge, will be collected in full when due, without
any counterclaim.

 

Section
3.09Notes and Accounts Receivable. 

 

Section
3.09 of its Company Disclosure Schedule provides an accurate reconciliation of all accounts receivable, notes receivable
and other receivables (other than Insider Receivables) of each member of its Company Group as of March 31, 2011. Except as
set forth in Section 3.09 of its Company Disclosure Schedule ,all notes and
accounts receivable of each Company Group(including those accounts receivable reflected on the Company's Financial Statements
that have not yet been collected and those accounts receivable that have arisen since the
Balance Sheet Date and have not yet been collected) are reflected properly on its books and records, are valid and existing
receivables arising from bona fide transactions not consummated in violation of any Applicable Law and are subject to no
refunds or other adjustments or rights enforceable by third parties. To the Knowledge of such Company, all notes and accounts
receivable of each Company Group will be collected in accordance with their terms at their recorded amounts, subject to the
reserve for bad debts set forth in the Company's Financial Statements as may be adjusted for the passage of time through the
respective Closing Date in accordance with the past custom and practice of such Company Group.

 

Section
3.10Deleted

 

Section
3.11Absence of Certain Changes.

 

Since the Balance
Sheet Date, the business of each Company Group has been conducted in the ordinary course of business and consistent with past
practices (except for actions taken in connection with the negotiation of this Agreement and the performance of the Transactions)
and, except as set forth in Section 3.11 of its Company Disclosure Schedule, there has not been:

 

    	39

    	 

    
Execution Copy

 

 

(a)any
event, occurrence, development or state of circumstances or facts that has had is reasonably expected to have, individually or
in the aggregate, a Material Adverse Effect with respect to the Company Group (collectively);

 

(b)any
amendment of the Charter Documents of each Company Group member;

 

(c)any
payment, discharge or satisfaction of any Liabilities in excess of US$100,000, other than the payment, discharge or satisfaction
of accounts payable or accrued expenses incurred in the ordinary course of business;

 

(d)any
capital expenditure or commitment for additions to property, plant or equipment, or lease agreement, which individually exceeds
US$100,000 or exceeds US$150,000 in the aggregate, and which, if purchased, would be reflected in the property, plant or equipment
accounts;

 

(e)any
damage, destruction or loss of any of such Company Group's Assets and Properties, whether or not covered by insurance, which individually
exceeds US$50,000or exceeds US$100,000 in the aggregate;

 

(f)except
for Liabilities incurred in the ordinary course of business, any incurrence of a Liability, including any Liability for nonperformance
or termination of any Company Material Contract;

 

(g)(i)
any splitting, combination or reclassification of any Companies Shares; (ii) any declaration, setting aside or payment of any dividend
or other distribution (whether in cash, shares or property or any combination thereof) in respect of any Companies Shares; (iii)
any redemption, repurchase or other acquisition or offer to redeem, repurchase, or otherwise acquire any Companies Shares; (i)
any issuance, delivery or sale, or authorization of the issuance, delivery or sale of, any Companies Shares, or (ii) any amendment
or waiver of (in each case, whether by merger, consolidation or otherwise) any term of any Companies Shares;

 

(h)any
cancellation or waiver of any claims or rights of value or incurrence of any Lien on, any assets, securities, properties, interests
or businesses of each Company Group in each case which individually exceeds US$100,000 or US$200,000 in the aggregate;

 

(i)the
making by any Company Group of any loans, guarantee or capital contributions to, or investments in, any other Person, which individually
exceeds US$50,000 or US$100,000 in the aggregate;

 

(j)the
creation of any Company Debt which individually exceeds US$50,000 or US$100,000 in the aggregate;

 

(k)the
sale, disposition of, transfer or license to any Person of any substantial rights or any rights to any Company IP Rights or other
material assets by any Company Group, or the acquisition, lease or license from any Person of any rights including any Intellectual
Property or other assets, in each case other than in the ordinary course of business;

 

(l)(i)
the grant or increase of any severance or termination pay to (or amendment of any existing arrangement with) any director, officer,
advisor, consultant or key employee, of any Company Group, (ii) any increase in benefits payable to any such director, officer,
advisor, consultant or key employee under any existing severance or termination pay policies or employment agreements, (iii) the
entering into of any employment, deferred compensation or other similar agreement (or amendment of any such existing agreement)
with any director, officer, advisor, consultant or key employee of any Company Group, (iv) the establishment or adoption or amendment
(except as required by Applicable Law) of any collective bargaining, bonus, commission, profit-sharing, thrift, pension, retirement,
deferred compensation, compensation, share option, restricted share or other benefit plan or arrangement covering any director,
officer, advisor, consultant or key employee of any Company Group or (v) any increase in compensation, bonus, commission or other
benefits payable to any director, officer, advisor, consultant or key employee of any Company Group;

 

    	40

    	 

    
Execution Copy

 

 

(m)any
change in the methods of accounting or accounting practices of such Company, except as required by concurrent changes in IFRS,
as agreed to by its independent public accountants;

 

(n)any
elimination of any reserves established on each Company Group’s books or any changing of the method of accrual unless there
is any change of significant facts or circumstances pertaining to any reserves which would justify their elimination;

 

(o)any
settlement of, or offer or proposal by any Company Group to settle, any Proceeding involving such Company Group or that relates
to the Transactions;

 

(p)any
Tax election made or materially changed; any claim, notice, audit report or assessment in respect of Taxes settled or compromised
(or agreement with respect thereto); any Tax Return filed (except as required under Applicable Law); any Tax allocation agreement,
Tax sharing agreement, advance pricing agreement, cost sharing agreement, pre-filing agreement, Tax indemnity agreement or closing
agreement relating to any Tax entered into; any annual Tax accounting period or method of Tax accounting changed or adopted; any
Tax petition, Tax complaint or administrative Tax appeal filed; any right to claim a Tax refund surrendered or foregone (which
is reasonably expected to be material to any Company Group); or any extension or waiver of the statute of limitations period applicable
to any Tax claim or assessment consented to, nor has any application or negotiation for or receipt of a Tax ruling or arrangement
been made by or on behalf of any Company Group member, whether or not in connection with the Transactions, except as explicitly
contemplated in this Agreement;

 

(q)any
write off as uncollectible of, or any establishment of extraordinary reserve with respect to, any account receivable or other Indebtedness,
which individually exceeds US$50,000 or US$100,000 in the aggregate;

 

(r)any
acquisition of a business or Person, by merger or consolidation, purchase of substantial assets or equity interests, or by any
other manner, in a single transaction or a series of related transactions, or entering into any Contract, letter of intent or similar
arrangement (whether or not enforceable), other than with the Purchaser, with respect to any of the foregoing;

 

(s)any
distribution by such Company to its shareholders of any asset or a declaration thereof;

 

(t)the
commencement of any Proceeding; or

 

(u)any
agreement or commitment to take any of the actions referred to in clauses (a) through (t).

 

Section
3.12No Undisclosed Liabilities.

 

    	41

    	 

    
Execution Copy

 

 

(a)No
Company Group member has any Liabilities of any kind, whether or not required to be reflected or reserved in financial statements
in accordance with IFRS, other than:

 

(i)Liabilities
reflected in the "liabilities" column of the balance sheet that is part of the Company's Financial Statements or in the
notes thereto;

 

(ii)accounts
payable and accrued salaries that have been incurred by each Company Group since the Balance Sheet Date in the ordinary course
of business and consistent with past practice; and

 

(iii)Liabilities
identified in Section 3.12

of its Company Disclosure Schedule.

 

Section
3.13Material Contracts.

 

(a)Except
as set forth in Section 3.13(a) of its Company Disclosure Schedule, no Company Group member is bound by any of the
following Contracts and to the Company's Knowledge, nor is any shareholder of such Company or any Affiliate thereof bound by
any such Contract that is necessary for the business, operations or assets of its Company Group (a Contract meeting any of
the following categories is hereinafter referred to as a "Company Material Contract"):

 

(i)
all leases or other Contracts under which a Company Group member is a lessee of, or holds or operates, any machinery, equipment,
vehicle or other tangible personal property owned by a third party and used in the business of such Company Group and which entails
annual payments, in the case of any such lease or agreement, in excess of US$100,000, or US$200,000 in the aggregate;

 

(ii)any
Contract relating to the acquisition, transfer, use, development, sharing or license, other than in the ordinary course of business,
of any technology, or Intellectual Property rights (including any joint development agreement, technical collaboration agreement
or similar agreement), to or from each Company Group member other than any end user license agreements for non-exclusive "off
the shelf" software used by any Company Group member;

 

(iii)any
Contract imposing any restriction on the right or ability of each Company Group, (A) to compete with any other Person with respect
to the products or services offered by such Company Group (including granting exclusive rights or rights of first refusal to license,
market, sell or deliver any of the products or services offered by such Company Group), (B) to acquire any product or other asset
or any services of the types offered by such Company Group from any other Person or to sell any product or other asset of the types
sold by such Company Group to, or perform any services of the types offered by such Company Group for, any other Person, or (C)
to develop, distribute, license, sell or transfer any Intellectual Property rights;

 

(iv)all
outstanding Contracts with customers or vendors expected to result in payment to or by any Company Group in excess of US$300,000
during a period of 12 months following the Closing Date;

 

(v)all
outstanding Contracts with Company Significant Customers and Company Significant Suppliers (as such terms are defined below);

 

    	42

    	 

    
Execution Copy

 

 

(vi)any
partnership, joint venture or any sharing of revenues, profits, losses, costs or liabilities Contract expected to result in payment
to or by any Company Group in excess of US$150,000 during a period of 12 months following the Closing Date;

 

(vii)any
Contract involving a loan in excess of US$100,000 (other than accounts receivable from trade debtors in the ordinary course of
business) or advance to (other than travel, accommodation or entertainment allowances to the employees, directors, officers and
advisors of each Company Group extended in the ordinary course of business), or investment in, any Person or any Contract relating
to the making of any such loan, advance or investment;

 

(viii)any
Contract relating to the acquisition, issuance or transfer of any securities, other than options to purchase shares under such
company's option plans, and the voting and any other rights or obligations of a shareholder of any Company Group entered into following
January 1, 2008 or that contains any outstanding obligations of any member of the Company Group;

 

(ix)any
Contract under which (A) any third party has directly or indirectly guaranteed any liabilities or obligations of any Company Group
in excess of US$100,000, or (B) any Company Group has directly or indirectly guaranteed liabilities or obligations in excess of
US$100,000 of any third party;

 

(x)any
Contract relating to the creation of any Lien with respect to any material asset of any Company Group and all mortgages, indentures,
security agreements, pledges, notes, loan agreements or guarantees creating any such Lien;

 

(xi)any
Contract which contains any provisions requiring any Company Group to indemnify any other party, other than in the ordinary course
of business;

 

(xii)any
Contract of any Company Group with any Related Person;

 

(xiii)all
management service, consulting, financial advisory or any other similar Contract, and any Contracts with any investment bank for
investment banking services;

 

(xiv)all
Contracts (including letters of intent that have not yet expired by their terms) involving the future disposition or acquisition
of assets or properties, other than in the ordinary course of business, or any merger, consolidation or similar business combination
transaction;

 

(xv)all
Contracts entered into since January 1, 2008, involving any resolution or settlement of any actual or threatened litigation, arbitration,
claim or other dispute; and

 

(xvi)all
Contracts that contain restrictions with respect to the payment of dividends or any other distribution in respect of the capital
stock or other equity interests of each Company member;

 

(xvii)all
other Contracts that are material to the business of each Company Group.

 

(b)Such
Company has made available to Purchaser materially accurate and complete copies of all written Company Material Contracts
required to be identified in Section 3.13(a) of its Company Disclosure Schedule, including all amendments thereto. Section
3.13(b) of its Company Disclosure Schedule provides an accurate description of the material terms of each Company
Material Contract identified in Section 3.13(a) of its Company Disclosure Schedule that is not in written form.

 

    	43

    	 

    
Execution Copy

 

(c)Each
Company Material Contract is a valid and binding agreement of the applicable Company Group member, and is in full force and effect,
and is enforceable by such Company Group member in accordance with its terms, subject to: (i) laws of general application relating
to bankruptcy, insolvency and the relief of debtors; and (ii) rules of law governing specific performance, injunctive relief and
other equitable remedies. No Company Group is in default or breach under the terms of any Company Material Contract and, to the
Knowledge of such Company, no other party thereto is in default or breach under the terms of any Company Material Contract. To
the Knowledge of such Company, no event has occurred, and no circumstance or condition exists, that (with or without notice or
lapse of time or both) will, or would reasonably be expected to, (i) result in a violation or breach of any provision of any
Company Material Contract by any party thereto, (ii) give any Person the right to declare a default or exercise any remedy
under any Company Material Contract, (iii) give any Person the right to accelerate the maturity or performance of any Company
Material Contract, or (iv) give any Person the right to cancel, terminate or modify any Company Material Contract. Since January
1, 2008, no Company Group member has waived any of its rights under any Company Material Contract.

 

(d)Except
as set fort in Section 3.13(d)

of its Company Disclosure Schedule, since January 1, 2008, no Company Group has received any written notice
regarding any violation or breach of, or default under, any Company Material Contract.

 

Section
3.14Restrictions on Business Activities.

 

There is no written
Contract or any order of Governmental Authority binding upon any Company Group member that has or could reasonably be expected
to have the effect of prohibiting or impairing any business practice of such Company Group member, acquisition of property by such
Company Group member, or the conduct of business by such Company Group member as currently conducted.

 

Section
3.15Litigation.

 

(a)Except
as set forth in Section 3.15(a) of its Company Disclosure Schedule there is no pending Proceeding that has been submitted to such
Company Group nor has any Person threatened in writing to commence any Proceeding: (i) that involves any Company Group or its business,
any of the assets or properties owned or used by such Company Group, any Company Product or any Person whose liability to the Company
Group has or may have been retained or assumed, either contractually or by operation of law; (ii) that challenges, or that may
be reasonably expected to have the effect of preventing, delaying, or making illegal the consummation of the Transactions; or (iii)
that relates to the ownership of any share capital of any Company Group member, or any Option or other right to acquire share capital
of any Company Group member, or any right to receive consideration as a result of this Agreement. The Company has not been informed
in writing of, and to its Knowledge no event has occurred, and no claim, dispute or other condition or circumstance exists, that
is reasonably expected to give rise to or serve as a basis for the commencement of any such Proceeding.

 

(b)There
is no order, writ, injunction, directive, restriction, judgment or decree issued by any Governmental Authority by which any Company
Group, or any of the assets owned or used by such Company Group member, is subject or which restricts in any respect the ability
of such Company Group to conduct its business as now being conducted. To the Knowledge of such Company, no officer, director, shareholder
or employee of any Company Group (in each case, in his or her capacity as such) is subject to any order, writ, injunction, judgment
or decree that prohibits such person from engaging in or continuing any conduct, activity or practice relating to the business
of such Company Group.

 

    	44

    	 

    
Execution Copy

 

 

Section
3.16Properties.

 

(a)No
Company Group member owns any real property. Each Company Group has a good and valid leasehold interest in each parcel of real
property leased by such Company Group or used or required for the conduct of its business (the "Company Leased Real Property").
Section 3.16(a) of each Company Disclosure Schedule lists each lease, subleases, license or other occupancy agreement or
arrangement relating to the Company Leased Real Property (each, a "Real Property Lease"). Each Company Group
has the right to use and occupy each respective Company Leased Real Property for the full term of the Real Property Lease relating
thereto, subject to its respective terms.

 

(b)Each
Company Group owns and has good and marketable title to, or a valid license or leasehold interest in, all tangible personal property
and assets used by such Company Group or required for the conduct of its business (the "Assets"). Except as set
fort in Section 3.16(b) of its Company Disclosure Schedule, none of the Assets is subject to any Lien, except Liens for taxes
not yet due and payable or mechanic’s, carrier’s, worker’s, material man’s, warehouse man’s, supplier’s,
vendor’s or similar Liens arising or incurred in the ordinary course of business.

 

(c)Section
3.16 (c) of its Company Disclosure Schedule identifies all Assets, including those Assets that are being licensed or
leased to each Company Group or used or required for the conduct of its business as of March 31, 2011 (the "Leased
Assets"). All Leased Assets are leased pursuant to valid, binding and enforceable Contracts in accordance with their
respective terms (the "Lease Contracts").

 

(d)The
Assets and Leased Assets have no material defects, are in good operating condition and repair, ordinary wear and tear excepted,
and have been reasonably maintained consistent with standards generally followed in the industry (giving due account to the age
and length of use of same, ordinary wear and tear excepted), and are adequate and suitable for their present uses.

 

(e)The
Assets and the Leased Assets constitute all of the tangible personal property and assets used or held for use in connection with
the business of each Company Group.

 

Section
3.17Customers and Suppliers.

 

Section 3.17
of its Company Disclosure Schedule sets forth a list of
the 10 (ten) largest customers of the Company Group (collectively) for the year ended December 31, 2010 (each, a "Company
Significant Customer") and
the 10 (ten) largest suppliers of products and/or services to the Company Group (collectively) for the year ended December 31,
2010 (each, a "Company Significant Supplier"),
in each case based on amounts paid or payable with
respect to such year, along with such amounts.

 

No Company Group member
has any outstanding material dispute with any Company Significant Customer or Company Significant Supplier. As of the date hereof,
the Company Group has not received any written notice from any Company Significant Customer or Company Significant Supplier that
such Company Significant Customer or Company Significant Supplier intends to discontinue its relationship with the respective Company
Group or that such Company Significant Customer or Company Significant Supplier intends to materially and adversely (to the Company
Group) modify its existing contractual relationship with such Company Group.

 

    	45

    	 

    
Execution Copy

 

 

Section
3.18Intellectual Property.

 

(a)As
used in this Agreement, the following terms shall have the meanings indicated below:

 

(1)"Intellectual
Property" means any and all intellectual property rights and all rights associated therewith, including all patents and
applications therefor and all reissues, divisions, renewals, extensions, provisionals, continuations and continuations-in-part
thereof, all inventions (whether patentable or not), invention disclosures, improvements, trade secrets, proprietary information,
know how, technology, technical data, proprietary processes and formulae, algorithms, specifications, all industrial designs and
any registrations and applications therefor, all trade names, logos, common law trademarks and service marks, trademark and service
mark registrations and applications therefor, Internet domain names, Internet and World Wide Web URLs or addresses, all copyrights,
copyright registrations and applications therefor, and all other rights corresponding thereto, all computer software, including
all source code, object code, firmware, development tools and related files, records and data, all test methodologies and all rights
in prototypes, and other devices, all databases and data collections and all rights therein, all moral and economic rights of authors
and inventors, however denominated, and any similar or equivalent rights to any of the foregoing, and all tangible embodiments
of the foregoing.

 

(2)"Company
IP Rights" means, with respect to each Company Group, (A) any and all Intellectual Property used in or required for the
conduct of the business of such Company Group as currently conducted by such Company Group; and (B) any and all other Intellectual
Property owned by or licensed to such Company Group.

 

(3)"Company-Owned
IP Rights" means, with respect to each Company Group, (A) Company IP Rights that are owned by or exclusively licensed
to such Company Group; and (B) Company IP Rights that were developed for such Company Group by full or part time employees, consultants
or service providers of such Company Group.

 

(4)
"Third Party Intellectual Property Rights" means any Intellectual Property owned by a third party.

 

(5)
"Company Source Code" means, collectively, any software source code or confidential manufacturing specifications
or designs, any material portion or aspect of software source code or confidential manufacturing specifications or designs, or
any material proprietary information or algorithm contained in or relating to any software source code or confidential manufacturing
specifications or designs, of any Company-Owned IP Rights or Company Products.

 

(b)Each
Company Group (i) owns and has independently developed or acquired, or (ii) has the valid right or license to all its Company IP
Rights. Such Company IP Rights are sufficient for the conduct of the business of such Company Group as currently conducted.

 

(c)No
Company Group has transferred ownership of any Intellectual Property that is or was Company-Owned IP Rights to any third party,
or knowingly permitted such Company Group’s rights in any Intellectual Property that is or was Company-Owned IP Rights to
enter the public domain or, with respect to any Intellectual Property for which such Company Group has submitted an application
or obtained a registration, lapse (other than through the expiration of registered Intellectual Property at the end of its maximum
statutory term).

 

    	46

    	 

    
Execution Copy

 

 

(d)Each
Company Group owns and has good and exclusive title to each item of Company-Owned IP Rights, free and clear of any Liens. The right,
license and interest of such Company Group in and to all Third Party Intellectual Property Rights licensed by such Company Group
from a third party are free and clear of all Liens (excluding conditions and restrictions contained in the applicable license agreements
with such third parties).

 

(e)After
the respective Closing, all Company-Owned IP Rights will be fully transferable, alienable or licensable by Purchaser without restriction
and without payment of any kind to any third party.

 

(f)Section
3.18(f) of its Company Disclosure Schedule lists for each Company Group all of its Company-Owned IP Rights including the
jurisdictions in which each such item of Company-Owned IP Rights, to the extent issued or registered, has been issued or
registered or in which any application for such issuance and registration has been filed, or in which any other filing or
recordation has been made. Each item of Company-Owned IP Rights is valid and subsisting (or in the case of applications,
applied for), all registration, maintenance and renewal fees currently due in connection with such Company-Owned IP Rights
have been paid and all documents, recordations and certificates in connection with such item of Company-Owned IP Rights
currently required to be filed have been filed.

 

(g)[Deleted]

 

(h)Except
as set forth in Section 3.18(h) of its Company Disclosure Schedule, no Company Group is or shall it be as a result of the
execution and delivery or effectiveness of this Agreement and the other Transaction Documents or the performance of such
Company’s obligations hereunder and thereunder, in breach of any Contract governing any Company IP Rights (the
"Company IP Rights Agreements") and the consummation of the Transactions will not result in the
modification, cancellation, termination, suspension of, or acceleration of any payments with respect to the Company IP Rights
Agreements, or give any third party to any Company IP Rights Agreement the right to do any of the foregoing. Following the
respective Closing, such Company (as wholly-owned by Purchaser) will be permitted to exercise all of such Company’s
rights under the Company IP Rights Agreements to the same extent such Company would have been able to had the Transactions
not occurred and without the payment of any additional amounts or consideration.

 

(i)Except
as set forth in Section 3.18(i) of its Company Disclosure Schedule, none of the Company IP Rights Agreements grants any third
party exclusive rights to or under any Company IP Rights or grants any third party the right to sublicense any Company IP
Rights.

 

(j)Except
as set forth in Section 3.18(j) of its Company Disclosure Schedule, there are no royalties, honoraria, fees or other payments
payable by any Company Group to any Person (other than salaries payable to employees, consultants and independent contractors
not contingent on or related to use of their work product) as a result of the ownership, use, possession, license-in,
license-out, sale, marketing, advertising or disposition of any Company-Owned IP Rights by any Company Group.

 

(k)To
the Knowledge of such Company, there is no unauthorized use, unauthorized disclosure, infringement or misappropriation of any of
its Company-Owned IP Rights, by any Person. No Company Group has brought any action, suit or proceeding for infringement or misappropriation
of any its Intellectual Property or breach of any of its Company IP Rights Agreement.

 

    	47

    	 

    
Execution Copy

 

 

(l)Except
as set forth in Section 3.18(l) of its Company Disclosure Schedule, no Company Group has been sued in any Proceeding (or
received any written notice or threat with respect to any Proceeding) which involves a claim of infringement or
misappropriation of any Intellectual Property right of any third party or which contests the validity, ownership or right of
such Company Group to exercise any Intellectual Property right.

 

(m)The
operation of the business of each Company Group as such business is currently conducted, and the use or exploitation of any Company
IP Rights by such Company Group does not and will not infringe or misappropriate the Intellectual Property of any third party and
does not constitute unfair competition or unfair trade practices under any Applicable Laws.

 

(n)Except
as set forth in Section 3.18(n) of its Company Disclosure Schedule, each Company Group has secured from all of its current
and former consultants, employees and independent contractors and the respective Affiliates thereof who independently or
jointly contributed to the conception, reduction to practice, creation or development of any of its Company IP Rights,
Company-Owned IP Rights or Company Products, unencumbered and unrestricted exclusive ownership of all such third
party’s Intellectual Property in such contribution that such Company Group does not already own by operation of law and
such third party has not retained any rights or licenses with respect thereto. Without limiting the foregoing, each Company
Group member has obtained valid and enforceable proprietary information and invention disclosure and assignment agreements
from all current and former employees, consultants, service providers and independent contractors of such Company Group.

 

(o)No
current or former shareholder, employee, consultant or independent contractor of any Company Group is or has been, to such Company’s
Knowledge, in violation of any term or covenant of any Contract relating to employment, invention disclosure, invention assignment,
non-disclosure or non-competition by virtue of such shareholder's employee, consultant or independent contractor being employed
by, or performing services for such Company Group with respect to any technology, software or other copyrightable, patentable or
otherwise proprietary work developed for such Company Group that is subject to any agreement under which such employee, consultant
or independent contractor or Affiliate thereof has assigned or otherwise granted to any third party any rights (including Intellectual
Property rights) in or to such technology, software or other copyrightable, patentable or otherwise proprietary work. To such Company’s
Knowledge, the employment of any employee of each Company Group or the use by the Company of the services of any consultant or
independent contractor (including the services of any employees and consultants of such independent contractors) does not subject
such Company Group to any liability to any third party for improperly soliciting such employee, consultant or independent contractor
to work for such Company Group.

 

(p)Each
Company Group has taken all commercially reasonable steps to protect and preserve the confidentiality of all material confidential
or non-public information included in the Company Owned IP Rights ("Confidential Information").

 

(q)Section 3.18(q) of
its Company Disclosure Schedule lists all software or other material that is distributed as "free
software", "open source software" or under a similar licensing or distribution terms (including but not
limited to the GNU General Public License (GPL), GNU Lesser General Public License (LGPL), Mozilla Public License (MPL), BSD
licenses, the Artistic License, the Netscape Public License, the Sun Community Source License (SCSL) the Sun Industry
Standards License (SISL) and the Apache License) ("Open Source Materials") used by each Company Group in
(i) its Company Products or (ii) the business of such Company Group. Each Company Group is in compliance with the
terms and conditions of all licenses for Open Source Materials.

 

    	48

    	 

    
Execution Copy

 

 

(r)The
Company IP Rights or Company Products (i) do not incorporate Open Source Materials, and are not combined with Open Source
Materials; (ii) are not distributed in conjunction with any Open Source Materials; and (iii) do not use Open Source Materials,
in each of (i), (ii) and (iii), in such a way that, with respect to each of (i), (ii) and (iii), creates, or purports to create
obligations for any Company Group with respect to its Company IP Rights or Company Products or grant, or purports to grant, to
any third party, any rights or immunities under any Company IP Rights or Company Products (including using any Open Source Materials
that require, as a condition for such use, modification and/or distribution of such Open Source Materials that other software incorporated
into, derived from or distributed with such Open Source Materials be (A) disclosed or distributed in source code form, (B) be
licensed for the purpose of making derivative works, or (C) be redistributable at no charge).

 

(s)No
Company Product contains any "back door," "drop dead device," "time bomb," "Trojan horse,"
"virus," or "worm" (as such terms are commonly understood in the software industry) or any other code designed
or intended to have, or capable of performing or facilitating, any of the following functions: (i) disrupting, disabling, harming,
or otherwise impeding in any manner the operation of, or providing unauthorized access to, a computer system or network or other
device on which such code is stored or installed or with which it interoperates, or (ii) compromising the privacy or data security
of a user or damaging or destroying any data or file without the user’s consent (collectively, "Malicious Code").
Each Company Group implements sufficient current industry standard measures designed to prevent the introduction of Malicious Code
into its Company Products.

 

(t)For
all software used by each Company Group in providing services, or in developing or making available any of its Company Products,
each Company Group has implemented sufficient security patches or upgrades that are generally available for that software.

 

(u)Except
as set forth in Section 3.18(u) of its Company Disclosure Schedule, no government funding or Governmental Grants or funding
from any Person was used in the development of the Company Owned IP Rights.

 

(v)Except
as set forth in Section 3.18(v) of its Company Disclosure Schedule, no Company Group nor any other Person acting on
its behalf has disclosed, delivered or licensed to any Person, agreed to disclose, deliver or license to any Person, or
permitted the disclosure or delivery to any escrow agent or other Person of, any Company Source Code. To such Company’s
Knowledge, no event has occurred, and no circumstance or condition exists, that (with or without notice or lapse of time, or
both) will, or would reasonably be expected to, result in the disclosure, delivery or license by any Company Group or any
Person acting on its behalf to any Person of any Company Source Code. Section 3.18(v)

of its Company Disclosure Schedule identifies each Contract pursuant to which any Company Group has deposited,
or is or may be required to deposit, with an escrow holder or any other Person, any of its Company Source Code. The Company Source
Code contains annotations and programmer’s comments, and otherwise has been documented in a manner that is both: (i) consistent
with customary code annotation conventions and common practices in the software industry; and (ii) sufficient to independently
enable a programmer of reasonable skill and competence to understand, analyze, and interpret program logic, correct errors and
improve, enhance, modify and support the Company Products.

 

Section
3.19Insurance Coverage.

 

Section
3.19 of its Company Disclosure Schedule identifies each insurance policy maintained by, at the expense of or for the
benefit of each Company Group or its business or Assets and Properties, each of which is in full force and effect. All
premiums payable under all such policies have been timely paid and each Company Group has otherwise complied with all
material terms and conditions of all such policies. Neither: (A) the execution or delivery of this Agreement or any other
Transaction Documents; nor (B) the consummation of the Transactions, will (with or without notice or lapse of time or both):
(1) result in the cancellation, invalidation or termination, or give any Person the right to cancel, invalidate or terminate,
any of the insurance policies of any Company Group; (2) result in the reduction of coverage, or give any Person the right to
reduce the coverage, under any such insurance policies; or (3) have any impact on the right or ability of any Company Group
to make a claim under any such insurance policies in respect of or relating to events or circumstances that have occurred
prior to the respective Closing.

 

    	49

    	 

    
Execution Copy

 

 

Section
3.20Tax Matters.

 

Except as set forth in Section 3.20 of
its Company Disclosure Schedule:

 

(a)Each
Company Group member has timely filed in a proper manner with the appropriate Taxing Authorities all Tax Returns required to be
filed by, or with respect to, such Company Group and has timely paid in full all Taxes shown as due on any Tax Return. All such
Tax Returns are true, complete and accurate. All Taxes due and payable by any member of each Company Group or with respect to the
income, assets or operations thereof, whether or not required to be shown on a Tax Return, have been timely paid in full. No written
claim has been served to the Company Group since January 1, 2008 by a Taxing Authority or any other Governmental Authority in a
jurisdiction where any Company Group does not file Tax Returns that any member of such Company Group is or may be subject to taxation
in that jurisdiction.

 

(b)A
proper and adequate accrual or reserve for Tax Liabilities of the respective Company Group in accordance with IFRS is included
in the respective Company’s Financial Statements. The unpaid Taxes of each Company Group (i) did not, as of the Balance Sheet
Date, exceed the reserve for Tax Liabilities set forth on the balance sheet (and not merely in the notes) included in the respective
Company’s Financial Statements, and (ii) do not, as of the date hereof, exceed such reserve except as set forth in Section
Section 3.20(b)

of the respective Company Disclosure Schedule.

 

(c)Except
as set forth in Section 3.20(c) of its Company Disclosure Schedule, since the Balance Sheet Date, no Company Group (i) has
incurred any Liability for Taxes (A) from extraordinary gains or losses within the meaning of IFRS or (B) outside the ordinary
course of business, or (C) otherwise inconsistent with past custom and practice and (ii) has, in accordance with IFRS, as applicable,
made due and sufficient accruals for such Liabilities for Taxes (excluding any "deferred taxes" or similar items that
reflect timing differences between tax and financial accounting principles) in the books and records of such Company Group.

 

(d)No
Company Group has been since January 1st, 2008 or, to the Knowledge of the respective Company, is currently the subject
of any audit or other examination of Taxes by any Taxing Authority. Except as set forth in Section 3.20(d) of its Company
Disclosure Schedule no written deficiencies for Taxes with respect to any Company Group have been claimed, or assessed by any Taxing
Authority or other Governmental Authority. There are currently no matters under discussion between the Company Group and any Taxing
Authority. Each Company has made available to Purchaser (i) complete and accurate copies of all Tax Returns of each Company Group
for the past three taxable years, and (ii) complete and accurate copies of all audit or examination reports and statements of deficiencies
assessed against or agreed to by each Company Group for the past five taxable years. During the past (5) five taxable years no
Company Group has waived or extended any statute of limitations in respect of Taxes or agreed to any extension of time with respect
to a Tax assessment or deficiency, nor has any Company Group submitted any request for any such extension or waiver.

 

    	50

    	 

    
Execution Copy

 

 

(e)No
closing agreements, private letter rulings, technical advice memoranda or similar agreements or rulings relating to Taxes have
been entered into or issued by any Governmental Authority with or in respect of any Company Group during the past (5) five taxable
years. Except as set forth in Section 3.20(e) of its Company Disclosure Schedule, no Company Group has requested or received
a ruling from any Taxing Authority during the past three taxable years (other than such rulings required by this Agreement).

 

Section
3.21Employees; Contractors and Benefit Plans

 

(a)Section 3.21(a) of
its Company Disclosure Schedule sets forth, with respect to each Company Group member, the name of each executive
officer and each independent contractor and consultant providing services customarily provided by executive officers and the
ten other employees with the highest total Compensation Package in the Company Group, together with his or her position or
function, date of hire or engagement, annual base salary or wages or the compensation, vacation entitlement and any
applicable incentive, severance or bonus arrangements such items are referred to collectively as the "Compensation
Package".

 

(b)Section
3.21(b) of its Company Disclosure Schedule sets forth an accurate and complete list identifying each employment,
consulting, severance, termination, retirement, profit sharing, bonus, incentive or deferred compensation, retention or
transaction bonus or change in control agreement, pension, stock Option, restricted stock or other equity-based benefit,
profit sharing, savings, retirement, life, health, disability, accident, medical, dental, insurance, vacation, paid time off,
long term care, perquisite, fringe benefit, death benefit or other material compensation or benefit plan, program,
arrangement, agreement, fund or commitment (i) for the benefit or welfare of any current or former director, officer,
shareholder, service provider or employee of any Company Group or any shareholder or Affiliate thereof employing such person
for the benefit of such Company Group, or (ii) with respect to which such Company Group has any Liability. Such plans are
referred to collectively herein as the "Benefit Plans." Such Company has made available to Purchaser (i)
accurate and complete copies of each Benefit Plan to the extent currently effective, including all amendments thereto and
copies of applicable resolutions adopting each such amendment, (ii) all material written Contracts relating to each Benefit
Plan to the extent currently effective, and (iii) material correspondence to or from any Governmental Authority relating to
any Benefit Plan. Each Company Group member has performed all obligations required to be performed by such Company Group
member under (including with respect to any grant, bonus or other benefit effected under any Benefit Plan), and is not in
default or violation of, and has no Knowledge of any default or violation by any other party to, any Benefit Plan, of any
material term thereunder. Each Benefit Plan has been established and maintained in accordance with its terms and in
compliance with Applicable Law. Each Benefit Plan of such Company that is intended to qualify under Section 401(a) of the
Code ("Section 401(a)") has received a favorable determination or approval letter from the Internal Revenue
Service and each Benefit Plan of such Company that is intended to qualify under Section 102 of the Tax Ordinance
("Section 102") has received a favorable determination or approval letter or is otherwise approved by the
ITA. All Companies Options and Companies Shares of such Company issued under Section 401(a) or any "Section 102
Plan" have been issued in compliance with the applicable requirements of Section 401(a) or Section 102, as the case may
be, including, without limitation, the adoption of the applicable board and shareholders resolutions, the filing of the
necessary documents with the ITA and the Internal Revenue Service, the issuance of Companies Options following the applicable
30 days restriction period following the submission of the application to the ITA to approve a "Section 102 Plan",
the appointment of trustees to hold the Companies Options and, if applicable Companies Shares pursuant to the terms of
Section 102 and the compliance by such trustees with the Section 102 requirements.

 

    	51

    	 

    
Execution Copy

 

 

(c)Except
as set forth in Section 3.21(c) of its Company Disclosure Schedule,  the consummation of the Transactions will
not (either alone or together with any other event, including a subsequent termination of employment or service or other
engagement) entitle any employee, service provider or independent contractor of any Company Group member or any employee of
such independent contractor or service provider to severance pay or accelerate the time of payment or vesting or trigger any
payment of funding (through a grantor trust or otherwise) of compensation or benefits under, increase the amount payable
under any Benefit Plan or trigger any other Liability to such Company Group member or any other right or benefit to such
person.

 

(d)Except
as set forth in Section 3.21(d) of its Company Disclosure Schedule, no Company Group member has engaged any
consultants, sub-contractors, sales agents or freelancers who, according to Applicable Law, would be entitled to the rights
of an employee vis-à-vis the Company Group, including rights to severance pay, vacation, recuperation pay (dmei
havraa) and other employee-related statutory or contractual benefits. Each Person providing services to any Company Group
member that has been characterized as a consultant, sub-contractor, sales agent or freelancer and not an employee has been
properly characterized as such including, where applicable, through the inclusion of appropriate and required provisions in
the relevant agreement with such Person.

 

(e)No
Company Group member is a party to any collective bargaining Contract, collective labor agreement or other Contract or arrangement
with a labor union, workers committee, trade union or other organization or body involving any of its employees, or is otherwise
required (under any legal requirement, under any Contract or otherwise) to provide benefits or working conditions beyond the minimum
benefits and working conditions required by Applicable Law or pursuant to applicable extension orders (tzavei harchava).

 

(f)No
Company Group member is subject to any Proceeding asserting that such Company Group has committed an unfair labor practice or seeking
to compel it to bargain with any labor union or labor organization nor is there pending or, to such Company’s Knowledge,
threatened, nor has there been, since January 1, 2008, any labor strike, dispute, walk-out, work stoppage, slow-down or lockout
involving any member of such Company Group

 

(g)No
Company Group member has or is subject to, and no employee of any Company Group member benefits from, any extension order except
for extension orders applicable to all employees in Israel.

 

(h)Except
as set fort in Section 3.07(b) of its Company Disclosure Schedule, the obligations of each Company Group member to provide
statutory social benefits pursuant to Applicable Law and any other benefits provided under any Contract to which such Company
Group member is party, are each fully funded or reflected on the Company's Financial Statements.

 

(i)Except
as set fort in Section 3.21(i) of its Company Disclosure Schedule, each Company Group member has complied in all material
respects with all Applicable Laws and/or Contracts and/or customs recognized as such by such Company Group member relating to
employment, employment practices, wages, bonuses and other compensation matters and terms and conditions of employment
related to its employees; and all amounts that the Company Group is legally or contractually required either (i) to deduct
from its employees’ salaries or to transfer to such employees’ pension or provident, life insurance, incapacity
insurance, continuing education fund or other similar funds, or (ii) to withhold from its employees’ salaries and
benefits and to pay to any Governmental Authority as required by under Applicable Law, have, in each case, been fully
deducted, transferred, withheld and paid.

 

    	52

    	 

    
Execution Copy

 

 

Section
3.22Affiliate Transactions.

 

Except as set
forth in Section 3.22 of its Company Disclosure Schedule, no shareholder, director, officer or employee of any Company Group
or member of any of their immediate family or any Affiliate thereof (each of the foregoing, a "Related
Person"), other than in its capacity as a shareholder, director, officer or employee of such Company Group, (i) has
been since January 1, 2008 involved, directly or indirectly, in any business arrangement, other than employment agreements
(and if applicable, engagements with directors in their capacity as such) or other material relationship with any Company
Group (whether written or oral), (ii) directly or indirectly owns, or otherwise has any right, title, interest in, to or
under, any property or right, tangible or intangible, that is used by such Company Group or (iii) is engaged, directly or
indirectly, in the conduct of the business of such Company Group. In addition, to the Knowledge of such Company, no such
Related Person has an interest in any Person that (A) competes with the business of its Company Group in any market presently
served by such Company Group, or (B) is a supplier, vendor, lessor, lessee, licensor or licensee of such Company Group, in
each case, except as explicitly set forth in Section 3.22 of its Company Disclosure
Schedule. For purpose of this Agreement, "immediate family" of any Person shall mean spouse, parents, children and
brothers and sisters of such Person.

 

Section
3.23Finder's Fees.

 

There is no investment
banker, broker, finder or other intermediary that has been retained by or is authorized to act on behalf of such Company or who
is entitled to any fee or commission from such Company in connection with the Transactions.

 

Section
3.24Bank Accounts.

 

Section 3.24 of
its Company Disclosure Schedule provides the following information with respect to each account maintained by or for the
benefit of any Company Group at any bank, trust company, securities broker or other financial institution: (i) the name of
the bank or other financial institution at which such account is maintained; (ii) the account number; (iii) the type of
account; and (iv) the names of all Persons who are authorized to sign checks or other documents or has any other amounts or
rights with respect to such account. Except as set fort in Section 3.24

of its Company Disclosure Schedule, no Company Group has any outstanding
credit facility, overdraft, loan, loan stock, debenture, letter of credit, acceptance credit or other financial facility.

 

Article
IV

Representations and Warranties of the Selling Shareholders

 

Except as set forth
in each Selling Shareholder's Disclosure Schedule, each of the Selling Shareholders represents and warrants, severally but not
jointly with the other Selling Shareholders, and in respect to himself/itself and his/its own shares, to and for the benefit of
Purchaser, that the statements contained in this Article IV are true and correct as of the date of this Agreement, and will
be true and correct as of the respective Closing Date:

 

    	53

    	 

    
Execution Copy

 

 

Section
4.01Title to Company Shares.

 

Such Selling Shareholder
has good and valid title to, and is the sole lawful owner, beneficially and of record, of all of the Companies Shares set forth
opposite the name of such Selling Shareholder in Exhibit C or Exhibit D, as applicable, which constitute the entire issued
and outstanding Companies Shares held by such Selling Shareholder, free and clear of any and all Liens. The Selling Shareholder
has sole voting power and sole power to issue instructions with respect to the matters set forth in this Agreement, sole power
of disposition and sole power to agree to all of the matters set forth in this Agreement, in each case with respect to the foregoing
Companies Shares. At the respective Closing, such Selling Shareholder shall convey to Purchaser, and Purchaser shall acquire, good
and marketable title to the respective Companies Shares referred to above, free and clear of any Liens and from any agreement,
obligation or commitments to create, grant, give or permit to subsist any Liens, except for such Liens created by the Purchaser
or under the respective Charter Documents or Applicable Law. The Selling Shareholder has not sold, pledged or otherwise transferred
(whether by operation of law or otherwise, including, without limitation, transfers pursuant to any decree of divorce or separate
maintenance, any property settlement, any separation agreement or any other agreement with a spouse) any interests in the respective
Companies Shares to any Person. The respective Companies Shares constitute all of the shares or other securities of the respective
Company over which any voting or dispositive power is held by the Selling Shareholder and the Selling Shareholder does not own,
beneficially or otherwise, directly or indirectly, any other share capital of, or other securities, equity or ownership interest
in the Company (including, without limitation, (i) any outstanding Options, warrants, purchase rights, subscription rights,
conversion rights, exchange rights or other securities of such Company, or (ii) outstanding stock appreciation rights, phantom
stock or similar rights). The respective Companies Shares referred to above are not subject to any shareholders agreement, voting
agreements, proxies, trusts or other agreement or understandings relating to the voting or disposition thereof, which would continue
to be binding upon the Purchaser after the respective Closing. Any proxies heretofore given in respect of the respective Companies
Shares are not irrevocable, and any such proxies are or shall be revoked by the Selling Shareholders by the respective Closing.

 

Section
4.02Authority; Binding Effect.

 

Such Selling
Shareholder has full right, power and authority to enter into and to perform such Selling Shareholder’s obligations under
each of the Transaction Documents to which such Selling Shareholder is or may become a party. Such Selling Shareholder has all
requisite power and authority to execute, deliver and perform its obligations under this Agreement and the other Transaction Documents
to which such Selling Shareholder is a party and to consummate the transactions contemplated hereunder and thereunder. The execution,
delivery and performance of this Agreement and the other Transaction Documents to which such Selling Shareholder is a party have
been duly authorized by such Selling Shareholder. All organizational actions and proceedings required to be taken by or on the
part of such Selling Shareholder to authorize and permit the execution, delivery and performance by such Selling Shareholder of
this Agreement and the other Transaction Documents to which such Selling Shareholder is a party, have been duly and properly taken.
This Agreement has been, and each other Transaction Document to which such Selling Shareholder is a party has been or will be,
duly executed and delivered by such Selling Shareholder. This Agreement constitutes the legal, valid and binding obligation of
such Selling Shareholder, and, assuming the due authorization, execution and delivery by the other parties thereto, is enforceable
against such Selling Shareholder in accordance with its terms, and upon the execution of each of the other Transaction Documents
to which such Selling Shareholder is a party, each of such other Transaction Documents will constitute the legal, valid and binding
obligation of such Selling Shareholder who is a party thereto, and will be, assuming the due authorization, execution and delivery
by the other parties thereto, enforceable against such Selling Shareholder in accordance with its terms, in each case, subject
to (a) laws of general application relating to bankruptcy, insolvency and the relief of debtors, and (b) rules of law governing
specific performance, injunctive relief and other equitable remedies. The spouse, if any, of such Selling Shareholder has the right,
power and capacity to execute and deliver and to perform her or his obligations under the Spousal Consent executed by her or him
and delivered to the Purchaser simultaneously herewith. Such Spousal Consent is accurate and constitutes such spouse’s legal,
valid and binding obligations, enforceable against him or her in accordance with its terms.

 

    	54

    	 

    
Execution Copy

 

 

Section
4.03Non-Contravention; Consents.

 

Except as set
forth in Section 4.03 of the Selling Shareholder's Disclosure Schedule, neither
(1) the execution, delivery or performance of this Agreement or any other Transaction Document by such Selling
Shareholder, nor (2) the consummation of the Transactions by such Selling Shareholder, will (with or without notice or
lapse of time or both), in each case, only to the extent reasonably expected to prevent the parties from consummating the
Transactions:

 

(a)contravene,
conflict with or result in a violation or breach of: (i) any of the provisions of any Charter Document of such Selling Shareholder
or (ii) any Applicable Law;

 

(b)contravene,
conflict with or result in a violation of any of the terms or requirements of, or give any Governmental Authority the right to
revoke, withdraw, suspend, cancel, terminate or modify, any Governmental Authorization that is held by such Selling Shareholder;

 

(c)contravene,
conflict with or result in a violation or breach of or a default under any provision of any Contract to which such Selling Shareholder
is bound or give any Person the right to: (i) declare a default or exercise any remedy under any such Contract; (ii) accelerate
the maturity or performance of any such Contract; or (iii) cancel, terminate or modify any such Contract; or

 

(d)Other
then Selling Shareholders that are required to file with the TASE, or with any other stock exchange or with any securities authority,
a report with respect to the Transactions, such Selling Shareholder neither was, is or will be required to make any filing with
or give any notice to, or to obtain any Consent from, any Person in connection with (x) the execution, delivery or performance
of the Transaction Documents to which such Selling Shareholder is a party or (y) the consummation of the Transactions.

 

Section
4.04Capacity of Selling Shareholder.

 

(a)Such
Selling Shareholder:

 

(i)has
not, at any time, (A) made a general assignment for the benefit of creditors, (B) filed, or had filed against such Selling
Shareholder, any bankruptcy petition or similar filing, (C) suffered the attachment or other judicial seizure of all or substantially
all of such Selling Shareholder’s assets, (D) admitted in writing such Selling Shareholder’s inability to pay
such Selling Shareholder’s debts as they become due, or (E) taken or been the subject of any action that will have an
adverse effect on such Selling Shareholder’s ability to comply with or perform any of such Selling Shareholder’s covenants
or obligations under any of the Transaction Documents; and

 

    	55

    	 

    
Execution Copy

 

 

(ii)is
not subject to any Applicable Law that is reasonably likely to have an adverse effect on such Selling Shareholder’s ability
to comply with or perform any of such Selling Shareholder’s covenants or obligations under any of the Transaction Documents.

 

(b)There
is no Proceeding pending, and, to such Selling Shareholder’s Knowledge, no Person has threatened to commence any Proceeding,
that may have an adverse effect on the ability of such Selling Shareholder to comply with or perform any of such Selling Shareholder’s
covenants or obligations under any of the Transaction Documents. To the Knowledge of such Selling Shareholder, no event has occurred,
and no claim, dispute or other condition or circumstance exists, that is reasonably expected to give rise to any such Proceeding.

 

Section
4.05Tax Withholding Information.

 

Any and all information
provided to Purchaser by or on behalf of such Selling Shareholder for purposes of enabling Purchaser to determine the amount to
be deducted and withheld from the consideration payable to such Selling Shareholder pursuant to this Agreement under Applicable
Law is true and accurate.

 

Section
4.06Finder’s Fees.

 

Except as set
forth in Section 4.06 of each Selling Shareholder's Disclosure Schedule, no broker, investment banker, financial
advisor or other Person is entitled to any broker’s, finder’s, financial advisor’s or similar fee or
commission in connection with the Transactions contemplated by this Agreement or any other Transaction Document to which such
Selling Shareholder is a party based on any Contract to which such Selling Shareholder is a party or that is otherwise
binding upon such Selling Shareholder.

 

Section
4.07Company Group Assets. 

 

Neither such Selling
Shareholder nor any of its Affiliates has any remaining rights or interest in any assets or properties of the respective Company
Group.

 

Section
4.08Securities Laws. 

 

(a)Subject
to and without derogating from Parent's and Purchaser's representations and warranties contained in Article V (including, without
limitation, Parent's and Purchaser's representations and warranties relating to the Parent SEC Documents and Parent Foreign Filings
(as set forth and defined in Section 5.01)), such Selling Shareholder has acquired sufficient information about Parent (through
the review by such Seller of the Parent’s reports filed with the SEC) to reach an informed and knowledgeable decision to
acquire the Consideration Shares, and if applicable, the Consideration Warrants and the Warrant Shares (the "Consideration
Securities"). Such Selling Shareholder is acquiring the respective Consideration Securities for such Selling Shareholder’s
own account for investment purposes only and not with a view to, or for the resale in connection with, any "distribution"
thereof for purposes of the Securities Act.

 

(b)Such
Selling Shareholder is (i) an accredited investor within the meaning of Regulation D prescribed by the SEC pursuant to the Securities
Act (a "Regulation D Investor") or (ii) not a U.S. Person as defined in Regulation S promulgated under the Act
(a "Regulation S Investor").If such Selling Shareholder is a Regulation D Investor and is U.S. Person, such
Selling Shareholder also represents that: (x) Such Selling Shareholder can afford to bear the economic risk of holding the Consideration
Securities for an indefinite period and can afford to suffer the complete loss of such Selling Shareholder’s investment in
the Consideration Securities; (y) its knowledge and experience in financial and business matters is such that such Selling Shareholder
is capable of evaluating the risks of the investment in the Consideration Securities; and (z) only to the extent that such Selling
Shareholder is not an individual, it has not been organized for the purpose of acquiring the Consideration Securities and all the
equity owners of such Selling Shareholder are Regulation D Investors. If such Selling Shareholder is a Regulation S Investor, such
Selling Shareholder also represents that: (1) it is not a U.S. Person, (2) on the date hereof, the Regulation S Investor is outside
the United States, (3) the Selling Shareholder is not acquiring the Consideration Securities for the account or benefit of any
U.S. Person, (4) it will not, during the 40 day period starting on the date of such Selling Shareholder’s purchase
and receipt of the Consideration Securities, offer or sell any of the Consideration Securities (or create or maintain any derivative
position equivalent thereto) in the United States, to or for the account or benefit of a U.S. Person other than in accordance with
Regulation S or pursuant to an effective registration statement under the Securities Act or any available exemption therefrom and,
in any case, in accordance with applicable state securities laws and (5) it will, after the expiration of such 40 day period, offer,
sell, pledge or otherwise transfer the Consideration Securities (or create or maintain any derivative position equivalent thereto)
only pursuant to an effective registration statement under the Securities Act or any available exemption therefrom and, in any
case, in accordance with applicable state securities laws. Each Executing Shareholder has confirmed on the signature page hereto
whether such Executing Shareholder is a Regulation D Investor and/or a Regulation S Investor, and such Executing Shareholder represents
and warrants that the information set forth in its respective signature page is true and correct. Selling Shareholder should refer
to the definition of terms set forth in Appendix A for additional information.

 

    	56

    	 

    
Execution Copy

 

 

(c)Such
Selling Shareholder understands that the Consideration Securities have not been registered under the Securities Act and the Consideration
Securities are being issued in reliance upon a specific exemption therefrom, which exemption depends upon, among other things,
the accuracy of its representations set forth herein. Moreover, such Selling Shareholder understands that Parent is under no obligation
to register the Consideration Securities with the SEC in the United States, except as set forth in the IRA (as defined in Section
8.03(d)(vi)

).

 

(d)Such
Selling Shareholder understands and agrees that the Consideration Securities cannot be offered, resold or otherwise transferred
except pursuant to (i) an effective registration statement under the Securities Act covering such offer, sale or transfer and
such offer, sale or transfer is made in accordance with such registration statement, or (ii) an available exemption from registration,
in which case such Selling Shareholder shall furnish Parent with, if reasonably requested by Parent, a customary representation
letter, in form and substance reasonably satisfactory to Parent. Such Selling Shareholder hereby covenants and agrees that he,
she or it will not offer, sell or otherwise transfer such Consideration Securities except in compliance with this Section 4.08 
and with Applicable Law. In order to prevent any transfer from taking place in violation of this Agreement or Applicable Law,
each Selling Shareholder hereby agrees that Parent may cause a stop transfer order to be placed with the Transfer Agent with respect
to the Consideration Securities; provided, however, that such stop order shall be immediately removed on the date
that such Consideration Securities no longer bear a restrictive legend in accordance with Section 2.09(a) and/or any of the circumstances
requiring the removal of such restrictive legend as set forth in Section 2.09(b) have occurred (regardless of whether Parent caused
the removal of such legend in accordance with its obligation pursuant to Section 2.09(b)). Parent will not be required to transfer
on its books any Consideration Securities that have been sold or transferred in violation of any provision of this Agreement or
Applicable Law.

 

    	57

    	 

    
 Execution Copy

 

 

Section
4.09Selling Shareholders Status. 

 

The indication by the
Selling Shareholder on the signature page hereto whether it qualifies as an "investor" under Section 15(A)(b)(1) of the
Israeli Securities Law, is true and correct.

 

Article
V

Representations and Warranties of Purchaser and parent

 

Except as set forth
either (i) in the Purchaser Disclosure Schedule, which relates to such Section and to any other Section of such Disclosure Schedule
to the extent that it is reasonably apparent on the face of such disclosure that such disclosure is applicable to such Section,
or (ii) in the Parent SEC Documents, Purchaser and Parent represent and warrant, with respect to the Parent Group, to the Companies
and the Selling Shareholders that the statements contained in this Article V are true and correct as of the date of this
Agreement and as of the respective Closing Date:

 

Section
5.01Corporate Existence and Power.

 

(a)The
Purchaser is a private company limited by shares, duly incorporated and validly existing under the laws of Israel. Parent was duly
organized under the laws of the Dutch Antilles and is currently validly existing under the laws of Curaçao. Each of the
Parent and its Subsidiaries (i) is duly licensed or qualified to do business and, where applicable, is in good standing as a foreign
corporation in all jurisdictions in which the conduct of its business or the activities it is engaged in make such licensing or
qualification necessary; and (iii) has all necessary power and authority: (A) to conduct its business in the manner in which its
business is currently being conducted; (B) to own, use and distribute its assets in the manner in which its assets are currently
owned, used and distributed; and (C) to perform its obligations under all Contracts to which it is a party.

 

Parent has timely filed
or furnished all material forms, documents and reports required to be filed or furnished prior to the date of this Agreement by
it with the SEC since December 31, 2008 (the "Parent SEC Documents")(all of which Parent SEC Documents were, as
of the date of their respective filing date, true and correct in all material respects), the Israeli Securities Authority ("ISA")
and TASE since December 31, 2008  (collectively, the "Parent Foreign Filings").  Parent
has made available to the Selling Shareholders (including through the electronic data gathering, analysis and retrieval database
of the SEC and MAGNA) all such Parent SEC Documents and Parent Foreign Filings that it has so filed or furnished
prior to the date hereof.  None of the Parent's Subsidiaries is required to file or furnish any forms, reports
or other documents with the SEC, ISA or with any other similar foreign securities authority.

 

 

(b)The
Parent's Subsidiaries are listed in Section 5.01(b) of the Purchaser Disclosure Schedule. Other than those Subsidiaries
listed in Section 5.01(b) of the Purchaser Disclosure Schedule, there are no corporations, limited liability companies,
partnerships, joint ventures, associations or other entities or Persons in which Parent owns, of record or beneficially, any
direct or indirect equity or other interest or any right (contingent or otherwise) to acquire the same.

 

(c)The
Purchaser has made available to Companies and Selling Shareholders materially accurate and complete copies of the Charter Documents
of the Parent in effect. There has not been any violation of any of the provisions of the Charter Documents of the Parent since
January 1, 2008. No Parent Group has taken any action that is materially inconsistent with any resolution adopted by its shareholders
or board of directors (or any committee thereof). The books of accounts, share register, minute books and other records that are
required to be maintained under Applicable Law of the Parent Group are true, up-to-date and complete in all material respects,
and have been maintained in accordance with prudent business practices and all Applicable Laws.

 

    	58

    	 

    
Execution Copy

 

 

(d)Section
5.01(d) of its Purchaser Disclosure Schedule accurately sets forth with respect to the Parent: (i) the names of the
members of the board of directors; (ii) the names of the members of each committee of the board of directors (or similar
body, to the extent applicable); and (iii) the names and titles of its executive officers.

 

(e)No
Parent Group member has conducted any business under or has otherwise used, for any purpose or in any jurisdiction, any fictitious
name, assumed name, business name or other name, other than its corporate name as set forth in this Agreement and in Section
5.01(e)

of the Purchaser Disclosure Schedule.

 

Section
5.02Corporate Authorization.

 

Each of Purchaser and
Parent has all necessary corporate power and authority to enter into and to perform its obligations under this Agreement and the
other Transaction Documents to which it is a party in accordance with the respective terms thereof, and the execution, delivery
and performance by each of Purchaser and Parent of this Agreement and the other Transaction Documents to which it is a party in
accordance with the respective terms thereof have been duly authorized by all necessary corporate action on its part. This Agreement
constitutes and any other Transaction Document to which any of Purchaser and Parent will be a party will constitute upon execution
thereof the legal, valid and binding obligation of Purchaser and/or Parent, and assuming the due authorization execution thereof
and delivery thereof by the other parties thereto, is enforceable against Purchaser and Parent in accordance with its terms, subject
to (a) laws of general application relating to bankruptcy, insolvency, reorganization, moratorium and the relief of debtors, and
(b) rules of law governing specific performance, injunctive relief and other equitable remedies. Upon the execution of each of
the other Transaction Documents at the respective Closing, each of such other agreements to which the Purchaser, Parent or any
other member of the Parent Group is a party will constitute the legal, valid and binding obligation of such member, and will be,
assuming the due authorization, execution and delivery by the other party thereto, enforceable against the Purchaser or such member
in accordance with its respective terms, subject to (i) laws of general application relating to bankruptcy, insolvency, reorganization,
moratorium and the relief of debtors, and (ii) rules of law governing specific performance, injunctive relief and other equitable
remedies.

 

Section
5.03Compliance with Applicable Law.

 

(a)Each
member of the Parent Group is, and has at all times been, in compliance in all material respects with, and has operated its respective
business and maintained its assets and properties in material compliance with, all Applicable Laws. Neither Parent Group has been
informed in writing that its operations are under investigation with respect to, given written notice of any violation or possible
violation of, or, to Parent's Knowledge, is currently threatened to be charged with any violation of, Applicable Law. To the Knowledge
of the Parent, no event has occurred, and no condition or circumstance exists, that will or is reasonably expected to constitute
or result in a violation by any member of the Parent Group of, or a failure on the part of any member of the Parent Group to comply
with or failure of its business and operations to be otherwise in compliance with, any Applicable Law.

 

    	59

    	 

    
Execution Copy

 

 

(b)The
information provided by the Parent and its Representatives in connection with the preparation of any filing or submission that
is necessary under the Antitrust Laws, as set forth in Section 6.06(b), is true and correct as of the date of this Agreement.

 

 

 

Section
5.04Governmental Authorizations; Governmental Grants.

 

(a)Section
5.04(a) of the Purchaser Disclosure Schedule identifies each Governmental Authorization held by the Parent Group or used
in the business of the Parent Group, and Parent has made available to Companies and Selling Shareholders accurate and
complete copies of all such Governmental Authorizations and any and all correspondence and amendments related thereto. The
Governmental Authorizations identified in Section 5.04(a) of its Purchaser Disclosure Schedule are valid and in full
force and effect, and collectively constitute all Governmental Authorizations necessary to enable the Parent Group to conduct
its business in the manner in which such business is currently being conducted. Each Parent Group member is, and has at all
times been, in material compliance with the terms and requirements of the respective Governmental Authorizations identified
in Section 5.04(a) of the Purchaser Disclosure Schedule. No written notice or other written communication from any
Governmental Authority was received by Parent regarding: (i) any actual or possible violation of or failure to comply with
any term or requirement of any Governmental Authorization; or (ii) any actual or possible revocation, withdrawal, suspension,
cancellation, termination or modification of any Governmental Authorization.

 

(b)Section
5.04(b) of the Purchaser Disclosure Schedule identifies all Governmental Grants that have been provided to each Parent Group
member. To the Knowledge of Parent, no event has occurred, and no circumstance or condition exists (other than the intended
consummation of the Transactions), that would reasonably be expected to give rise to: (A) the annulment, revocation,
withdrawal, suspension, cancellation, recapture or material adverse modification of any such Governmental Grant; (B) the
imposition of any material limitation on any Governmental Grant or any benefit available in connection with any Governmental
Grant; (C) a requirement that a member of such Parent Group return or refund any benefits provided therefor under any
Governmental Grant or (D) the applicability of any Governmental Grant (and any limitation or requirement arising therefrom)
to its Parent Group, its business or assets.

 

Section
5.05Non Contravention.

 

Except as set
forth in Section 5.05 of the Purchaser Disclosure Schedule, neither the execution,
delivery or performance by the Purchaser or Parent of this Agreement or any of the Transaction Documents to which the
Purchaser or Parent is a party nor the consummation of the Transactions by the Purchaser or Parent, will (with or without
notice or lapse of time or both): 

 

(a)contravene,
conflict with or result in a violation of (i) any of the provisions of the Charter Documents of the Parent or the Purchaser or
(ii) any Applicable Law;

 

(b)give
any Governmental Authority or other Person the right to challenge any of the Transactions or to exercise any remedy or obtain any
relief under any Applicable Law;

 

(c)
contravene, conflict with or result in a violation of any of the terms or requirements of, or give any Governmental Authority the
right to revoke, withdraw, suspend, cancel, terminate or materially and aversely modify, any Governmental Authorization that is
held by the Parent Group or that, to the Parent's Knowledge, otherwise relates to the Parent Group's business or to any of the
assets owned or used by the Parent Group;

 

    	60

    	 

    
Execution Copy

 

 

(d)contravene,
conflict with, or result in a violation or breach of, or result in a default under, any provision of any Parent Material Contract
by which the Parent Group is bound, or give any Person the right to: (i) declare a default or exercise any remedy under any such
Parent Material Contract; (ii) accelerate the maturity or performance of any such Parent Material Contract; or (iii) cancel, terminate
or modify any such Parent Material Contract; or

 

(e)result
in the imposition or creation of any Lien upon or with respect to any asset owned or used by the Parent Group.

 

Section
5.06Capitalization of Parent Group. 

 

(a)The
authorized capital stock of Parent consists of (i) 1,000,000 Preferred Shares, €0.01 par value per share, none of which are
issued and outstanding, and (ii) 54,000,000 Common Shares, €0.01 par value per share, of which 22,400,490 are issued (out
of which 22,072,194 are outstanding, and 328,296 are dormant).

 

(b)Except
as set forth in Section 5.06(b)

of the Purchaser Disclosure Schedule, there are no outstanding (i) shares of Parent Group or (ii) securities,
instruments or obligations of Parent Group that are or may become convertible into or exchangeable for shares or other securities
of Parent Group or conditions or circumstances that may give rise to the assertion of a claim by any Person to the effect that
such Person is entitled to acquire or receive any shares or other securities of Parent Group.

 

(c)All
outstanding shares of Parent have been issued and granted in compliance with (i) all Applicable Laws; (ii) all requirements set
forth in Parent's Charter Documents, and (iii) all requirements set forth in applicable Contracts. None of the outstanding shares
of Parent were issued in violation of any preemptive rights or other rights to subscribe for or purchase securities of Parent.

 

(d)Unless
otherwise provided in this Agreement, at the respective Closing, the Selling Shareholders will receive good and valid title, free
and clear of any Liens other than Liens provided under Applicable Law or the Parent's Charter Documents, in and to all Consideration
Shares and Consideration Warrants (as applicable).

 

Section
5.07Products. 

 

(a)Each
Parent Product fits, in all material respects, for the purposes for which it is intended to be used as set out in Contracts under
which such Parent Group sells such Parent Product.

 

(b)There
are no claims pending and submitted, to the Knowledge of Parent, threatened against any Parent Group member with respect to the
quality of or absence of defects in any Parent Products.

 

(c)Since
January 1, 2008, there have been no recalls with respect to any of the Parent Products or any written request to either terminate
services provided by any Parent Group member or purchase any of its products, and to the Knowledge of Parent, there are no facts,
events or circumstances reasonably expected to cause the withdrawal or recall of any product sold by any Parent Group member.

 

    	61

    	 

    
Execution Copy

 

 

Section
5.08Valid Issuance of Consideration Shares and Warrants Shares. 

 

The Consideration Shares
and the Consideration Warrants, when issued and delivered in accordance with the terms of this Agreement for the consideration
expressed herein or the Warrants Shares, when issued for the consideration set forth in the Consideration Warrants, will be duly
and validly issued, fully paid, non-assessable and issued in compliance with Applicable Law, and will be free of any Liens other
than restrictions on transfer under Applicable Law or the Parent's Charter Documents.

 

Section
5.09Financial Statements.

 

(a)Parent
has made available to the Companies Parent’s audited consolidated balance sheet as of, and the related audited statements
of income, changes in shareholders’ equity and cash flows for, the Balance Sheet Date (collectively, the "Parent's
Financial Statements").

 

(b)The
Parent's Financial Statements (i) have been prepared based on the books and records of each Parent Group, (ii) comply as to form
with applicable accounting requirements with respect thereto, (iii) have been prepared in accordance with US GAAP applied on a
consistent basis throughout the periods indicated (except as may be indicated therein or in the notes thereto) and consistent with
each other, (iv) fairly present the financial condition of the respective Parent Group as of December 31st, 2010, (the
“Financial Statements Date") and the consolidated results of operations and cash flows of the Parent Group for
the periods therein specified, and (v) accurately reflect all of the Parent Group's guarantees for Liabilities of other Persons.

 

(c)The
books of account of the Parent have been kept accurate in the ordinary course of business consistent in all material respects with
Applicable Law, the transactions entered therein represent bona fide transactions, and the revenues, expenses, assets and liabilities
of the Parent Group have been properly recorded therein. The other financial records of Parent Group have been kept accurate in
the ordinary course of business consistent with Applicable Law, the transactions entered therein represent bona fide transactions,
and the revenues, expenses, assets and liabilities of Parent have been properly recorded therein.

 

(d)Neither
Parent Group member nor any director or officer, or, to the Knowledge of the Parent Group, any employee, auditor, accountant or
representative of such Parent Group member, has received any written complaint, allegation, assertion or claim, regarding any material
deficiency in the accounting or auditing practices, procedures, methodologies or methods of the Parent Group or its internal accounting
controls, including any complaint, allegation, assertion or claim that such Parent Group member has engaged in questionable accounting
or auditing practices.

 

(e)Section
5.09(e) of the Purchaser Disclosure Schedule provides an accurate and complete breakdown of all Parent Group's Insider
Receivables. All Insider Receivables (including those receivables reflected in the Parent's Financial Statements that have
not yet been collected and those receivables that have arisen since the Financial Statement Date and have not yet been
collected, and which are in material amount): (i) represent valid obligations arising from bona fide transactions entered
into between such Parent Group member and a director, officer, employee or shareholder of such Parent Group member in the
ordinary course of business and not in violation of any Applicable Law; and (ii) to the Company's Knowledge will be collected
in full when due, without any counterclaim.

 

    	62

    	 

    
Execution Copy

 

 

(f)The
total revenues of the Parent Group from Menora Mivtachim Pensions Ltd. and its subsidiaries (collectively, the "Menora
Revenues") during the period commencing on July 1st, 2011 and ending on June 30, 2012, as recognized under
US GAAP, shall not be lower than NIS39,000,000 (the "Expected Revenues"). Notwithstanding anything to the contrary
in Section 10.03(a)(i), in determining the Loss incurred by the Sellers as a result of any inaccuracy in the representation set
forth in this clause (f), such Loss shall be equal to (i) the excess of the Expected Revenues over the actual Menora Revenues
of the Parent Group during the period commencing on July 1st, 2011 and ending on June 30, 2012, as recognized under
US GAAP, multiplied by (ii) 1.35.

 

Section
5.10Notes and Accounts Receivable. 

 

Section 5.10 of
the Purchaser Disclosure Schedule provides an accurate reconciliation of all accounts
receivable, notes receivable and other receivables (other than Insider Receivables) of each member of the Parent Group as of
March 31, 2011. Except as set forth in Section 5.10 of the Purchaser Disclosure Schedule
,all notes and accounts receivable of Parent Group (including those accounts receivable reflected on the Parent's Financial
Statements that have not yet been collected and those accounts receivable that have arisen since the Financial Statements
Date and have not yet been collected) are reflected properly on its books and records, are valid and existing receivables
arising from bona fide transactions not consummated in violation of any Applicable Law and, are subject to no refunds or
other adjustments or rights enforceable by third parties. To the Knowledge of Parent, all notes and accounts receivable of
each Parent Group will be collected in accordance with their terms at their recorded amounts, subject to the reserve for bad
debts set forth in the Parent's Financial Statements as may be adjusted for the passage of time through the respective
Closing Date in accordance with the past custom and practice of Parent Group.

 

Section
5.11Absence of Certain Changes.

 

Since the Financial
Statements Date, the business of Parent Group has been conducted in the ordinary course of business and consistent with past practices
(except for actions taken in connection with the negotiation of this Agreement and the performance of the Transactions) and, except
as set forth in Section 5.11

of the Purchaser Disclosure Schedule, there has not been: 

 

(a)any
event, occurrence, development or state of circumstances or facts that has had or is reasonably expected to have, individually
or in the aggregate, a Material Adverse Effect with respect to the Parent Group (collectively);

 

(b)any
amendment of the Charter Documents of any Parent Group other than the amendment of the authorized share capital of Parent effected
on May 12, 2011;

 

(c)any
payment, discharge or satisfaction of any Liabilities in excess of US$200,000, other than the payment, discharge or satisfaction
of accounts payable or accrued expenses incurred in the ordinary course of business;

 

(d)any
capital expenditure or commitment for additions to property, plant or equipment, or lease agreement, which individually exceeds
US$200,000 or exceeds US$300,000 in the aggregate, and which, if purchased, would be reflected in the property, plant or equipment
accounts;

 

    	63

    	 

    
Execution Copy

 

 

(e)any
damage, destruction or loss of any of Parent Group's Assets and Properties, whether or not covered by insurance, which individually
exceeds US$200,000 or exceeds US$300,000 in the aggregate;

 

(f)except
for Liabilities incurred in the ordinary course of business, any incurrence of a Liability, including any Liability for nonperformance
or termination of any Parent Material Contract;

 

(g)(i)
any splitting, combination or reclassification of any shares of Parent; (ii) any declaration, setting aside or payment of any dividend
or other distribution (whether in cash, shares or property or any combination thereof) in respect of any shares of Parent; (iii)
any redemption, repurchase or other acquisition or offer to redeem, repurchase, or otherwise acquire any shares of Parent; (i)
any issuance, delivery or sale, or authorization of the issuance, delivery or sale of, shares of Parent, or (ii) any amendment
or waiver of (in each case, whether by merger, consolidation or otherwise) any term of any shares of Parent;

 

(h)any
cancellation or waiver of any claims or rights of value or incurrence of any Lien on, any assets, securities, properties, interests
or businesses of Parent Group in each case which individually exceeds US$200,000 or US$400,000 in the aggregate;

 

(i)the
making by Parent Group of any loans, guarantee or capital contributions to, or investments in, any other Person which individually
exceeds US$200,000 or US$400,000 in the aggregate;

 

(j)the
creation of any Parent Debt which individually exceeds US$100,000 or US$200,000 in the aggregate;

 

(k)the
sale, disposition of, transfer or license to any Person of any substantial rights, or any rights to any Parent IP Rights or other
material assets by any Parent Group, or the acquisition, lease or license from any Person of any rights including any Intellectual
Property or other assets, in each case other than in the ordinary course of business;

 

(l)(i)
the grant or increase of any severance or termination pay to (or amendment of any existing arrangement with) any director, officer,
advisor, consultant or key employee of Parent Group, (ii) any increase in benefits payable to any such director, officer, advisor,
consultant or key employee under any existing severance or termination pay policies or employment agreements, (iii) the entering
into of any employment, deferred compensation or other similar agreement (or amendment of any such existing agreement) with any
director, officer, advisor, consultant or key employee of any Parent Group, (iv) the establishment or adoption or amendment (except
as required by Applicable Law) of any collective bargaining, bonus, commission, profit-sharing, thrift, pension, retirement, deferred
compensation, compensation, share option, restricted share or other benefit plan or arrangement covering any director, officer,
advisor, consultant or key employee of Parent Group or (v) any increase in compensation, bonus, commission or other benefits payable
to any director, officer advisor, consultant or key employee of Parent Group;

 

(m)any
change in the methods of accounting or accounting practices of Parent, except as required by concurrent changes in US GAAP, as
agreed to by its independent public accountants;

 

    	64

    	 

    
Execution Copy

 

 

(n)any
elimination of any reserves established on Parent Group’s books or any changing of the method of accrual unless there is
any change of significant facts or circumstances pertaining to any reserves which would justify their elimination;

 

(o)any
settlement of, or offer or proposal by Parent Group to settle, any Proceeding involving Parent Group or that relates to the Transactions;

 

(p)any
Tax election made or materially changed; any claim, notice, audit report or assessment in respect of Taxes settled or compromised
(or agreement with respect thereto); any Tax Return filed (except as required under Applicable Law); any Tax allocation agreement,
Tax sharing agreement, advance pricing agreement, cost sharing agreement, pre-filing agreement, Tax indemnity agreement or closing
agreement relating to any Tax entered into; any annual Tax accounting period or method of Tax accounting changed or adopted; any
Tax petition, Tax complaint or administrative Tax appeal filed; any right to claim a Tax refund surrendered or foregone (which
is reasonably expected to be material to any Parent Group); or any extension or waiver of the statute of limitations period applicable
to any Tax claim or assessment consented to, nor has any application or negotiation for or receipt of a Tax ruling or arrangement
been made by or on behalf of any each Parent Group member, whether or not in connection with the Transactions, except as explicitly
contemplated in this Agreement;

 

(q)any
write off as uncollectible of, or any establishment of extraordinary reserve with respect to, any account receivable or other Indebtedness,
which individually exceeds US$100,000 or US$200,000 in the aggregate;

 

(r)any
acquisition of a business or Person, by merger or consolidation, purchase of substantial assets or equity interests, or by any
other manner, in a single transaction or a series of related transactions, or entering into any Contract, letter of intent or similar
arrangement (whether or not enforceable), other than with the Companies, with respect to any of the foregoing;

 

(s)any
distribution by Parent to its shareholders of any asset or a declaration thereof;

 

(t)the
commencement of any Proceeding; or

 

(u)any
agreement or commitment to take any of the actions referred to in clauses (a) through (t).

 

Section
5.12No Undisclosed Liabilities.

 

No Parent Group
member has any Liabilities of any kind, whether or not required to be reflected or reserved in financial statements in accordance
with US GAAP, other than:

 

(a)Liabilities
reflected in the "liabilities" column of the balance sheet that is part of the Parent's Financial Statements or in the
notes thereto;

 

(b)accounts
payable and accrued salaries that have been incurred by Parent Group since the Financial Statement Date in the ordinary course
of business and consistent with past practice; and

 

(c)Liabilities
identified in Section 5.12(c) of Purchaser Disclosure Schedule.

 

    	65

    	 

    
 Execution Copy

 

 

Section
5.13Material Contracts.

 

(a)Except
as set forth in Section 5.13(a) of Purchaser Disclosure Schedule, no Parent Group member is bound by any of the following
Contracts (a Contract meeting any of the following categories is hereinafter referred to as a "Parent Material
Contract", and each Company Material Contract or Parent Material Contract shall be referred to as "Material
Contract"):

 

(i)
all leases or other Contracts under which a Parent Group member is a lessee of, or holds or operates, any machinery, equipment,
vehicle or other tangible personal property owned by a third party and used in the business of Parent Group member and which entails
annual payments, in the case of any such lease or agreement, in excess of US$200,000, or US$400,000 in the aggregate;

 

(ii)any
Contract relating to the acquisition, transfer, use, development, sharing or license, other than in the ordinary course of business,
of any technology, or Intellectual Property rights (including any joint development agreement, technical collaboration agreement
or similar agreement), to or from each Parent Group member other than any end user license agreements for non-exclusive "off
the shelf" software used by any Parent Group member;

 

(iii)any
Contract imposing any restriction on the right or ability of Parent Group, (A) to compete with any other Person with respect to
the products or services offered by Parent Group (including granting exclusive rights or rights of first refusal to license, market,
sell or deliver any of the products or services offered by Parent Group), (B) to acquire any product or other asset or any services
of the types offered by Parent Group from any other Person, or to sell any product or other asset of the types sold by any Parent
Group or perform any services of the types offered by Parent Group to, for, any other Person, or (C) to develop, distribute, license,
sell or transfer any Intellectual Property rights;

 

(iv)all
outstanding Contracts with customers or vendors expected to result in payment to or by Parent Group in excess of US$600,000 during
a period of 12 months following the respective Closing Date;

 

(v)all
outstanding Contracts with Parent Significant Customers and Parent Significant Suppliers (as such terms are defined below).

 

(vi)any
partnership, joint venture or any sharing of revenues, profits, losses, costs or liabilities Contract expected to result in payment
to or by Parent Group in excess of US$300,000 during a period of 12 months following the respective Closing Date;

 

(vii)any
Contract involving a loan in excess of US$200,000 (other than accounts receivable from trade debtors in the ordinary course of
business) or advance to (other than travel, accommodation or entertainment allowances to the employees, directors, officers and
advisors of Parent Group extended in the ordinary course of business), or investment in, any Person or any Contract relating to
the making of any such loan, advance or investment;

 

(viii)any
Contract relating to the acquisition, issuance or transfer of any securities, other than options to purchase common shares of Parent,
and the voting and any other rights or obligations of a shareholder of Parent entered into following January 1, 2008 or that contains
any outstanding obligations of any member of the Parent Group;

 

    	66

    	 

    
Execution Copy

 

 

(ix)any
Contract under which (A) any third party has directly or indirectly guaranteed any liabilities or obligations of any Parent Group
in excess of US$200,000, or (B) any Parent Group has directly or indirectly guaranteed liabilities or obligations in excess of
US$200,000 of any third party;

 

(x)any
Contract relating to the creation of any Lien with respect to any material asset of any Parent Group and all mortgages, indentures,
security agreements, pledges, notes, loan agreements or guarantees creating any such Lien;

 

(xi)any
Contract which contains any provisions requiring any Parent Group to indemnify any other party, other than in the ordinary course
of business;

 

(xii)any
Contract of any Parent Group with any Related Person;

 

(xiii)all
management service, consulting, financial advisory or any other similar Contract, and any Contracts with any investment bank for
investment banking services;

 

(xiv)all
Contracts (including letters of intent that have not yet expired by their terms) involving the future disposition or acquisition
of assets or properties, other than in the ordinary course of business, or any merger, consolidation or similar business combination
transaction;

 

(xv)all
Contracts entered into since January 1, 2008 involving any resolution or settlement of any actual or threatened litigation, arbitration,
claim or other dispute;

 

(xvi)all
Contracts that contain restrictions with respect to the payment of dividends or any other distribution in respect of the capital
stock or other equity interests of Parent Group; and

 

(xvii)all
other Contracts that are material to the business of Parent Group.

 

(b)Purchaser
has made available to Companies and Selling Shareholders accurate and complete copies of all written Parent Material Contracts
required to be identified in Section 5.13(a) of the Purchaser Disclosure Schedule, including all amendments thereto. Section 5.13(a)
of Purchaser Disclosure Schedule provides an accurate description of the material terms of each Parent Material Contract identified
in Section 5.13(a) of Purchaser Disclosure Schedule that is not in written form.

 

(c)Each
Parent Material Contract is a valid and binding agreement of the applicable Parent Group member, and is in full force and effect,
and is enforceable by Parent Group member in accordance with its terms, subject to: (i) laws of general application relating to
bankruptcy, insolvency and the relief of debtors; and (ii) rules of law governing specific performance, injunctive relief and other
equitable remedies. No Parent Group member is in default or breach under the terms of any Parent Material Contract and, to the
Knowledge of Parent, no other party thereto is in default or breach under the terms of any Parent Material Contract. To the Knowledge
of Parent, no event has occurred, and no circumstance or condition exists, that (with or without notice or lapse of time or both)
will, or would reasonably be expected to, (i) result in a violation or breach of any of the provisions of any Parent Material
Contract by any party thereto, (ii) give any Person the right to declare a default or exercise any remedy under any Parent
Material Contract, (iii) give any Person the right to accelerate the maturity or performance of any Parent Material Contract,
or (iv) give any Person the right to cancel, terminate or modify any Parent Material Contract. Since January 1, 2008 no Parent
Group member has waived any of its rights under any Parent Material Contract.

 

    	67

    	 

    
Execution Copy

 

 

(d)Since
January 1, 2008, no Parent Group has received any written notice regarding any violation or breach of, or default under, any Parent
Material Contract.

 

Section
5.14Restrictions on Business Activities.

 

There is no written
Contract or any order of Governmental Authority binding upon any Parent Group member that has or could reasonably be expected to
have the effect of prohibiting or impairing any business practice of such Parent Group member, acquisition of property by Parent
Group member, or the conduct of business by such Parent Group member as currently conducted.

 

Section
5.15Litigation.

 

(a)There
is no pending Proceeding that has been submitted to such Company Group nor to and to no Person has threatened in writing to commence
any Proceeding: (i) that involves any Parent Group or its business, any of the assets or properties owned or used by Parent Group,
any Parent Product or any Person whose liability to the Parent Group has or may have been retained or assumed, either contractually
or by operation of law; (ii) that challenges, or that may be reasonably expected to have the effect of preventing, delaying, or
making illegal the consummation of the Transactions; or (iii) that relates to the ownership of any share capital of any Parent
Group member, or any Option or other right to acquire share capital of any Parent Group, or any right to receive consideration
as a result of this Agreement. The Parent has not been informed in writing of, and to its Knowledge no event has occurred, and
no claim, dispute or other condition or circumstance exists, that is reasonably expected to give rise to or serve as a basis for
the commencement of any such Proceeding.

 

(b)There
is no order, writ, injunction, directive, restriction, judgment or decree issued by any Governmental Authority by which any Parent
Group member, or any of the assets owned or used by such Parent Group member, is subject or which restricts in any respect the
ability of Parent Group to conduct its business as now being conducted. To the Knowledge of Parent, no officer, director, shareholder,
or employee of any Parent Group (in each case, in his or her capacity as such) is subject to any order, writ, injunction, judgment
or decree that prohibits such person from engaging in or continuing any conduct, activity or practice relating to the business
of such Parent Group.

 

Section
5.16Properties.

 

(a)No
Parent Group member owns any real property. Parent Group has a good and valid leasehold interest in each parcel of real
property leased by such Parent Group or used or required for the conduct of its business (the "Parent Leased Real
Property"). Section 5.16(a) of Purchaser Disclosure Schedule lists each lease, subleases, license or other occupancy
agreement or arrangement relating to the Parent Leased Real Property (each, a "Parent Real Property Lease").
Parent Group has the right to use and occupy each Parent Leased Real Property for the full term of the Parent Real Property
Lease relating thereto, subject to its respective terms.

 

(b)Parent
Group owns and has good and marketable title to, or a valid license or leasehold interest in, all tangible personal property and
assets used by Parent Group or required for the conduct of its business (the "Parent Assets"). None of the Parent
Assets is subject to any Lien, except Liens for taxes not yet due and payable or mechanic’s, carrier’s, worker’s,
material man’s, warehouse man’s, supplier’s, vendor’s or similar Liens arising or incurred in the ordinary
course of business.

 

    	68

    	 

    
Execution Copy

 

 

(c)Section
5.16(c) of the Purchaser Disclosure Schedule identifies all Parent Assets, including those Parent Assets that are being
licensed or leased to Parent Group or used or required for the conduct of its business as of March 31, 2011 (the
"Parent Leased Assets"). All Parent Leased Assets are leased pursuant to valid, binding and enforceable
Contracts in accordance with their respective terms (the "Parent Lease Contracts").

 

(d)The
Parent Assets and Parent Leased Assets have no material defects, are in good operating condition and repair, ordinary wear and
tear excepted, and have been reasonably maintained consistent with standards generally followed in the industry (giving due account
to the age and length of use of same, ordinary wear and tear excepted), and are adequate and suitable for their present uses.

 

(e)The
Parent Assets and the Parent Leased Assets constitute all of the tangible personal property and assets used or held for use in
connection with the business of the Parent Group.

 

Section
5.17Customers and Suppliers.

 

Section 5.17 of Purchaser
Disclosure Schedule sets forth a list of the 10 (ten) largest
customers of Parent Group (collectively) for the year ended December 31, 2010 (each, a "Parent
Significant Customer") and the 10 (ten) largest suppliers
of products and/or services to the Parent Group (collectively) for the year ended December 31, 2010 (each, a "Parent
Significant Supplier"), in
each case based on amounts paid or payable with respect to such year, along with such
amounts.

 

No Parent Group member
has any outstanding material dispute with any Parent Significant Customer or Parent Significant Supplier. As of the date hereof,
the Parent Group has not received any written notice from any Parent Significant Customer or Parent Significant Supplier that such
Parent Significant Customer or Parent Significant Supplier intends to discontinue its relationship with the Parent Group or that
such Parent Significant Customer or Parent Significant Supplier intends to materially and adversely (to the Parent Group) modify
its existing contractual relationship with Parent Group.

 

Section
5.18Parent Intellectual Property 

 

(a)As
used in this Agreement, the following terms shall have the meanings indicated below:

 

(1)"Parent
IP Rights" means, (A) any and all Intellectual Property used in or required for the conduct of the business of the Parent
Group as currently conducted by the Parent Group; and (B) any and all other Intellectual Property owned by or licensed to the Parent
Group.

 

(2)"Parent-Owned
IP Rights" means, (A) Parent IP Rights that are owned by or exclusively licensed to the Parent Group; and (B) Parent IP
Rights that were developed for the Parent Group by full or part time employees, consultants or service providers of the Parent
Group.

 

(3)"Parent
Source Code" means, collectively, any software source code or confidential manufacturing specifications or designs, any
material portion or aspect of software source code or confidential manufacturing specifications or designs, or any material proprietary
information or algorithm contained in or relating to any software source code or confidential manufacturing specifications or designs,
of Parent-Owned IP Rights or Parent Products.

 

    	69

    	 

    
Execution Copy

 

 

(b)Parent
Group (i) owns and has independently developed or acquired, or (ii) has the valid right or license to all its Parent IP Rights.
Such Parent IP Rights are sufficient for the conduct of the business of the Parent Group as currently conducted.

 

(c)No
member of the Parent Group has transferred ownership of any Intellectual Property that is or was Parent-Owned IP Rights to any
third party, or knowingly permitted the Parent Group’s rights in any Intellectual Property that is or was Parent-Owned IP
Rights to enter the public domain or, with respect to any Intellectual Property for which the Parent Group has submitted an application
or obtained a registration, lapse (other than through the expiration of registered Intellectual Property at the end of its maximum
statutory term).

 

(d)The
Parent Group owns and has good and exclusive title to each item of Parent-Owned IP Rights, free and clear of any Liens. The right,
license and interest of the Parent Group in and to all Third Party Intellectual Property Rights licensed by the Parent Group from
a third party are free and clear of all Liens (excluding condition and restrictions contained in the applicable license agreements
with such third parties).

 

(e)Section
5.18(e) of the Purchaser Company Disclosure Schedule lists all of Parent-Owned IP Rights including the jurisdictions in which
each such item of Parent-Owned IP Rights, to the extent issued or registered, has been issued or registered or in which any
application for such issuance and registration has been filed, or in which any other filing or recordation has been made.
Each item of Parent-Owned IP Rights is valid and subsisting (or in the case of applications, applied for), all registration,
maintenance and renewal fees currently due in connection with such Parent-Owned IP Rights have been paid and all documents,
recordations and certificates in connection with such item of Parent-Owned IP Rights currently required to be filed have been
filed.

 

(f)The
Parent Group is not nor shall it be as a result of the execution and delivery or effectiveness of this Agreement and the other
Transaction Documents or the performance of the Parent’s obligations hereunder and thereunder, in breach of any Contract
governing any Parent IP Rights (the "Parent IP Rights Agreements") and the consummation of the Transactions will
not result in the modification, cancellation, termination, suspension of, or acceleration of any payments with respect to the Parent
IP Rights Agreements, or give any third party to any Parent IP Rights Agreement the right to do any of the foregoing.

 

(g)None
of the Parent IP Rights Agreements grants any third party exclusive rights to or under any Parent IP Rights or grants any third
party the right to sublicense any Parent IP Rights.

 

(h)There
are no royalties, honoraria, fees or other payments payable by the Parent Group to any Person (other than salaries payable to employees,
consultants and independent contractors not contingent on or related to use of their work product) as a result of the ownership,
use, possession, license-in, license-out, sale, marketing, advertising or disposition of any Parent-Owned IP Rights by the Parent
Group.

 

(i)To
the Knowledge of the Parent, there is no unauthorized use, unauthorized disclosure, infringement or misappropriation of any of
its Parent-Owned IP Rights, by any Person. Parent Group has not brought any action, suit or proceeding for infringement or misappropriation
of any its Intellectual Property or breach of any of the Parent IP Rights Agreement.

 

(j)Parent
Group has not been sued in any Proceeding (or received any written notice or threat with respect to any Proceeding) which involves
a claim of infringement or misappropriation of any Intellectual Property right of any third party or which contests the validity,
ownership or right of the Parent Group to exercise any Intellectual Property right.

 

    	70

    	 

    
Execution Copy

 

 

(k)The
operation of the business of the Parent Group as such business is currently conducted, and the use or exploitation of any Parent
IP Rights by the Parent Group does not and will not infringe or misappropriate the Intellectual Property of any third party and
does not constitute unfair competition or unfair trade practices under any Applicable Laws.

 

(l)The
Parent Group has secured from all of its current and former consultants, employees and independent contractors and the respective
Affiliates thereof who independently or jointly contributed to the conception, reduction to practice, creation or development of
any of the Parent IP Rights, Parent-Owned IP Rights or the Parent Products, unencumbered and unrestricted exclusive ownership of
all such third party’s Intellectual Property in such contribution that the Parent Group does not already own by operation
of law and such third party has not retained any rights or licenses with respect thereto. Without limiting the foregoing, each
Parent Group member has obtained valid and enforceable proprietary information and invention disclosure and assignment agreements
from all current and former employees, consultants, service providers and independent contractors of the Parent Group.

 

(m)No
current or former, employee, consultant or independent contractor of the Parent Group is or has been, to the Parent’s Knowledge,
in violation of any term or covenant of any Contract relating to employment, invention disclosure, invention assignment, non-disclosure
or non-competition by virtue of such employee, consultant or independent contractor being employed by, or performing services for,
the Parent Group with respect to any technology, software or other copyrightable, patentable or otherwise proprietary work development
for the Parent Group that is subject to any agreement under which such employee, consultant or independent contractor or Affiliate
thereof has assigned or otherwise granted to any third party any rights (including Intellectual Property rights) in or to such
technology, software or other copyrightable, patentable or otherwise proprietary work. To the Parent’s Knowledge, the employment
of any employee of the Parent Group or the use by the Parent Group of the services of any consultant or independent contractor
(including the services of any employees and consultants of such independent contractors) does not subject the Parent Group to
any liability to any third party for improperly soliciting such employee, consultant or independent contractor to work for the
Parent Group.

 

(n)Each
Parent Group has taken all commercially reasonable steps to protect and preserve the confidentiality of all material confidential
or non-public information included in the Parent IP Rights ("Parent Confidential Information").

 

(o)Section
5.18(o) of the Purchaser Disclosure Schedule lists Open Source Materials used by the Parent Group in (i) the Parent
Products or (ii) the business of the Parent Group. Each Parent Group is in compliance with the terms and conditions of
all licenses for Open Source Materials.

 

(p)The
Parent IP Rights or the Parent Products (i) do not incorporate Open Source Materials, and are not combined with Open Source
Materials; (ii) are not distributed in conjunction with any Open Source Materials; or (iii) do not use Open Source Materials,
in each of (i), (ii) and (iii), in such a way that, with respect to each of (i), (ii) and (iii), creates or purports to create
obligations for the Parent Group with respect to the Parent IP Rights or Parent Products or grant, or purports to grant, to any
third party, any rights or immunities under any Parent IP Rights or Parent Products (including using any Open Source Materials
that require, as a condition for such use, modification and/or distribution of such Open Source Materials that other software incorporated
into, derived from or distributed with such Open Source Materials be (A) disclosed or distributed in source code form, (B) be
licensed for the purpose of making derivative works, or (C) be redistributable at no charge).

 

    	71

    	 

    
Execution Copy

 

 

(q)No
Parent Product contains any Malicious Code. The Parent implements sufficient current industry standard measures designed to prevent
the introduction of Malicious Code into the Parent Products.

 

(r)For
all software used by the Parent in providing services, or in developing or making available any of its products, the Parent has
implemented sufficient security patches or upgrades that are generally available for that software.

 

(s)Except
as set forth in Section 5.18(s) of the Purchaser Disclosure Schedule, no government funding or Governmental Grants or funding
from any Person was used in the development of the Parent Owned IP Rights.

 

(t)Except
as set forth in Section 5.18(t) of the Purchaser Disclosure Schedule, neither the Parent Group nor any other Person acting
on its behalf has disclosed, delivered or licensed to any Person, agreed to disclose, deliver or license to any Person, or
permitted the disclosure or delivery to any escrow agent or other Person of, any Parent Source Code. To Parent’s
Knowledge, no event has occurred, and no circumstance or condition exists, that (with or without notice or lapse of time, or
both) will, or would reasonably be expected to, result in the disclosure, delivery or license by the Parent Group or any
Person acting on its behalf to any Person of any Parent Source Code. Section 5.18(t) of the Purchaser Disclosure Schedule
identifies each Contract pursuant to which the Parent Group has deposited, or is or may be required to deposit, with an
escrow holder or any other Person, any of its Parent Source Code. The Parent Source Code contains annotations and
programmer’s comments, and otherwise has been documented in a manner that is both: (i) consistent with customary code
annotation conventions and common practices in the software industry; and (ii) sufficient to independently enable a
programmer of reasonable skill and competence to understand, analyze, and interpret program logic, correct errors and
improve, enhance, modify and support the Parent Products.

 

Section
5.19Insurance Coverage.

 

Section 5.19 of
Purchaser Disclosure Schedule identifies each insurance policy maintained by, at the expense of or for the benefit of Parent
Group or its business or Assets and Properties, each of which is in full force and effect. All premiums payable under all
such policies have been timely paid and Parent Group has otherwise complied with all material terms and conditions of all
such policies. Neither: (A) the execution or delivery by Parent or Purchaser of this Agreement or any other Transaction
Document to which any of them is party; nor (B) the consummation by them of the Transactions, will (with or without notice or
lapse of time or both): (1) result in the cancellation, invalidation or termination, or give any Person the right to cancel,
invalidate or terminate, any of the insurance policies of the Parent Group; (2) result in the reduction of coverage, or give
any Person the right to reduce the coverage, under any such insurance policies; or (3) have any impact on the right or
ability of Parent Group to make a claim under any such insurance policies in respect of or relating to events or
circumstances that have occurred prior to the respective Closing.

 

Section
5.20Tax Matters.

 

    	72

    	 

    
Execution Copy

 

 

(a)Each
Parent Group member has timely filed in a proper manner with the appropriate Taxing Authorities all Tax Returns required to be
filed by or with respect to, such Parent Group and has timely paid in full all Taxes shown as due on any such Tax Return. All such
Tax Returns are true, complete and accurate. All Taxes due and payable by any member of the Parent Group or with respect to the
income, assets or operations thereof, whether or not required to be shown on a Tax Return, have been timely paid in full. No written
claim has been served to the Parent Group since January 1, 2008 by a Taxing Authority or any other Governmental Authority in a
jurisdiction where the Parent Group does not file Tax Returns that any member of the Parent Group is or may be subject to taxation
in that jurisdiction.

 

(b)A
proper and adequate accrual or reserve for Tax Liabilities of the Parent Group in accordance with US GAAP is included in the Parent's
Financial Statements. The unpaid Taxes of the Parent Group (i) did not, as of the Financial Statements Date, exceed the reserve
for Tax Liabilities set forth on the balance sheet (and not merely in the notes) included in the Parent Financial Statements, and
(ii) do not, as of the date hereof, exceed such reserve except as set forth in Section 5.20(b)

of the Purchaser Disclosure Schedule.

 

(c)Since
the Financial Statements Date, the Parent Group (i) has not incurred any Liability for Taxes (A) from extraordinary gains or losses
within the meaning of US GAAP, (B) outside the ordinary course of business, or (C) otherwise inconsistent with past custom and
practice and (ii) has, in accordance with US GAAP, made due and sufficient accruals for such Liabilities for Taxes (excluding any
"deferred taxes" or similar items that reflect timing differences between tax and financial accounting principles) in
the books and records of the Parent Group.

 

(d)The
Parent Group has not been since January 1, 2008 nor, to the Knowledge of the Parent, is currently the subject of any audit or other
examination of Taxes by any Taxing Authority. No written deficiencies for Taxes with respect to the Parent Group have been claimed,
or assessed by any Taxing Authority or other Governmental Authority. There are currently no matters under discussion between the
Parent Group and any Taxing Authority. The Parent has made available to the Companies (i) complete and accurate copies of all Tax
Returns of the Parent Group for the past three taxable years, and (ii) complete and accurate copies of all audit or examination
reports and statements of deficiencies assessed against or agreed to by the Parent for the past five taxable years. During the
past five taxable years the Parent Group has not waived or extended any statute of limitations in respect of Taxes or agreed to
any extension of time with respect to a Tax assessment or deficiency, nor has the Parent submitted any request for any such extension
or waiver.

 

(e)No
closing agreements, private letter rulings, technical advice memoranda or similar agreements or rulings relating to Taxes have
been entered into or issued by any Governmental Authority with or in respect of the Parent Group during the past five taxable years.
The Parent Group has not requested or received a ruling from any Taxing Authority during the past three taxable years (other than
such rulings required by this Agreement).

 

Section
5.21Employees; Contractors and Benefit Plans

 

(a)Section
5.21(a) of Purchaser Disclosure Schedule sets forth with respect to each Parent Group member, the name of each executive
officer, and each independent contractor and consultant providing services customarily provided by executive officers and the
ten other employees with the highest total Compensation Package in the Parent Group, together with his or her position or
function, date of hire or engagement, annual base salary or wages or the compensation, vacation entitlement and any
applicable incentive, severance or bonus arrangements.

 

    	73

    	 

    
Execution Copy

 

 

(b)
Parent has made available to Companies and Selling Shareholders (i) accurate and complete copies of each employment, consulting,
severance, termination, retirement, profit sharing, bonus, incentive or deferred compensation, retention or transaction bonus or
change in control agreement, pension, stock Option, restricted stock or other equity-based benefit, profit sharing, savings, retirement,
life, health, disability, accident, medical, dental, insurance, vacation, paid time off, long term care, perquisite, fringe benefit,
death benefit or other material compensation or benefit plan, program, arrangement, agreement, fund or commitment (i) for the benefit
or welfare of any current or former director, officer, shareholder, service provider or employee of any Parent Group or any shareholder
or Affiliate thereof employing such person for the benefit of Parent Group, or (ii) with respect to which such Parent Group has
any Liability (such plans are referred to collectively herein as the "Parent Benefit Plans”), to the extent currently
effective, including all amendments thereto, and Section 5.21(b)

of Purchaser Disclosure Schedule sets forth an accurate and complete list of all Parent Benefit Plans.
Each Parent Group member has performed all material obligations required to be performed by such Parent Group member thereunder,
and is not in default or violation of, and has no Knowledge of any default or violation by any other party to any Parent Benefit
Plan, of any material term thereunder. Each Parent Benefit Plan has been established and maintained in accordance with its terms
and in compliance with Applicable Law.

 

(c)Except
as set forth in Section 5.21(c) of Purchaser Disclosure Schedule,  the consummation of the Transactions will not (either
alone or together with any other event, including a subsequent termination of employment or service or other engagement)
entitle any employee, service provider or independent contractor of any Parent Group member or any employee of such
independent contractor or service provider to severance pay or accelerate the time of payment or vesting or trigger any
payment of funding (through a grantor trust or otherwise) of compensation or benefits under, increase the amount payable
under any Parent Benefit Plan or trigger any other Liability to such Parent Group member or any other right or benefit to
such person.

 

(d)Except
as set forth in Section 5.21(d) of the Purchaser Disclosure Schedule, no Parent Group member has engaged any consultants,
sub-contractors, sales agents or freelancers who, according to Applicable Law, would be entitled to the rights of an employee
vis-à-vis the Parent Group, including rights to severance pay, vacation, recuperation pay (dmei havraa) and other
employee-related statutory or contractual benefits. Each Person providing services to any Parent Group member that has been
characterized as a consultant, sub-contractor, sales agent or freelancer and not an employee has been properly characterized
as such including, where applicable, through the inclusion of appropriate and required provisions in the relevant agreement
with such Person.

 

(e)No
Parent Group member is a party to any collective bargaining Contract, collective labor agreement or other Contract or arrangement
with a labor union, workers committee, trade union or other organization or body involving any of its employees, or is otherwise
required (under any legal requirement, under any Contract or otherwise) to provide benefits or working conditions beyond the minimum
benefits and working conditions required by any Applicable Law or pursuant to applicable extension orders (tzavei harchava).

 

(f)No
Parent Group member is subject to any Proceeding asserting that Parent Group has committed an unfair labor practice or seeking
to compel it to bargain with any labor union or labor organization nor is there pending or, to Parent's Knowledge, threatened,
nor has there been since January 1, 2008, any labor strike, dispute, walk-out, work stoppage, slow-down or lockout involving any
member of the Parent Group.

 

    	74

    	 

    
Execution Copy

 

 

(g)No
Parent Group member has or is subject to, and no employee of any Parent Group member benefits from, any extension order except
for extension orders applicable to all employees in Israel.

 

(h)The
obligations of each Parent Group member to provide statutory social benefits pursuant to Applicable Law and any other benefits
provided under any Contract to which such Parent Group member is party, are each fully funded or reflected on the Parent's Financial
Statements.

 

(i)Each
Parent Group member has complied in all material respects with all Applicable Laws and/or Contracts and/or customs recognized as
such by such Parent Group member relating to employment, employment practices, wages, bonuses and other compensation matters and
terms and conditions of employment related to its employees; and all amounts that the Parent Group is legally or contractually
required either (i) to deduct from its employees’ salaries or to transfer to such employees’ pension or provident,
life insurance, incapacity insurance, continuing education fund or other similar funds, or (ii) to withhold from its employees’
salaries and benefits and to pay to any Governmental Authority as required by under Applicable Law, have, in each case, been fully
deducted, transferred, withheld and paid.

 

Section
5.22Affiliate Transactions.

 

No shareholder,
director, officer or employee of Parent Group or member of any of their immediate family or any Affiliate thereof (each of
the foregoing, a "Parent Related Person"), other than in its capacity as a shareholder, director, officer or
employee of such Parent Group, (i) has been since January 1, 2008 involved, directly or indirectly, in any business
arrangement, other than employment agreements (and if applicable, engagements with directors in their capacity as such) or
other material relationship with Parent Group (whether written or oral), (ii) directly or indirectly owns, or otherwise has
any right, title, interest in, to or under, any property or right, tangible or intangible, that is used by such Parent Group
or (iii) is engaged, directly or indirectly, in the conduct of the business of such Parent Group. In addition, to the
Knowledge of Parent, no such Parent Related Person has an interest in any Person that (A) competes with the business of
Parent Group in any market presently served by Parent Group, or (B) is a supplier, vendor, lessor, lessee, licensor or
licensee of Parent Group, in each case, except as explicitly set forth in Section 5.22 of Purchaser Disclosure
Schedule. For purpose of this Agreement, "immediate family" of any Person shall mean spouse, parents, children and
brothers and sisters of such Person.

 

Section
5.23Finder’s Fees.

 

There is no investment
banker, broker, finder or other intermediary that has been retained by or is authorized to act on behalf of Purchaser or Parent
who is entitled to any fee or commission from the Purchaser or Parent in connection with the Transactions.

 

Section
5.24Investment Company. 

 

Neither the Purchaser
nor the Parent is an "investment company" within the meaning of the United States Investment Company Act of 1940, as
amended.

 

Section
5.25Private Placement; Securities Law. 

 

    	75

    	 

    
Execution Copy

 

 

(a)Assuming
the accuracy of the Selling Shareholders’ representations and warranties set forth in Section 4.08, no registration
under the Securities Act is required for the offer and sale of the Consideration Securities by the Parent to the Selling
Shareholders as contemplated hereby (the "Offering"), and based on the accuracy of the Selling
Shareholders’ representations and warranties set forth in Section 4.08(b) the Offering by Parent to the Regulation S
Investors will qualify as a "Category 2" offering under Rule 903(b)(2) of Regulation S.

 

(b)Parent
is a "foreign issuer" as that term is defined in Regulation S, promulgated under the Securities Act.

 

(c)The
Offering by Parent to the Regulation S Investors was made in an "offshore transaction" (as that term is defined under
Regulation S).

 

(d)None
of the Parent, its affiliates or any person acting on their behalf has engaged in any "directed selling efforts" (as
that term is defined under Regulation S) with respect to the Offering.

 

(e)Parent
has implemented "offering restrictions" (as that term is defined under Regulation S) with respect to the Offering by
Parent to the Regulation S Investors.

 

(f)None
of the Parent, its affiliates or any person acting on their behalf has effected over the last 12 months a general solicitation
in the United States or to non U.S. Persons with respect to the offering of any of its securities.

 

(g)The
Parent has a class of securities registered pursuant to Section 12(b) of the United States Securities Exchange Act of 1934, as
amended (the “Exchange Act”).

 

(h)The
Parent has filed all the material required to be filed pursuant to Section 13(a) of the Exchange Act for a period of at least twelve
months preceding the date of this Agreement.

 

Article
VI

PRE CLOSING Covenants

 

Section
6.01Conduct of Business.

 

From the date of this
Agreement until the respective Closing Date, or the earlier termination of this Agreement in accordance with its terms, each of
the Companies, the Purchaser and Parent shall, and shall cause their Subsidiaries to, conduct their businesses in the ordinary
course consistent with their past practice and use commercially reasonable efforts to (i) preserve intact its respective present
business organizations, (ii) maintain in effect Governmental Authorizations necessary for the conduct of their business, and (iii) maintain
satisfactory relationships with their customers, lenders and suppliers and others having a business relationship with them. Without
limiting the generality of the foregoing, except as expressly contemplated by this Agreement or required under Applicable Law,
or pursuant to the prior written consent of the respective Shareholder Representative or Purchaser, as applicable, each of the
Companies, the Purchaser and Parent, shall not and shall cause their Subsidiaries not to do any of the following actions (except
if such action is required for consummation of the Transactions):

 

(a)Charter
Documents. Amend their Charter Documents (whether by merger, consolidation or otherwise);

 

    	76

    	 

    
Execution Copy

 

 

(b)Issuance
of Shares. (i) issue, deliver or sell, or authorize the issuance, delivery or sale of any of their shares or Options exercisable
into their shares; or (ii) amend any term of any of their shares or Options (whether by merger, consolidation or otherwise), other
than the issuance of shares pursuant to the exercise of Options and provided that such limitation will not apply with respect
to the Purchaser or Parent other than where the issuance and sale of securities is made pursuant to a transaction that is reasonably
expected to be an alternative transaction to the Transactions;

 

(c)Acquisitions.
Acquire (by merger, consolidation, acquisition of shares or assets or otherwise), directly or indirectly, any securities or all
or substantially all of the assets, properties or businesses of any third party or otherwise acquire or agree to acquire any securities
or assets which are material, individually or in the aggregate to its business, or enter into any Contract with respect to a joint
venture, strategic alliance or partnership; provided that such limitation will not apply with respect to the Parent other than
where the underlying transaction is reasonably expected to be an alternative transaction to the Transactions;

 

(d)Dispositions.
Sell, lease, license or otherwise transfer, or create or incur any Lien, on any of their tangible or intangible assets or rights
or any of their properties or assets, except in the ordinary course of business;

 

(e)Loans
and Investments. Make any loans, advances or capital contributions to, or investments in, any other Person or forgive or discharge
in whole or in part any outstanding loans or advances, or prepay any Indebtedness for borrowed money, except in the ordinary course
of business;

 

(f)Contracts.
(i) with respect to the Companies only and unless approved by the respective Company's board of directors - enter into, amend or
modify in any respect any Material Contract or (ii) terminate any Material Contract or otherwise waive, release or assign any of
their rights, claims or benefits under any Material Contract;

 

(g)Employees;
Consultants; Independent Contractors; Severance Arrangements. Other than as required under Applicable Law or made in the ordinary
course of business: (i) grant or increase any severance or termination pay to (or amend any existing arrangement with) any of their
directors, officers, advisors, consultants, independent contractors, or employees, (ii) other than in accordance with agreements
entered into prior to the date hereof and disclosed in each Company Disclosure Schedule, or Parent Disclosure Schedule, as applicable,
increase benefits payable under any existing severance or termination pay policies or employment agreements or any other benefits
payable to any of their directors, officers, advisors, consultants, independent contractors or employees, (iii) enter into any
employment, deferred compensation or other agreement or offer (or amend any such existing agreement or offer) with any of their
directors, officers, advisors, consultants, independent contractors or employees, (iv) establish, adopt or amend (except as required
by Applicable Law) any collective bargaining, Benefit Plan covering any of their directors, officers, advisors, consultants, independent
contractors or employee, or (v) promote any of their employees;

 

(h)Accounting.
Change their methods of accounting or accounting practices, except as required by concurrent changes in IFRS or US GAAP, as applicable,
and as agreed to by their respective independent public accountants;

 

(i)Proceedings;
Settlements. Commence, settle, or offer or propose to settle (i) any material Proceeding involving or against any of them,
(ii) any material litigation or dispute against any of their officers or directors or (iii) any Proceeding that relates to the
Transactions;

 

    	77

    	 

    
Execution Copy

 

 

(j)Taxes.
With respect to each of the following, other than in the ordinary course of business, make or change any Tax election other than
as is required under Applicable Law; settle or compromise any claim, notice, audit report or assessment in respect of Taxes; enter
into any closing agreement with a Taxing Authority; file any Tax Return; enter into any Tax allocation agreement, Tax sharing agreement,
Tax indemnity agreement, pre-filing agreement, advance pricing agreement, cost sharing agreement or closing agreement relating
to any Tax; change or adopt any annual Tax accounting period or method of Tax accounting; surrender or forfeit any right to claim
a Tax refund; file any Tax petition, Tax complaint or administrative Tax appeal; or consent to any extension or waiver of the statute
of limitations period applicable to any Tax claim or assessment or request, negotiate, apply for or receive a Tax ruling on their
own behalf or, with respect to the Companies, on behalf of any of the Selling Shareholders;

 

(k)Intellectual
Property. Purchase or license from any Person any rights to any Intellectual Property, or transfer or license to any Person
any rights to any Company IP Rights, or Parent IP Rights, as applicable, except in the ordinary course of business;

 

(l)New
Line of Business. Enter into agreements that contemplate their engaging in a new line of business;

 

(m)Subsidiaries.
With respect to the Companies only, form or acquire any Subsidiaries;

 

(n)Distributions.
Distribute to its shareholders any asset of such Company Group, or Parent Group, as applicable or make a declaration thereof;

 

(o)Grants.
Apply for or accept any Governmental Grant other than acceptance of such Governmental Grants pursuant to applications submitted
before the date hereof and disclosed herein; or

 

(p)Other.
Take, agree, resolve or commit to do, any of the foregoing actions, or prevent it from performing one or more covenants required
hereunder to be performed by them or otherwise consummate the Transactions.

 

From the date of this
Agreement until the respective Closing Date, or the earlier termination of this Agreement in accordance with its terms, each Selling
Shareholder and/or the Purchaser and or Parent shall not take, agree, resolve or commit to do, any action which would reasonably
be expected to make any of such Selling Shareholder's and/or the Purchaser's and/or Parent's representations or warranties contained
in this Agreement untrue or incorrect or prevent such Selling Shareholder, Purchaser of Parent from performing one or more covenants
required hereunder to be performed by it or otherwise consummate the Transactions.

 

Section
6.02No Solicitation; Other Offers.

 

From the date of this
Agreement until the earlier of the respective Closing Date or the termination of this Agreement in accordance with its terms, each
Selling Shareholder, each Company, the Purchaser and Parent (provided that such limitation will not apply with respect to the Parent
or Purchaser other than where the underlying transaction is considered by Parent to be an alternative transaction to the Transactions)
shall not, and shall cause each of its respective Representatives not to, directly or indirectly: (i) solicit, initiate, facilitate,
support, seek, induce, entertain or encourage, or take any action to solicit, initiate, facilitate, support, seek, induce, or encourage
any inquiries, announcements or communications relating to, or the making of any submission, proposal or offer that constitutes,
or that would reasonably be expected to lead to, an Acquisition Proposal; (ii) enter into, participate in, maintain or continue
any discussions or negotiations relating to, any Acquisition Proposal with any Person other than each other; (iii) furnish to any
Person other than to each other any information that is reasonably expected to be used for the purposes of formulating any inquiry,
expression of interest, proposal or offer relating to an Acquisition Proposal or take any other action regarding any inquiry, expression
of interest, proposal or offer that constitutes, or would reasonably be expected to lead to, an Acquisition Proposal; (iv) accept
any Acquisition Proposal or enter into any agreement, arrangement or understanding (whether written or oral) providing for the
consummation of any transaction contemplated by any Acquisition Proposal or otherwise relating to any Acquisition Proposal; or
(v) submit any Acquisition Proposal or any matter related thereto to the vote of their shareholders. Each Selling Shareholder,
each Company, the Purchaser and the Parent (provided that such limitation will not apply with respect to the Parent or Purchaser
other than where the underlying transaction is reasonably expected to be an alternative transaction to the Transactions), shall,
and shall cause each of its respective Representatives to, immediately cease and cause to be terminated any and all existing activities,
discussions or negotiations with any Persons conducted prior to or on the date of this Agreement with respect to any Acquisition
Proposal, and shall promptly (and in any event within 24 hours) provide Purchaser or the Shareholders Representatives, as applicable,
with: (i) a written description of any expression of interest, inquiry, proposal or offer relating to a possible Acquisition Transaction
that is received by them from any Person, including in such description the identity of the Person from which such expression of
interest, inquiry, proposal or offer was received (the "Other Interested Party"); and (ii) a copy of each written
communication and a complete summary of each other communication transmitted on behalf of the Other Interested Party or any of
the Other Interested Party’s Representatives to any of them or transmitted on behalf of any of them to the Other Interested
Party or any of the Other Interested Party’s Representatives.

 

    	78

    	 

    
Execution Copy

 

 

Section
6.03Access to Information.

 

From the date of this
Agreement until the respective Closing Date, or the earlier termination of this Agreement in accordance with its terms, each Company,
the Purchaser and the Parent shall (a) give each other and its Representatives reasonable access to key employees, the offices,
properties, books and records of each other, and (b) furnish to Purchaser or the respective Company, as applicable, and its Representatives
such information that is reasonably required by the requesting party in connection with the consummation of the Transactions and
the operations of the Parent Group and the respective Company Group post Closing, including with respect to the respective Company
Products and the Parent Products, as applicable, methodologies and related matters.

 

Section
6.04Notices of Certain Events.

 

(a)From
the date of this Agreement until the respective Closing Date, or the earlier termination of this Agreement in accordance with its
terms, the Companies and each of their Selling Shareholders, each with respect to its relevant notices shall promptly notify Purchaser,
and the Purchaser, on the other hand, shall promptly notify each Shareholders Representative of:

 

(i)any
notice or other communication from any Person alleging that the Consent of such Person is or may be required in connection with
the consummation of the Transactions;

 

(ii)any
notice or other communication from any Governmental Authority (A) delivered in connection with the Transactions, or (B) indicating
that a Governmental Authorization is revoked or about to be revoked or that a Governmental Authorization is required in any jurisdiction
in which such Governmental Authorization has not been obtained, which revocation or failure to obtain has had or would reasonably
be expected to have a Material Adverse Effect on such Company or on the Parent;

 

    	79

    	 

    
Execution Copy

 

 

(iii)any
actions, suits, claims, investigations or Proceedings commenced or, to their respective Knowledge, threatened against, relating
to or involving or otherwise affecting the respective Company or the Purchaser or Parent, as applicable, that relate to the consummation
of the Transactions and which has had or would reasonably be expected to have a Material Adverse Effect; and

 

(iv)any
event, condition, fact or circumstance that would make the timely satisfaction of any of the respective conditions set forth in
Article VIII impossible or unlikely.

 

(b)If
any event, condition, fact or circumstance that is required to be disclosed pursuant to Section 6.04(a) requires any change
in the respective Purchaser Disclosure Schedule, Company Disclosure Schedule or the Selling Shareholder Disclosure Schedule,
as applicable, or if any such event, condition, fact or circumstance would require such a change assuming such Purchaser
Disclosure Schedule, Company Disclosure Schedule or the Selling Shareholder Disclosure Schedules, as applicable, were dated
as of the date of the occurrence, existence or discovery of such event, condition, fact or circumstance, then the Purchaser
or such Company or such Selling Shareholder, as applicable, shall promptly deliver to each other an update to its Purchaser
Disclosure Schedule, Company Disclosure Schedule or the respective Selling Shareholder Disclosure Schedule, as applicable,
specifying such change. No such notice or update shall be deemed to supplement or amend the Purchaser Disclosure Schedule,
Company Disclosure Schedule or Selling Shareholder Disclosure Schedule, as applicable, for the purpose of
(i) determining the accuracy of any of the representations and warranties made by any of the Companies, any Selling
Shareholder, the Purchaser or the Parent, as applicable, in this Agreement and any indemnification obligation hereunder, or
(ii) determining whether any of the respective conditions set forth in Article VIII

has been satisfied.

 

Section
6.05Restriction on Transfer.

 

(a)Each
Selling Shareholder agrees that, prior to the respective Closing or the earlier termination of this Agreement, such Selling Shareholder
shall not directly or indirectly sell or otherwise transfer or dispose of, or pledge or otherwise permit to be subject to any Lien
(other than any Lien existing as of the date hereof, which shall be removed prior to the respective Closing), any Companies Shares
or any other security of the Companies owned by such Selling Shareholder, or any direct or indirect beneficial interest therein,
and the Companies shall not register any transfer of Companies Shares in the registers of shareholders of the Companies until the
earlier of the respective Closing Date or the earlier termination of this Agreement.

 

(b)Each
Selling Shareholder, severally and not jointly with the other Selling Shareholders, agrees that such Selling Shareholder will not
sell any of the Consideration Securities on the TASE except in compliance with the Israeli Securities Law and the rules and regulations
promulgated thereunder.

 

Section
6.06Filings.

 

(a)As
promptly as practicable after the execution of this Agreement, each Company, the Purchaser and the Parent (a) shall make all filings
and give all notices reasonably required to be made and given by such party in connection with the Transactions, to the extent
such filings or notices were not submitted prior to the execution of this Agreement, except that any such filing or notice shall
be subject to the prior review and approval of Purchaser or the Companies, as applicable, (b) with respect to the Companies, shall
take such actions as are reasonably required to comply with Section 341 of the Companies Law as provided in Section 2.10 of this
Agreement, and (c) shall use all commercially reasonable efforts to obtain all Consents required to be obtained (pursuant to any
Applicable Law or Contract, or otherwise) in connection with the consummation of the Transactions. Each Company shall, upon request
of the Purchaser, and Purchaser shall, upon request of the Companies, promptly deliver to each other a copy of each such filing
made, each such notice given and each such Consent obtained by them. Notwithstanding the generality of the foregoing, the Companies
or the Purchaser or Parent, as applicable, shall not amend or modify or otherwise waive, release or assign any of their material
rights, claims or benefits or pay any fee or other compensation to any Person in order to obtain any Consent required to be obtained
(pursuant to any Applicable Law or Contract, or otherwise) by such party in connection with the Transactions.

 

    	80

    	 

    
Execution Copy

 

 

(b)As
promptly as practicable after the execution of this Agreement, Parent shall cause its Israeli counsel to prepare and file with
the Israeli Securities Authority an application for an exemption from the requirements of the Israeli Securities Law concerning
the publication of a prospectus in respect of the replacement of the Assumed Options pursuant to Section 15D of the Israeli Securities
Law (the "Israeli Securities Exemption"). Each Company and each Selling Shareholder shall cooperate and cause
its Representatives to cooperate with Parent in connection with the preparation and filing of such application and in the preparation
of any written or oral submissions that may be necessary, proper or advisable to obtain the Israeli Securities Exemption.

 

(c)As
promptly as practicable after the execution of this Agreement, Parent shall cause its Israeli counsel to prepare and file with
the TASE an application to approve the issuance of the Consideration Shares, the Warrant Shares and the Parent's shares issuable
upon exercise of the Assumed Options (the "TASE Approval"). Each Company and each Selling Shareholder shall cooperate
and cause its Representatives to cooperate with Parent in connection with the preparation and filing of such application and in
the preparation of any written or oral submissions that may be necessary, proper or advisable to obtain the TASE Approval.

 

(d)As
promptly as practicable after the execution of this Agreement, each of the parties hereto shall file any filings, reports, information
and documentation required for the transactions contemplated hereby pursuant to any antitrust or competition law (collectively,
"Antitrust Laws"). Each of the parties hereto shall furnish to each other's counsel such necessary information
and reasonable assistance as the other may request in connection with its preparation of any filing or submission that is necessary
under the Antitrust Laws. Each of the parties hereto shall use its reasonable best efforts to obtain promptly such clearances listed
in Schedule C attached hereto, required under the Antitrust Laws for the consummation of the Transaction ("Antitrust Approvals")
and shall keep each other apprised of the status of any communications with, and any inquiries or requests for additional information
from, any Governmental Authority and shall comply promptly with any such inquiry or request. Each of the parties hereto shall promptly
and timely respond to a request for additional information from any Governmental Entity.

 

Section
6.07Adoption of New Parent Option Plan.

 

Immediately
prior to the date hereof, the Parent has adopted a new option plan in the form attached hereto as Exhibit M1, in order to
enable the replacement of the Assumed Options pursuant to Section 2.04

.

 

Section
6.08Israeli Tax Ruling.

 

    	81

    	 

    
Execution Copy

 

 

(a)Immediately
following execution of this Agreement, each Company will file with the ITA applications for the following rulings:

 

(i)A
ruling confirming that (A) the replacement of the Companies Options with Options to purchase commons shares of Parent
in accordance with Section 2.04 above will not result in a requirement for an immediate Israeli Tax payment and that the
Israeli taxation will be deferred until the exercise of the Options to purchase common shares of Parent, or in the case of
Assumed Options that are part of a "Section 102 Plan," until the actual sale of the underlying shares of Parent
issued to the holders of such Assumed Options; (B) the "lock-up period" under any "Section 102 Plan" will
continue to run and will not be restarted as a result of the replacement of the Assumed Options; and (C) the issuance of any
shares of Parent pursuant to this Agreement in exchange for Companies Shares held in trust at the respective Closing under a
"Section 102 Plan" will not result in an immediate taxable event for the Person entitled to such shares of Parent
if such issuance is made directly to the "Section 102 Plan" trustee and until such time as such shares of Parent
are subsequently transferred by such trustee to the Person entitled thereto, whether at the end of the statutory holding
period or otherwise, in accordance with the terms of such ruling (the "Israeli Options Tax Ruling").

 

(ii)A
ruling permitting any Selling Shareholder who elects to become a party to such tax pre-ruling (the "Electing Holder"),
(i) to defer the payment of any applicable Israeli tax with respect to any respective Consideration Securities that such Electing
Holder will receive pursuant to this Agreement until the "Day of Sale" (as defined in Section 104(h) of the Tax Ordinance),
of such Consideration Securities by such Electing Holder and (ii) to defer the determination of the applicable Israeli tax with
respect to such Electing Holder's Consideration Securities held in the respective Escrowed Funds until their release from the IDIT
Escrow Deposit or FIS Escrow Deposit to such Electing Holder, which determination shall be based on the value of such Consideration
Securities at such time of their release (the "Israeli 104(h) Tax Ruling"). The Israeli 104(h) Tax Ruling shall
not impose any restrictions or obligations on the Purchaser, the Parent or any of the Companies.

 

(b)Each
Company shall, and shall instruct its Representatives to, cooperate with Purchaser and its Israeli counsel, Representatives with
respect to the application by such Company for the Israeli Options Tax Ruling and in the preparation of any written or oral submissions
that may be necessary, proper or advisable to obtain such ruling. Subject to the terms and conditions hereof, the parties shall
use commercially reasonable efforts to promptly take, or cause to be taken, all action and to do, or cause to be done, all things
necessary, proper or advisable under Applicable Law to obtain the Israeli Options Tax Ruling, as promptly as practicable. Each
Company and its Representatives shall not make any application to, or conduct any negotiation with, the ITA with respect to any
matter relating to the Israeli Options Tax Ruling without prior coordination with the Purchaser or its Representatives, and will
enable Purchaser’s Representatives to participate in all discussions and meetings relating thereto. To the extent that the
Purchaser’s Representative elects not to participate in any such meeting or discussion, the Companies’ Representatives
shall provide to the Purchaser's Representatives a prompt and full report of any such discussions held. In any event, the final
text of the application for the Israeli Tax Rulings in all circumstances be subject to the prior approval of Purchaser. The Companies
and their Representatives will provide to the Purchaser and its Representatives a draft of the Israeli 104(h) Tax Ruling prior
to the submission thereof to the ITA and shall incorporate into such ruling the Purchaser’s and its Representatives’
comments thereto.

 

Section
6.09FIS Shareholders Meeting.

 

    	82

    	 

    
Execution Copy

 

 

Immediately
following the execution of this Agreement, FIS shall call and give notice of a general meeting
of the holders of FIS Shares for the approval of the FIS Transaction in the form attached hereto as Exhibit 6.09 (the "EGM
Notice"), and take all other necessary measures in order to convene such meeting within seven (7) days after the date
of the EGM Notice. Each FIS Executing Shareholder undertakes to vote or cause to be voted, all of the FIS Shares now or hereafter
owned, controlled or beneficially held, by such FIS Executing Shareholder, in favor of the resolutions set forth in the EGM Notice.

 

Section
6.10Transactions in Parent's Shares.

 

During the period
beginning on the date hereof and until the applicable Closing, none of the Companies, the Selling Shareholders, their Affiliates
or anyone on their behalf (collectively, the "Restricted Parties") shall sell, contract to sell, solicit offers
to sell, make any short sale or otherwise dispose of, directly or indirectly, any of Parent's shares or any securities convertible
into, exchangeable for or that represent the right to receive Parent's shares, whether now owned or hereinafter acquired, owned
directly by the Restricted Party (including holding as a custodian) or with respect to which the Restricted Party has beneficial
ownership or dispositive power within the rules and regulations of the SEC, or otherwise actively adversely influence the prices
of Parent's shares as reported on the Nasdaq (except by virtue of entering into this Agreement). The foregoing restriction is expressly
agreed to preclude the Restricted Parties from, directly or indirectly, engaging in any hedging or other transaction which is designed
to or which reasonably could be expected to lead to or result in a sale or disposition of Parent’s shares. Such prohibited
hedging or other transactions include without limitation any short sale or any purchase, sale or grant of any right (including
without limitation any put or call option) with respect to any of the Parent’s shares or with respect to any security that
includes, relates to, or derives any significant part of its value from such Parent's shares.

 

 

 

Article
VII

Additional agreements

 

Section
7.01Public Announcements.

 

Prior to and
after the respective Closing, the parties hereto hereby agree not to (and to use reasonable efforts to cause their Representatives
and Affiliates not to) make any public announcement, notice, or any other communication or disclosure to any other third party
regarding the existence or any subject matter, terms or conditions of this Agreement, the other Transaction Documents or the Transactions
without the prior written approval of the Purchaser or the Companies, as applicable, except as such release, disclosure or announcement
may be required by Applicable Law or under this Agreement, in which case the Person required to make the release or announcement
will allow the Person whose consent would otherwise be required reasonable time (subject to the timing required under the Applicable
Law for such release, disclosure or announcement to be made) to comment on such release, disclosure or announcement in advance
of such issuance.

 

Section
7.02Commercially Reasonable Efforts.

 

Subject to the
terms and conditions contained herein, the Companies, the Selling Shareholders, the Purchaser and the Parent shall cooperate and
use their respective commercially reasonable efforts (a) to take, or cause to be taken, all appropriate action, and to make, or
cause to be made, all filings necessary, proper or advisable under Applicable Law, to consummate and make effective the Transactions,
(b) to obtain, prior to the respective Closing Date, all Consents of Governmental Authorities and other Persons as are necessary
for consummation of the Transactions, and (c) to fulfill the respective conditions to consummation of the Transactions contemplated
hereby set forth in Article VIII

of this Agreement.

 

    	83

    	 

    
Execution Copy

 

 

Section
7.03Litigation Support

 

After the respective
Closing, in the event that, and for so long as, the Purchaser, the Parent or any of the Companies is actively contesting or defending
against any Proceeding in connection with (a) any transaction contemplated by the Transaction Documents or (b) any fact, situation,
circumstance, status, condition, activity, practice, plan, occurrence, event, incident, action, failure to act, or transaction
on or prior to the respective Closing Date involving the Companies, the Purchaser or the Parent, the parties hereto will reasonably
cooperate with such contesting or defending party and its counsel in the contest or defense, make their personnel reasonably available,
and provide such testimony as shall be reasonably necessary in connection with the contest or defense.

 

Section
7.04Tax Matters.

 

(a)Cooperation.
The Selling Shareholders, the Shareholders Representatives and the Purchaser shall reasonably cooperate, and shall cause their
respective Representatives and Affiliates reasonably to cooperate, in preparing and filing all Tax Returns of the Companies for
years ended in the year hereof, including maintaining and making available to each other all records reasonably necessary in connection
therewith and in resolving all disputes and audits with respect to Taxes.

 

(b)Transfer
Taxes. All transfer, documentary, sales, use, stamp, registration and other substantially similar Taxes and fees (including
any penalties and interest) incurred in connection with this Agreement (collectively, "Transfer Taxes") shall
be paid by the Purchaser and/or the Companies when due, and the Purchaser and/or the Companies will, at their own expense, file
all necessary Tax Returns and other documentation with respect to all such Transfer Taxes. It is hereby clarified that any income
tax and/or capital gain tax imposed on the Selling Shareholders in connection with the consummation of the Transactions shall be
the responsibility of the Selling Shareholders.

 

Section
7.05Confidentiality.

 

The parties
acknowledge that the Parent and the Companies have previously executed a Confidentiality and Non-disclosure Agreement, dated as
of March 2, 2011 (the "Nondisclosure Agreement"), the provisions of which shall apply to all information furnished
to the parties hereto, for the time periods set forth therein (subject to Section 7.01

above).

 

Section
7.06Appointment of Board Member. 

 

At the respective Closing
following which Kardan Technologies Ltd. ("Kardan") shall hold, directly or indirectly, at least 9% of the Parent's
issued and outstanding share capital, the Parent shall cause the appointment of one person designated by Kardan as a member of
the board of directors of Parent, to hold office until the next general meeting of the Parent's shareholders.

 

Section
7.07Waiver of Claims. 

 

    	84

    	 

    
Execution Copy

 

 

As a material
inducement to the Purchaser’s willingness to enter into and perform this Agreement and to purchase the Companies Shares
for the consideration to be paid to the Selling Shareholders in connection with such purchase, each Selling Shareholder, on
behalf of such Selling Shareholder and each of the Affiliates thereof hereby releases and forever discharges, effective as of
the respective Closing, the respective Company including its office holders in which it owns shares and each of its past,
present and future Representatives (excluding agents, attorneys, accountants, advisors and investment bankers) and office
holders (individually, a "Releasee" and collectively, "Releasees") from any and all
Proceedings, Contracts and Liabilities whatsoever, whether known or unknown, suspected or unsuspected, both at law and in
equity, which each Selling Shareholder or any of its Representatives (excluding agents, attorneys, accountants, advisors and
investment bankers) now has, has ever had or may hereafter have against the respective Releasees arising contemporaneously
with or prior to the respective Closing Date, including, but not limited to, any rights to indemnification or reimbursement
from the respective Company, whether pursuant to their respective Charter Documents, Contract or otherwise and whether or not
relating to claims pending on, or asserted after, the respective Closing Date, except to the extent such claim is accrued
prior to the respective Closing Date; provided, however, that nothing contained herein shall operate to release
any obligation of the Purchaser or Parent arising under this Agreement and provided further that such releases will not apply
with respect to: (i) claims by any Selling Shareholder solely in his capacity as a director or as an office holder of the
respective Company for indemnification with respect to third party claims against such Selling Shareholder solely in his
capacity as a director or as an office holder of such Company, pursuant to the terms of such Selling
Shareholder's indemnification agreement; and (ii) any claim of an office holder under any of his or her employment terms with
the Company. Each Selling Shareholder hereby irrevocably covenants to refrain from, directly or indirectly, asserting any
claim or demand, or commencing, instituting or causing to be commenced, any Proceeding of any kind against any Releasee,
based upon any matter purported to be released hereby. Without limitation of the foregoing, each Selling Shareholder agrees,
effective as of respective Closing, to terminate any and all Contracts by and between the respective Company in which it
holds shares and any such Selling Shareholder (other than (i) to the extent any such Contract assigns rights to Intellectual
Property to such Company, (ii) officers and directors indemnification agreements to the extent such Selling Shareholder is a
director or an office holder in the respective Company, (iii) officers employment agreements without any remaining Liability
of such Company and to repay and discharge any Liability of the Selling Shareholder to such Company and each Company hereby
agrees, effective as of respective Closing, to terminate any and all Contracts by and between such Company and any such
Selling Shareholder, except to the extent any such Contract assigns rights to Intellectual Property to such Company, without
any obligation on the part of such Company to make any royalty or other payments after the respective Closing, which
assignment shall survive such termination. For the purpose of this Section 7.07 all Releasees that are not parties to this
Agreement shall be deemed as third party beneficiaries of the Selling Shareholders' undertakings hereunder.

 

Section
7.08Further Actions

 

In case at any time
after the respective Closing any further actions are necessary to achieve the purposes of this Agreement, each party hereto will
take such further actions (including the execution and delivery of all necessary instruments and documents) as any other party
may reasonably request.

 

Section
7.09D&O Insurance

 

The Parent and the
Purchaser shall provide to the Companies' current directors and "Office Holders" (as such term is defined under the Companies
Law) an insurance having the same terms as the terms of the insurance currently provided by the Parent to its directors and executive
officers, for a period of not less than seven (7) years after the respective Closings.

 

    	85

    	 

    
Execution Copy

 

 

Section
7.10Registration Statement on Form S-8

 

Within 90 days after
the first Closing Date, Parent shall prepare and file with the SEC a Registration Statement on Form S-8 to register the Assumed
Options and the Parent's common shares issuable upon exercise of the Assumed Options, and pay all expenses incident thereto.

 

Section
7.11Form D

 

Parent shall promptly
prepare and file with the SEC, in a timely manner in accordance with Applicable Law, a Form D with respect to the Consideration
Securities offered by Parent to the Regulation D Investors.

 

 

 

Article
VIII

Conditions to the transactions

 

Section
8.01Conditions to the Obligations of the Parties to the FIS Transaction.

 

The obligations of
FIS, Purchaser and the FIS Selling Shareholders to consummate the FIS Transaction are subject to the satisfaction of the following
conditions, as applicable:

 

(a)No
Injunction. No temporary restraining order, preliminary or permanent injunction or other order or decree issued by any
Governmental Authority of competent jurisdiction shall be in effect which prevents the consummation of the FIS Transaction on the
terms contemplated herein, and no Applicable Law shall have been enacted that makes the consummation of the FIS Transaction illegal.

 

(b)Governmental
Authorizations. The Governmental Authorizations listed on Section 3.05 of FIS' Disclosure Schedule and the Israeli
Securities Exemption shall have been obtained or shall become inapplicable or not required.

 

(c)TASE
Approval. The TASE Approval shall have been obtained. 

 

(d)Antitrust
Approval. The Antitrust Approvals shall have been obtained.

 

(e)Section
341 Action. In the event that any Non Executing Shareholder of FIS is forced to sell its FIS Companies Shares in accordance
with Section 341 of the Companies Law and such FIS Charter Documents, the 30-day period to file an action under Section 341 of
the Companies Law by any such FIS Non Executing Shareholder shall have expired.

 

(f)Listing
of FIS Consideration Shares and Warrants Shares. Parent shall have filed with the Nasdaq a Notification Form: Listing of Additional
Shares covering the Warrants Shares issuable to and the Consideration Shares issued to the FIS Selling Shareholders and such listing
shall have been approved by Nasdaq.

 

Section
8.02Conditions to the Obligations of the Parties to the IDIT Transaction

 

    	86

    	 

    
Execution Copy

 

 

The obligations of
IDIT, Purchaser and the IDIT Selling Shareholders to consummate the IDIT Transaction are subject to the satisfaction of the following
conditions, as applicable:

 

(a)No
Injunction. No temporary restraining order, preliminary or permanent injunction or other order or decree issued by any
Governmental Authority of competent jurisdiction shall be in effect which prevents the consummation of the IDIT Transaction on
the terms contemplated herein, and no Applicable Law shall have been enacted that makes the consummation of the IDIT Transaction
illegal.

 

(b)Governmental
Authorizations. The Governmental Authorizations listed on Section 3.05 of IDIT's Disclosure Schedule and the Israeli
Securities Exemption shall have been obtained or shall become inapplicable or not required.

 

(c)TASE
Approval. The TASE Approval shall have been obtained. 

 

(d)Antitrust
Approval. The Antitrust Approvals shall have been obtained.

 

(e)Section
341 Action. In the event that any Non Executing Shareholder of IDIT is forced to sell its IDIT Shares in accordance with Section
341 of the Companies Law and IDIT's Charter Documents, the 30-day period to file an action under Section 341 of the Companies Law
by any such IDIT Non Executing Shareholder shall have expired.

 

(f)Listing
of IDIT Consideration Shares. Parent shall have filed with the Nasdaq a Notification Form: Listing of Additional Shares covering
the IDIT Consideration Shares issuable to the IDIT Selling Shareholders and such listing shall have been approved by Nasdaq.

 

Section
8.03Conditions to the Obligations of Purchaser and Parent to Consummate the FIS Transaction

 

The obligations of
Purchaser and Parent to consummate the FIS Transaction are subject to the satisfaction, or waiver by Purchaser, at or prior to
the FIS Closing Date, of the following further conditions:

 

(a)Representations
and Warranties. (i) each of the representations and warranties made by FIS in this Agreement (other than the
representations referred to in clause (ii) below) shall have been (a) true and correct in all material respects as of the
date of this Agreement, without giving effect to any materiality qualifications contained or incorporated directly or
indirectly in such representations and warranties, and (b) true and correct as of the date of the FIS Closing, as if made as
of the FIS Closing Date, except for any inaccuracies that do not constitute, individually or in the aggregate, a Material
Adverse Effect on FIS; (ii) each of the representations and warranties made by FIS in Section 3.02 (Corporate Authorization),
Section 3.05 (Non-Contravention) and Section 3.06 (Capitalization), shall be true and correct in all respects as of the date
of this Agreement and as of the FIS Closing Date, except that changes to the issued share capital of FIS between the date
hereof and the FIS Closing Date due to exercise of FIS Options shall not be deemed as an inaccuracy or a breach of the
representations and warranties contained in Section 3.06 (Capitalization), (iii) each of the representations and warranties
made by the FIS Selling Shareholders in this Agreement (other than the representations referred to in clause (iv) below)
shall have been true and correct in all material respects as of the date of this Agreement and as of the FIS Closing Date as
if made as of the FIS Closing Date, without giving effect to any materiality qualifications contained or incorporated
directly or indirectly in such representations and warranties, and (iv) each of the representations and warranties of the FIS
Selling Shareholders contained in Section 4.01 (Title to Company Shares), Section 4.02 (Authority; Binding Effect)
and Section 4.03

(Non-Contravention; Consents), shall be true and correct in all respects as of the date of this Agreement
and as of the FIS Closing Date.

 

    	87

    	 

    
Execution Copy

 

 

(b)Covenants.
(i) Each of the covenants and obligations that FIS is required to comply with or to perform at or prior to the FIS Closing
shall have been complied with and performed in all material respects; and (ii) each of the covenants and obligations that the FIS
Selling Shareholders are required to comply with or to perform at or prior to the FIS Closing shall have been complied with and
performed in all material respects.

 

(c)Consents
and Approvals. Each of the Consents listed on Section 3.05 of the FIS Disclosure Schedule, shall have been
obtained in form and substance reasonably satisfactory to the Purchaser and shall be in full force and effect.

 

(d)Executed
Agreements and Certificates. Purchaser shall have received the following agreements and other documents and certificates,
each of which shall be in full force and effect:

 

(i)a
certificate, in the form attached hereto as Exhibit N, executed on behalf of FIS by its Chief Executive Officer (the "FIS
Closing Certificate") certifying (i) that the conditions set forth in Section 8.01

and this Section 8.03

(to the extent applicable to FIS) have been duly satisfied; and (ii) the resolutions of the board of directors
and the shareholders of FIS in forms satisfactory to Purchaser's counsel, approving this Agreement and the FIS Transactions.

 

(ii)a
certificate, in the form attached hereto as Exhibit O, executed by each FIS Selling Shareholder (the "FIS Selling
Shareholder Closing Certificate"), certifying that the conditions set forth in Section 8.03

(to the extent applicable to the FIS Selling Shareholder) have been duly satisfied;

 

(iii)executed
written resignations of all directors of FIS, effective as of the FIS Closing Date, in the form attached hereto as Exhibit P;

 

(iv)a
counterpart of the FIS Escrow Agreement executed by the FIS Shareholders Representative and the Escrow Agent;

 

(v)a
counterpart of the side letter between Purchaser, on the one hand, and Formula Vision Technologies (F.V.T.) Ltd. ("Formula
Vision") and Kardan Technologies Ltd. Kardan, on the other hand, in the form attached hereto as Exhibit Q (the
"Formula and Kardan Side Letter") executed by Formula and Kardan.

 

(vi)a
counterpart of the Registration Rights Agreement between the Parent, the Selling Shareholders and Formula System (1985) Ltd., ("Formula
Systems") in the form attached hereto as Exhibit R, providing for certain registration rights to the Selling Shareholders
and Formula Systems (the "IRA"), executed by the FIS Selling Shareholders.

 

(e)Share
Certificates and Share Registry.

 

(i)FIS
Executing Shareholders shall have delivered to Purchaser all certificates representing the FIS Shares set forth on Exhibit D
with respect to such Executing Shareholder (or, in lieu thereof, affidavits and indemnity letters of lost shares with respect thereto
in the form of Exhibit S), together with share transfer deeds in the form of Exhibit T.

 

    	88

    	 

    
Execution Copy

 

 

(ii)FIS
shall have delivered to Purchaser the share registry of FIS Company evidencing the transfer of ownership of all of the relevant
FIS Shares to Purchaser.

 

(f)Termination
of Shareholders Agreements. The Investors' Rights Agreement dated as of July 2002 between FIS and certain of its shareholders
shall have been terminated, and all obligations of the parties thereunder shall have been released, pursuant to an agreement in
form and substance reasonably satisfactory to the Purchaser.

 

(g)Litigation.
There shall not be: pending by or before any Governmental Authority any Proceeding that (A) seeks or is reasonably expected
to frustrate, prevent or restrict the consummation of the FIS Transactions on the terms set forth herein, or (B) seeks the award
of material Losses that would be payable by FIS if the FIS Transactions are consummated.

 

(h)Escrow
Deliverables. The Escrow Agent shall have received (a) with respect to each FIS Selling Shareholder who is an individual, a
copy of his Israeli ID or Passport; and (b) with respect to each FIS Selling Shareholder that is a corporation, a copy of an official
document, as applicable in the country of its incorporation, approving that the corporation was duly incorporated therein.

 

(i)Material
Adverse Effect. There shall have been no Material Adverse Effect with respect to FIS.

 

(j)Purchaser
Approval. The Purchaser shall have approved the FIS Closing as required under Section 2.12

, if applicable.

 

(k)Price
of the Parent’s Shares. The closing price of the common shares of the Parent as reported on Nasdaq at the close of business
on the last trading day immediately prior to the FIS Closing Date shall not be less than US$3.50 per share.

 

(l)FIS
Public Records. FIS shall have provided to the Purchaser all of the applicable documents required to be filed under the Companies
Law with the Israeli Companies Registrar (the "Registrar") which are necessary in order to update the FIS registry
held by the Registrar, together with evidence of the filing of such documents with the Registrar.

 

(m)Compliance
with US Securities Laws. The Parent shall have received representation letters in form satisfactory to the Parent, executed
by each Selling Shareholder and each holder of IDIT Option or FIS Option (collectively, the "Rep Letters"), which
Rep Letters shall provide that among the Selling Shareholders and the holders of IDIT Options or FIS Options, as a group, there
are no more than 35 persons who are U.S. Persons and not Regulation D Investors. Each Rep Letter executed by either an FIS Selling
Shareholder or a holder of FIS Options shall include the signature page hereof, duly executed (including the checking of all required
boxes included therein) by each such person (including each FIS Selling Shareholder executing this Agreement herewith).

 

Section
8.04Conditions to the Obligations of Purchaser and Parent to Consummate the IDIT Transaction

 

The obligations of
Purchaser and Parent to consummate the IDIT Transaction are subject to the satisfaction, or waiver by Purchaser, at or prior to
the IDIT Closing Date, of the following further conditions:

 

    	89

    	 

    
Execution Copy

 

 

(a)Representations
and Warranties. (i) each of the representations and warranties made by IDIT in this Agreement (other than the
representations referred to in clause (ii) below) shall have been (a) true and correct in all material respects as of the
date of this Agreement, without giving effect to any materiality qualifications contained or incorporated directly or
indirectly in such representations and warranties, and (b) true and correct as of the date of the IDIT Closing, as if made as
of the IDIT Closing Date, except for any inaccuracies that do not constitute, individually or in the aggregate, a Material
Adverse Effect on IDIT; (ii) each of the IDIT's representations and warranties contained in Section 3.02 (Corporate
Authorization), Section 3.05 (Non-Contravention) and Section 3.06 (Capitalization), shall be true and correct in all respects
as of the date of this Agreement and as of the IDIT Closing Date, except that changes to the issued share capital of IDIT
between the date hereof and the IDIT Closing Date due to exercise of IDIT Options shall not be deemed as an inaccuracy or a
breach of the representations and warranties contained in Section 3.06 (Capitalization), (iii) each of the representations
and warranties made by the IDIT Selling Shareholders in this Agreement (other than the representations referred to in clause
(iv) below) shall have been true and correct in all material respects as of the date of this Agreement and as of the IDIT
Closing Date as if made as of the IDIT Closing Date, without giving effect to any materiality qualifications contained or
incorporated directly or indirectly in such representations and warranties, and (iv) each of the representations and
warranties of the IDIT Selling Shareholders contained in Section 4.01 (Title to Company Shares), Section 4.02
(Authority; Binding Effect) and Section 4.03 (Non-Contravention; Consents), shall be true and correct in all respects as of
the date of this Agreement and as of the IDIT Closing Date.

 

(b)Covenants.
(i) Each of the covenants and obligations that IDIT is required to comply with or to perform at or prior to the IDIT
Closing shall have been complied with and performed in all material respects; and (ii) each of the covenants and obligations that
the IDIT Selling Shareholders are required to comply with or to perform at or prior to the IDIT Closing shall have been complied
with and performed in all material respects.

 

(c)Consents
and Approvals. Each of the Consents listed on Section 3.05

of the IDIT Disclosure Schedule, shall have been obtained in form and substance satisfactory to the Purchaser
and shall be in full force and effect.

 

(d)Executed
Agreements and Certificates. Purchaser shall have received the following agreements and other documents and certificates,
each of which shall be in full force and effect:

 

(i)a
certificate, in the form attached hereto as Exhibit U, executed on behalf of IDIT by its Chief Executive Officer (the
"IDIT Closing Certificate") certifying (i) that the conditions set forth in Section 8.02 and this Section
8.04 (to the extent applicable to IDIT) have been duly satisfied; and (ii) the resolutions of the board of directors and the
shareholders of IDIT in forms satisfactory to Purchaser's counsel, approving this Agreement and the IDIT Transactions.

 

(ii)a
certificate, in the form attached hereto as Exhibit V, executed by each IDIT Selling Shareholder (the "IDIT Selling
Shareholder Closing Certificate"), certifying that the conditions set forth in Section 8.04

  (to the extent applicable to the IDIT Selling Shareholder) have been duly satisfied;

 

(iii)executed
written resignations of all directors of IDIT, effective as of the IDIT Closing Date, in the form attached hereto as Exhibit
W;

 

    	90

    	 

    
Execution Copy

 

 

(iv)a
counterpart of the IDIT Escrow Agreement executed by the IDIT Shareholders Representative and the Escrow Agent;

 

(v)a
counterpart of the Formula and Kardan Side Letter executed by Formula and Kardan.

 

(vi)a
counterpart of the IRA, executed by the IDIT Selling Shareholders.

 

(e)Share
Certificates and Share Registry.

 

(i)IDIT
Executing Shareholders shall have delivered to Purchaser all certificates representing the IDIT Shares set forth on Exhibit
C with respect to such Executing Shareholder (or, in lieu thereof, affidavits and indemnity letters of lost shares with respect
thereto in the form of Exhibit X), together with share transfer deeds in the form of Exhibit Y.

 

(ii)IDIT
shall have delivered to Purchaser the share registry of IDIT Company evidencing the transfer of ownership of all of the relevant
IDIT Shares to Purchaser.

 

(f)Termination
of Shareholders Agreements. The Investors Rights and Share Purchase Agreement between IDIT and Formula Vision Technology (F.V.T.)
Ltd., dated March 23, 2005 and the Investors Rights and Shareholders Agreement, dated as of May 2008, among IDIT and certain of
its shareholders shall have been terminated, and all obligations of the parties thereunder shall have been released, pursuant to
agreements in form and substance reasonably satisfactory to the Purchaser.

 

(g)Litigation.
There shall not be: pending by or before any Governmental Authority any Proceeding that (A) seeks or is reasonably expected
to frustrate, prevent or restrict the consummation of the IDIT Transactions on the terms set forth herein, or (B) seeks the award
of material Losses that would be payable by IDIT if the IDIT Transactions are consummated.

 

(h)Escrow
Deliverables. The Escrow Agent shall have received (a) with respect to each IDIT Selling Shareholder who is an individual,
a copy of his Israeli ID or Passport; and (b) with respect to each IDIT Selling Shareholder that is a corporation, a copy of an
official document, as applicable in the country of its incorporation, approving that the corporation was duly incorporated therein.

 

(i)Material
Adverse Effect. There shall have been no Material Adverse Effect with respect to any of IDIT.

 

(j)Purchaser
Approval. The Purchaser shall have approved the IDIT Closing as required under Section 2.12

, if applicable.

 

(k)Price
of the Parent’s Shares. The closing price of the common shares of the Parent as reported on Nasdaq at the close of business
on the last trading day immediately prior to the IDIT Closing Date shall not be less than US$3.50 per share.

 

(l)IDIT
Public Records. IDIT shall lave provided to the Purchaser all of the applicable documents required to be filed under the Companies
Law with the Registrar which are necessary in order to update the IDIT registry held by the Registrar, together with evidence of
the filing of such documents with the Registrar.

 

    	91

    	 

    
Execution Copy

 

 

(m)Compliance
with US Securities Laws. The Parent shall have received the Rep Letters. Each Rep Letter executed by either an IDIT Selling
Shareholder or a holder of IDIT Options shall include the signature page hereof, duly executed (including the checking of all required
boxes included therein) by each such person (including each IDIT Selling Shareholder executing this Agreement herewith).

 

Section
8.05 Conditions to the Obligations of the FIS Selling Shareholders.

 

The obligations of
each of the FIS Selling Shareholders to consummate the FIS Transactions are subject to the satisfaction, or waiver by the FIS Shareholders
Representative other than with respect to the Super Majority Approval set forth in 8.05(h) below, of the following further conditions:

 

(a)Representations
and Warranties. (i) each of the representations and warranties made by the Parent or the Purchaser in this
Agreement (other than the representations referred to in clause (ii) below) shall have been (a) true and correct in all
material respects as of the date of this Agreement, without giving effect to any materiality qualifications contained or
incorporated directly or indirectly in such representations and warranties, and (b) true and correct as of the date of the
FIS Closing, as if made as of the FIS Closing Date, except for any inaccuracies that do not constitute, individually or in
the aggregate, a Material Adverse Effect on Parent; (ii) each of the representations and warranties contained in Section 5.02
(Corporate Authorization), Section 5.05 (Non Contravention) and Section 5.06 (Capitalization), shall be true and correct in
all respects as of the date of this Agreement and as of the FIS Closing Date, except that changes to the authorized and
issued share capital of Purchaser between the date hereof and the FIS Closing Date shall not be deemed as an inaccuracy or a
breach of the representations and warranties contained in Section 5.06(b)

(Capitalization).

 

(b)Covenants.
Each of the covenants and obligations that the Purchaser or Parent is required to comply with or to perform at or prior to
the FIS Closing shall have been complied with and performed in all material respects.

 

(c)Consents
and Approvals. Each of the Consents listed on Section 5.05 of the Purchaser Disclosure Schedule, shall have been
obtained in form and substance reasonably satisfactory to the FIS Shareholders Representative and shall be in full force and
effect.

 

(d)Executed
Agreements and Certificates. FIS Shareholders Representative shall have received the following agreements and other
documents and certificates, each of which shall be in full force and effect:

 

(i)(a)
a certificate, in the form attached hereto as Exhibit Z1, executed on behalf of Purchaser by its Chief Executive
Officer (the "Purchaser FIS Closing Certificate") certifying (i) that the conditions set forth in Section
8.01 and this Section 8.05 (to the extent applicable to Purchaser) have been duly satisfied; and (ii) the resolutions of the
board of directors of Purchaser in form satisfactory to FIS Shareholders Representative's counsel, approving this Agreement
and the FIS Transactions; and (b) a certificate, in the form attached hereto as Exhibit Z3, executed on behalf of
Parent by its Chief Executive Officer (the "Parent FIS Closing Certificate") certifying (i) that the
conditions set forth in Section 8.01 and this Section 8.05 (to the extent applicable to Parent) have been duly satisfied; and
(ii) the resolutions of the board of directors of Parent in form satisfactory to FIS Shareholders Representative's counsel,
approving this Agreement and the FIS Transactions.

 

(ii)a
counterpart of the FIS Escrow Agreement executed by the Purchaser and Parent;

 

    	92

    	 

    
Execution Copy

 

 

(iii)a
counterpart of the IRA, executed by the Parent and Formula Systems.

 

(e)Litigation.
There shall not be: pending by or before any Governmental Authority any Proceeding that (A) seeks or is reasonably expected
to frustrate, prevent or restrict the consummation of the FIS Transactions on the terms set forth herein, or (B) seeks the award
of material Losses that would be payable by Purchaser if the FIS Transactions are consummated.

 

(f)Material
Adverse Effect. There shall have been no Material Adverse Effect with respect to Parent.

 

(g)Appointment
of Board Member. The person designated by Kardan shall have been appointed as a member of the board of directors of Parent.

 

(h)Super
Majority Approval. The applicable Super Majority shall have approved the FIS Closing as required under Section 2.12

, if applicable.

 

(i)Price
of the Parent’s Shares. The closing price of the common shares of the Parent as reported on Nasdaq at the close of business
on the last trading day immediately prior to the FIS Closing Date shall not be less than US$3.50 per share.

 

(j)Closing
Certificate. Purchaser shall have delivered to the FIS Selling Shareholders a certificate, dated as of the FIS Closing, executed
on behalf of Parent by its Chief Executive Officer, certifying that Parent has delivered to the Tel Aviv Stock Exchange prior
to the FIS Closing an opinion of Parent's U.S. counsel, (i) referring to the Category 2 40-day holding period required under
Rule 903(b)(2) of Regulation S and (ii) stating that no registration under the Securities Act is required for the offer and
sale of the Consideration Securities by the Parent to the FIS Selling Shareholders as contemplated hereby (the “TASE Certificate”).

 

Section
8.06Conditions to the Obligations of the IDIT Selling Shareholders.

 

The obligations of
each of the IDIT Selling Shareholders to consummate the IDIT Transactions are subject to the satisfaction, or waiver by the IDIT
Shareholders Representative other than with respect to the Super Majority Approval set forth in 8.06(g) below, of the following
further conditions:

 

(a)Representations
and Warranties. (i) each of the representations and warranties made by the Parent or the Purchaser in this Agreement
(other than the representations referred to in clause (ii) below) shall have been (a) true and correct in all material respects
as of the date of this Agreement, without giving effect to any materiality qualifications contained or incorporated directly or
indirectly in such representations and warranties, and (b) true and correct as of the date of the IDIT Closing, as if made as
of the IDIT Closing Date, except for any inaccuracies that do not constitute, individually or in the aggregate, a Material Adverse
Effect on Parent; (ii) each of the representations and warranties contained in Section 5.02 (Corporate Authorization), Section
5.05 (Non Contravention) and Section 5.06 (Capitalization), shall be true and correct in all respects as of the date of this Agreement
and as of the IDIT Closing Date, except that changes to the authorized and issued share capital of Purchaser between the date
hereof and the IDIT Closing Date shall not be deemed as an inaccuracy or a breach of the representations and warranties contained
in Section 5.06 (Capitalization).

 

    	93

    	 

    
Execution Copy

 

 

(b)Covenants.
Each of the covenants and obligations that the Purchaser or Parent is required to comply with or to perform at or prior to
the IDIT Closing shall have been complied with and performed in all material respects.

 

(c)Consents
and Approvals. Each of the Consents listed on Section 5.05

of the Purchaser Disclosure Schedule, shall have been obtained in form and substance reasonably satisfactory
to the IDIT Shareholders Representative and shall be in full force and effect.

 

(d)Executed
Agreements and Certificates. IDIT Shareholders Representative shall have received the following agreements and other
documents and certificates, each of which shall be in full force and effect:

 

(i)(a)
a certificate, in the form attached hereto as Exhibit Z2, executed on behalf of Purchaser by its Chief Executive
Officer (the "Purchaser IDIT Closing Certificate") certifying (i) that the conditions set forth in Section
8.02 and this Section 8.06 (to the extent applicable to Purchaser) have been duly satisfied; and (ii) the resolutions of the
board of directors of Purchaser in form satisfactory to IDIT Shareholders Representative's counsel, approving this Agreement
and the IDIT Transactions, and (b) a certificate, in the form attached hereto as Exhibit Z4, executed on behalf of
Parent by its Chief Executive Officer (the "Parent IDIT Closing Certificate") certifying (i) that the
conditions set forth in Section 8.02 and this Section 8.06 (to the extent applicable to Parent) have been duly satisfied; and
(ii) the resolutions of the board of directors of Parent in form satisfactory to IDIT Shareholders Representative's counsel,
approving this Agreement and the IDIT Transactions.

 

(ii)a
counterpart of the IDIT Escrow Agreement executed by the Purchaser and Parent;

 

(iii)a
counterpart of the IRA, executed by the Parent.

 

(e)Litigation.
There shall not be: pending by or before any Governmental Authority any Proceeding that (A) seeks or is reasonably expected
to frustrate, prevent or restrict the consummation of the IDIT Transactions on the terms set forth herein, or (B) seeks the award
of material Losses that would be payable by Purchaser if the IDIT Transactions are consummated.

 

(f)Material
Adverse Effect. There shall have been no Material Adverse Effect with respect to Parent.

 

(g)Super
Majority Approval. The applicable Super Majority shall have approved the IDIT Closing as required under Section 2.12

, if applicable.

 

(h)Price
of the Parent’s Shares. The closing price of the common shares of the Parent as reported on Nasdaq at the close of business
on the last trading day immediately prior to the IDIT Closing Date shall not be less than US$3.50 per share.

 

(i)Closing
Certificate. Purchaser shall have delivered to the IDIT Selling Shareholders the TASE Certificate with respect to the
Consideration Securities to be delivered to the IDIT Selling Shareholders.

 

    	94

    	 

    
Execution Copy

 

 

Article
IX

Termination

 

Section
9.01Termination of FIS Transactions.

 

This Agreement may
be terminated with respect to the FIS Transactions and such FIS Transactions may be abandoned at any time prior to the FIS Closing:

 

(a)by
mutual written agreement of the FIS Shareholders Representative and Purchaser;

 

(b)by
either FIS Shareholders Representative or Purchaser, by written notice to the other parties, if the FIS Closing has not been
consummated on or before October 21, 2011 (the "FIS End Date"), except that the FIS End Date may be extended
by a written notice provided by either Parent or the FIS Shareholders Representative to the other parties hereto for an
additional thirty (30) days in the event that in the reasonable judgment of Parent or the FIS Shareholders Representative the
FIS Closing may occur prior to the FIS End Date (as so extended); provided that the right to terminate this Agreement
pursuant to this Section 9.01(b) or to extend the period as set forth in this Section 9.01(b) shall not be available
to any party whose breach of or failure to comply with any provision of this Agreement with respect to the FIS Transactions,
results in the failure of the FIS Transactions to be consummated by such time;

 

(c)by
either FIS Shareholders Representative or Purchaser, by written notice to the other parties, if a Governmental Authority shall
have issued any order, injunction or other decree or taken any other action, in each case, which has become final and non-appealable
and which restrains, enjoins or otherwise prohibits the FIS Transactions or if there shall be any statute, rule, regulation or
order enacted, promulgated or issued or deemed applicable to the FIS Transactions by any Governmental Entity that would make consummation
of the FIS Transactions illegal;

 

(d)by
Purchaser, by written notice to FIS, if (i) any representation or warranty of any of FIS or the FIS Selling Shareholder
specified in Section 8.03(a) shall be inaccurate or untrue to the extent that any such inaccuracy or untruth would cause the
failure of the condition set forth in Section 8.03(a) to be complied with, or any of the covenants or obligations of FIS or
any FIS Selling Shareholders contained in this Agreement shall have been breached in any material respect, provided, that
such breach(es) are not capable of cure, or, if capable of cure, are not cured within fifteen (15) days of delivery of
written notice thereof from the Purchaser, or (ii) there shall have occurred a Material Adverse Effect with respect to
FIS;

 

(e)by
either FIS Shareholders Representative or Purchaser, by written notice to the other parties, if there shall be any action taken,
or any Applicable Law enacted, promulgated or issued or deemed applicable to the FIS Transactions by any Governmental Authority,
which would (x) prohibit or restrict in any material respect Purchaser’s ownership or operation of all or any portion
of the business or assets of FIS, or (y) compel Purchaser to dispose of or hold separate all or any significant portion of
FIS' assets or properties, or significantly limit its operation of FIS' business, as a result of the FIS Transactions;

 

(f)by
FIS or the FIS Shareholders Representative, by written notice to the Purchaser, if (i) any representation or warranty of
Purchaser or Parent specified in Section 8.05(a) shall be inaccurate or untrue to the extent that any such inaccuracy or
untruth would cause the failure of the condition set forth in Section 8.05(a) to be complied with, or any of the covenants or
obligations of the Purchaser or Parent contained in this Agreement shall have been breached in any material respect, provided
such breach(es) are not capable of cure, or, if capable of cure, are not cured within fifteen (15) days of delivery of
written notice thereof from FIS or the FIS Shareholders Representatives, or (ii) there shall have occurred a Material Adverse
Effect with respect to Purchaser or Parent.

 

    	95

    	 

    
Execution Copy

 

 

(g)The
party desiring to terminate this Agreement pursuant to this Section 9.01 (other than pursuant to Section 9.01(a)) shall give written
notice of such termination to the other parties setting forth a brief description of the basis on which such party is terminating
this Agreement.

 

Section
9.02Effect of Termination of FIS Transaction.

 

If this Agreement
is terminated pursuant to Section 9.01, this Agreement shall become void and of no effect with respect to the FIS Transactions
and there shall be no liability or obligation on the part of any party or any of its or their Affiliates
to any other Person by virtue of, arising out of or otherwise in connection with this Agreement with respect to the FIS Transactions
or any other FIS Transaction Document; provided that: (a) none of the FIS Selling Shareholders, FIS or the Purchaser shall be
relieved of any obligation or liability arising from any prior breach by such party of any provision of this Agreement; and (b)
the parties shall, in all events, remain bound by and continue to be subject to the provisions set forth in Section 7.01,
Section 7.05 and Article XII

. 

Section
9.03Termination of IDIT Transactions.

 

This Agreement may
be terminated with respect to the IDIT Transactions and such IDIT Transactions may be abandoned at any time prior to the IDIT Closing:

 

(a)by
mutual written agreement of the IDIT Shareholders Representatives and Purchaser;

 

(b)by
either IDIT Shareholders Representative or Purchaser, by written notice to the other parties, if the IDIT Closing has not
been consummated on or before October 21, 2011 (the "IDIT End Date"), except that the IDIT End Date may be
extended by written notice provided by either Parent or the IDIT Shareholders Representative to the other parties hereto for
an additional thirty (30) days in the event that in the reasonable judgment of Parent or the IDIT Shareholders Representative
the IDIT Closing may occur prior to the IDIT End Date (as so extended); provided that the right to terminate this
Agreement pursuant to this Section 9.03(b) shall not be available to any party whose breach of or failure to comply with any
provision of this or to extend the period as set forth in this Section 9.03(b) Agreement, results in the failure of the IDIT
Transactions to be consummated by such time;

 

(c)by
either IDIT Shareholders Representative or Purchaser, by written notice to the other parties, if a Governmental Authority shall
have issued any order, injunction or other decree or taken any other action, in each case, which has become final and non-appealable
and which restrains, enjoins or otherwise prohibits the IDIT Transactions or if there shall be any statute, rule, regulation or
order enacted, promulgated or issued or deemed applicable to the IDIT Transactions by any Governmental Entity that would make consummation
of the IDIT Transactions illegal;

 

(d)by
Purchaser, by written notice to IDIT, if (i) any representation or warranty of any of IDIT or the IDIT Selling Shareholder
specified in Section 8.04(a) shall be inaccurate or untrue to the extent that any such inaccuracy or untruth would cause the
failure of the condition set forth in Section 8.04(a) to be complied with, or any of the covenants or obligations of IDIT or
any IDIT Selling Shareholders contained in this Agreement shall have been breached in any material respect, provided, that
such breach(es) are not capable of cure, or, if capable of cure, are not cured within fifteen (15) days of delivery of
written notice thereof from the Purchaser, or (ii) there shall have occurred a Material Adverse Effect with respect to
IDIT;

 

    	96

    	 

    
Execution Copy

 

 

(e)by
either IDIT Shareholders Representative or Purchaser, by written notice to the other parties if there shall be any action taken,
or any Applicable Law enacted, promulgated or issued or deemed applicable to the IDIT Transactions by any Governmental Authority,
which would (x) prohibit or restrict in any material respect Purchaser’s ownership or operation of all or any portion
of the business or assets of IDIT, or (y) compel Purchaser to dispose of or hold separate all or any significant portion of
IDIT's assets or properties, or significantly limit its operation of IDIT's business, as a result of the IDIT Transactions;

 

(f)by
IDIT or the IDIT Shareholders Representative, by written notice to the Purchaser, if (i) any representation or warranty of
Purchaser or Parent specified in Section 8.06(a) shall be inaccurate or untrue to the extent that any such inaccuracy or
untruth would cause the failure of the condition set forth in Section 8.06(a) to be complied with, or any of the covenants or
obligations of the Purchaser or Parent contained in this Agreement shall have been breached in any material respect, provided
such breach(es) are not capable of cure, or, if capable of cure, are not cured within fifteen (15) days of delivery of
written notice thereof from IDIT or the IDIT Shareholders Representatives, or (ii) there shall have occurred a Material
Adverse Effect with respect to Purchaser.

 

(g)The
party desiring to terminate this Agreement pursuant to this Section 9.03 (other than pursuant toSection 9.03(a)) shall give written
notice of such termination to the other parties setting forth a brief description of the basis on which such party is terminating
this Agreement.

 

Section
9.04Effect of Termination of IDIT Transaction.

 

If this Agreement
is terminated pursuant to Section 9.03, this Agreement shall become void and of no effect with respect to the IDIT Transactions
and there shall be no liability or obligation on the part of any party or any of its or their Affiliates
to any other Person by virtue of, arising out of or otherwise in connection with this Agreement or any other IDIT Transaction
Document; provided that: (a) none of the IDIT Selling Shareholders, IDIT or the Purchaser shall be relieved of any obligation
or liability arising from any prior breach by such party of any provision of this Agreement; and (b) the parties shall, in all
events, remain bound by and continue to be subject to the provisions set forth in Section 7.01, Section
7.05 and Article XII

.

 

 

 

Article
X

Indemnification

 

Section
10.01Survival of Representations.

 

(a)Companies
and Selling Shareholders Representations. Subject to Section 10.01(b), all representations, warranties, covenants and
agreements of the Companies and the Selling Shareholders contained herein or in any Transaction Documents shall survive the
execution and delivery of this Agreement or such Transaction Documents and the consummation of the transactions contemplated
hereby and thereby, regardless of any investigation made by or on behalf of any party hereto or its Affiliates or the
knowledge of any such party’s (or its Affiliates’) officers, directors, shareholders, managers, members,
partners, employees or agents. Notwithstanding anything herein to the contrary, the Selling Shareholders will not be liable
with respect to any claim for the breach or inaccuracy of any representation or warranty pursuant to Section 10.02(a)(i),
unless written notice of a claim thereof is delivered to the respective Shareholders Representative prior to the applicable
Sellers Survival Date and a claim was filed, with respect to such claim, within six months from the date such written notice
was delivered to the Shareholders Representative. For the purposes of this Agreement, the term "Sellers Survival
Date", with respect to either the FIS Transaction or the IDIT Transaction, shall mean the date that is twelve (12)
months after the respective Closing Date of the FIS Transaction or the IDIT Transaction, as applicable, except for the
representations and warranties contained in Section 3.02 (Corporate Authorization), Section 3.05(b) (Non-Contravention),
Section 3.06 (Capitalization), Section 4.02 (Authority; Binding Effect) and Section 4.03 (Non-Contravention), with respect to
which the Sellers Survival Date shall be 36 months after the respective Closing Date (such representations and warranties are
hereinafter referred to, collectively, as the "Sellers Fundamental Representations"). The parties agree that
so long as written notice in accordance with the terms herein is given on or prior to the applicable Sellers Survival Date
with respect to such claim and a claim is filed with the applicable court within six months from the applicable Sellers
Survival Date, the representations and warranties with respect to such breach shall continue to survive until such matter is
finally resolved.

 

    	97

    	 

    
Execution Copy

 

 

(b)Sellers
Willful Breach; Intentional Misrepresentation; Fraud. Notwithstanding anything to the contrary contained in Section
10.01(a) in case of claims based upon willful breach, intentional misrepresentation or fraud, by a Selling Shareholder or any
respective Representative of such Selling Shareholder (the liability for which shall be several and not joint) the Sellers
Survival Date with respect to such claims shall be 36 months after the respective Closing Date.

 

(c)Purchaser’s
and Parent's Representations. All representations, warranties, covenants and agreements of the Purchaser and Parent
contained herein or in any Transaction Documents shall survive the execution and delivery of this Agreement or such
Transaction Documents and the consummation of the transactions contemplated hereby and thereby, regardless of any
investigation made by or on behalf of any party hereto or its Affiliates or the knowledge of any such party’s (or its
Affiliates’) officers, directors, shareholders, managers, members, partners, employees or agents. Notwithstanding
anything herein to the contrary, the Purchaser and Parent will not be liable with respect to any claim for the breach or
inaccuracy of any representation or warranty pursuant to Section 10.03(a)(i), unless written notice of a claim thereof is
delivered to the Purchaser prior to the applicable Purchaser Survival Date and a claim was filed, with respect to such claim,
within six months from the date such written notice was delivered to the Purchaser. For the purposes of this Agreement, the
term "Purchaser Survival Date" shall mean, with respect to each of the FIS Transaction and the IDIT
Transaction, as applicable, the date that is twelve (12) months after the respective Closing Date, except for the
representations and warranties contained in Section 5.02 (Corporate Authorization), Section 5.05(b) (Non-Contravention), and
Section 5.06 (Capitalization), with respect to which the Purchaser Survival Date shall be the date which is 36 months after
the respective Closing Date (the foregoing representations and warranties hereinafter referred to, collectively, as the
"Purchaser Fundamental Representations"). The parties agree that so long as written notice in
accordance with the terms herein is given on or prior to the applicable Purchaser Survival Date with respect to such claim
and a claim is filed with the applicable court within six months from the applicable Purchaser Survival Date, the
representations and warranties with respect to such breach shall continue to survive until such matter is finally
resolved.

 

 

Section
10.02Indemnification by Selling Shareholders.

 

    	98

    	 

    
Execution Copy

 

 

(a)Selling
Shareholders Indemnification. The Selling Shareholders of each Company shall, severally and not jointly, indemnify the Purchaser
and its Affiliates (including the respective Company in which they hold shares prior to the respective Closing) and each of their
respective Representatives, successors and assigns (collectively, the "Purchaser Indemnified Parties") and hold
each of them harmless from and against, and pay on behalf of or reimburse any such Purchaser Indemnified Party, in respect of the
entirety of any Loss which such Purchaser Indemnified Party may suffer, sustain or become subject to, as a result of, arising out
of, relating to or in connection with:

 

(i)any
inaccuracy in or breach of any representation or warranty of (i) the respective Company in which the Selling Shareholders
hold shares or (ii) of the Selling Shareholders of such Company (it being clarified that, with respect to clause (ii), each
Selling Shareholder shall be liable only with respect to the representations and warranties made thereby) contained in this
Agreement or in any Transaction Document: (i) as of the date of this Agreement and (ii) as of the respective Closing(in each
of (i) and (ii) except in the case of any representation or warranty which by its terms speaks only as of a specified date or
dates, in which case the inaccuracy or breach shall be determined as of such date or dates), in each case without giving
effect to: (A) any limitation or qualification as to "materiality," "material," "Material Adverse
Effect" or similar qualifiers set forth in such representation or warranty for purposes of determining whether there is
a breach and the Losses resulting from, arising out of or relating to such breach; or (B) any update of or modification to
the respective Company Disclosure Schedule made or purported to have been made on or after the date of this Agreement, unless
such update or modification results from changes of facts between the date of this Agreement and the respective Closing Date
which do not constitute a Material Adverse Effect as to the respective Company; provided that any inaccuracy in the
representations made by any specific Selling Shareholder in Section 4.01 (Title to Company Shares) which was Known to the
respective Company on the date hereof or on the date of the respective Closing shall not constitute, for the purpose of this
Section 10.02(a)(i), also a basis for indemnification by all Selling Shareholders of the respective Company due to inaccuracy
of the representations made by such Company in Section 3.06 (Capitalization), unless the Purchaser is not indemnified by the
relevant Selling Shareholder to the fullest extent provided herein, after taking all necessary steps hereunder with respect
to such right of indemnification. It is hereby agreed and clarified that prior to the relevant Closing, the relevant Company
shall be allowed to notify the Purchaser or Parent as to changes in such Company's representation as of the respective
Closing Date resulting from changes of facts between the date of this Agreement and the date of such respective Closing Date,
and, provided that such changes shall not constitute a Material Adverse Effect as to the respective Company, the
Purchaser and the Parent shall not be entitled to any indemnification due to such changes;

 

(ii)any
breach of any covenant or obligation of the respective Company in which the Selling Shareholders hold shares or of the Selling
Shareholders of such Company (each of whom shall be liable only with respect to the covenants and obligations of such Selling Shareholder)
in this Agreement or in any other Transaction Document.

 

Notwithstanding
the above, in the event of termination of this Agreement pursuant to Section 9.01 or Section 9.03, as applicable, the indemnifying
party with respect to any breach of covenant or obligation of a Company contained in this Agreement or in any Transaction Document
shall be such respective Company.

 

(b)IDIT
Selling Shareholders Indemnification Cap. The maximum aggregate liability of each of the IDIT Selling Shareholders for Losses
arising under Section 10.02(a) hereof, shall be limited to such Selling Shareholder's Participation Portion in the IDIT Escrow
Deposit, excluding in the event of an inaccuracy in any of IDIT's and IDIT Selling Shareholders' Sellers Fundamental Representations,
a breach of an IDIT Selling Shareholders obligation under Section 7.07, or in the event of willful breach, intentional misrepresentation
or fraud by the respective IDIT Selling Shareholder in which cases the maximum aggregate liability of each of the IDIT Selling
Shareholders for Losses arising under Section 10.02(a)  hereof, shall be limited to such Selling Shareholder's Participation
Portion in the IDIT Aggregate Transaction Value. For the avoidance of doubt, the maximum aggregate liability of each of the IDIT
Selling Shareholders for any Losses arising under this Agreement shall be such Selling Shareholder's Participation Portion in
the IDIT Aggregate Transaction Value.

 

    	99

    	 

    
Execution Copy

 

 

(c)FIS
Selling Shareholders Indemnification Cap. The maximum aggregate liability of each of the FIS Selling Shareholders for Losses
arising under Section 10.02(a) hereof, shall be limited to such Selling Shareholder's Participation Portion in the FIS Escrow
Deposit, excluding in the event of an inaccuracy in any of FIS' and FIS' Selling Shareholders' Sellers Fundamental Representations,
a breach of an FIS Selling Shareholder obligation under Section 7.07, or in the event of willful breach, intentional misrepresentation
or fraud by the respective FIS Selling Shareholder in which cases the maximum aggregate liability of each of the FIS Selling Shareholders
for Losses arising under Section 10.02(a)  hereof, shall be limited to such Selling Shareholder's Participation Portion in
the FIS Aggregate Transaction Value. For the avoidance of doubt, the maximum aggregate liability of each of the FIS Selling Shareholders
for any Losses arising under this Agreement shall be such Selling Shareholder's Participation Portion in the FIS Aggregate Transaction
Value.

 

(d)Selling
Shareholders Basket. Notwithstanding anything herein to the contrary, no Purchaser Indemnified Party shall be entitled to indemnification
in respect of any breach of a representation or warranty of a Company or either of its Selling Shareholders set forth herein unless
and until all such breaches result in total Losses incurred by all Purchaser Indemnified Parties in an amount of at least 3% of
the IDIT Aggregate Transaction Value, or 3% of the FIS Aggregate Transaction Value, as applicable, (the "Sellers Basket
Amount"), in which case the Purchaser Indemnified Parties shall be entitled to the entire amount of Losses, including
the respective Sellers Basket Amount. The foregoing limitation shall not apply (i) in the case of willful breach, intentional misrepresentation
or fraud by any ofthe Selling Shareholders or the Companies and (ii) to inaccuracies in or breaches of any of the Sellers Fundamental
Representations.  

 

(e)Sole
Remedy. After the respective Closing Date, the indemnity provisions of this Agreement shall be the sole and exclusive remedy
of Purchaser for any Losses arising out of or related to this Agreement and the Transactions.

 

(f)Injunctive
Relief; Specific Performance. Notwithstanding Section 10.02(e) above, in addition to the remedies provided in this Article
X, injunctive relief may be obtained to enjoin the breach, or threatened breach, of any provision of this Agreement and each party
shall be entitled to specific performance by the other party of its obligations hereunder or thereunder.

 

Section
10.03Indemnification by Purchaser.

 

(a)Purchaser
Indemnification. The Purchaser shall indemnify the Selling Shareholders and their Affiliates and each of their respective Representatives,
successors and assigns (collectively, the "Selling Shareholders Indemnified Parties") (each of the Selling Shareholders
Indemnified Parties and the Purchaser Indemnified Parties shall be referred to as an "Indemnified Party") and
hold each of them harmless from and against, and pay on behalf of or reimburse any such Selling Shareholders Indemnified Party,
in respect of the entirety of any Loss which such Selling Shareholders Indemnified Party may suffer, sustain or become subject
to, as a result of, arising out of, relating to or in connection with:

 

    	100

    	 

    
Execution Copy

 

 

(i)any
inaccuracy in or breach of any representation or warranty of Purchaser or Parent contained in this Agreement or in any Transaction
Document: (i) as of the date of this Agreement and (ii) as of the respective Closing(in each of (i) and (ii) except in the case
of any representation or warranty which by its terms speaks only as of a specified date or dates, in which case the inaccuracy
or breach shall be determined as of such date or dates), in each case without giving effect to: (A) any limitation or qualification
as to "materiality," "material," "Material Adverse Effect" or similar qualifiers set forth in such
representation or warranty for purposes of determining whether there is a breach and the Losses resulting from, arising out of
or relating to such breach or (B) any update of or modification to the Purchaser Disclosure Schedule made or purported to have
been made on or after the date of this Agreement, unless such update or modification results from changes of facts between the
date of this Agreement and the respective Closing Date which do not constitute a Material Adverse Effect as to the Parent, and
except that changes to the authorized and issued share capital of Parent between the date hereof and the respective Closing Date
may not be deemed as an inaccuracy or a breach of the representations and warranties contained in Section 5.06 (Capitalization).
It is hereby agreed and clarified that prior to the relevant Closing, Purchaser shall be allowed to notify the respective Company
as to changes in such Parent's or Purchaser's representation as of the respective Closing Date resulting from changes of facts
between the date of this Agreement and the date of such respective Closing Date, and, provided that such changes shall not constitute
a Material Adverse Effect as to the Parent, the Selling Shareholders of the respective Company shall not be entitled to any indemnification
due to such changes; and

 

(ii)any
breach of any covenant or obligation of the Purchaser or Parent in this Agreement or in any other Transaction Document.

 

(b)Purchaser
Indemnification Cap. The maximum aggregate liability of Purchaser for Losses arising under Section 10.03(a) hereof to
IDIT's Selling Shareholders Indemnified Parties, shall be limited to such number of common shares of Parent equal to 10% of
the number of IDIT Consideration Shares, and the maximum aggregate liability of Purchaser for Losses arising under Section
10.03(a) hereof to the FIS Selling Shareholders Indemnified Parties, shall be limited to such number of common shares of
Parent equal to 10% of the number of FIS Consideration Shares plus the number of common shares of Parent equal to 10% of the
product of the Cash Consideration divided by the Parent Share Value, provided however, that the above limitation shall not
apply to i) in the case of willful breach, intentional misrepresentation or fraud by Purchaser or Parent or any respective
Representative of Purchaser or Parent; (ii) inaccuracies in or breaches of any of the Purchaser Fundamental Representations,
with respect to each of (i) and (ii) the maximum aggregate liability for Losses arising under Section 10.03(a) hereof shall
be limited to: with respect to Losses of IDIT Selling Shareholders Indemnified Parties, the IDIT Aggregate Transaction Value
and with respect to Losses of FIS Selling Shareholders Indemnified Parties, the FIS Aggregate Transaction Value. For the
avoidance of doubt, the maximum aggregate liability of the Purchaser for any Losses arising under this Agreement shall be the
IDIT Aggregate Transaction Value or the FIS Aggregate Transaction Value, as applicable.

 

(c)Purchaser
Indemnification Basket. Notwithstanding anything herein to the contrary, no Selling Shareholders Indemnified Party shall be
entitled to indemnification in respect of any breach of a representation or warranty of Purchaser or Parent unless and until all
such breaches result in total Losses incurred by the Selling Shareholders Indemnified Parties, in an amount of at least 3% of the
IDIT Aggregate Transaction Value with respect to IDIT's Selling Shareholders Indemnified Parties and in an amount of at least 3%
of the FIS Aggregate Transaction Value with respect to FIS Selling Shareholders Indemnified Parties (the "Purchaser Basket
Amount"), in which case the Selling Shareholders Indemnified Parties shall be entitled to the entire amount of Losses,
including the respective Purchaser Basket Amount. The foregoing limitation shall not apply (i) in the case of willful breach, intentional
misrepresentation or fraud by the Purchaser or Parent and (ii) to inaccuracies in or breaches of any of the Purchaser Fundamental
Representations.  

 

    	101

    	 

    
Execution Copy

 

 

(d)Sole
Remedy. After the respective Closing Date, the indemnity provisions of this Agreement shall be the sole and exclusive remedy
of Selling Shareholders for any Losses arising out of or related to this Agreement and the Transactions.

 

Section
10.04Claims and Procedures.

 

(a)Officer’s
Claim Certificate. If any Indemnified Party has or claims to have incurred or suffered Losses for which it is or may be
entitled to indemnification, compensation or reimbursement pursuant to this Article X from the Purchaser or any of the
Selling Shareholders, as the case me be (each of the forgoing, an "Indemnifying Party"), Purchaser or the
applicable Shareholders Representative, as the case may be, may deliver to the other party (and if any Purchaser's claim
relates to a specific Selling Shareholder, also to such Selling Shareholder) (each delivering party shall be referred to as a
"Delivering Party" and each receiving party shall be referred to as an "Addressee"), a
certificate signed by any officer of the Delivering Party; provided, however that failure of the Delivering Party to give any
such certificate will relieve the relevant Indemnifying Party of its indemnification obligations hereunder to the extent that
it is delivered or claimed after the applicable Sellers Survival Date or the Purchaser Survival Date, as applicable (any
certificate delivered in accordance with the provisions of this Section 10.04(a) is referred to as a "Officer’s
Claim Certificate"):

 

(i)stating
that an Indemnified Party believes that there is or may have been a breach of a representation, warranty or covenant contained
in this Agreement and that such Indemnified Party is entitled to indemnification under this Article X;

 

(ii)containing
the amount which such Indemnified Party claims to be entitled to receive as indemnification pursuant to this Article X (the aggregate
amount of shares or cash claimed by such Indemnified Party being referred to as the "Claimed Amount"); and

 

(iii)containing
a brief description (based upon the information then possessed by such Indemnified Party) of the material facts known to the Indemnified
Party giving rise to such claim.

 

(b)Dispute
Procedure. During the twenty (20) day period commencing upon the date that notice of an Officer’s Claim
Certificate is given or deemed duly given pursuant to Section 12.08 below to an Addressee (the "Dispute
Period"), the Addressee may deliver to the Delivering Party a written response (the "Response
Notice") in which the Addressee: (i) agrees that the full Claimed Amount is owed to the Indemnified Party; (ii)
agrees that part, but not all, of the Claimed Amount (the "Agreed Amount") is owed to the Indemnified Party;
or (iii) indicates that no part of the Claimed Amount is owed to the Indemnified Party. Any part of the Claimed Amount
that is not an Agreed Amount shall be referred to as a "Contested Amount". If a Response Notice is not duly
given to the Delivering Party prior to the expiration of the Dispute Period, then the Addressee shall be conclusively deemed
to have agreed that the full Claimed Amount is owed to the Indemnified Party. 

 

(c)Payment
of Claimed Amount. If: (a) the Addressee delivers a Response Notice agreeing that the full Claimed Amount or an Agreed Amount
is owed to the Indemnified Party; or (b) the Addressee does not deliver a Response Notice during the Dispute Period, then, subject
to the limitation of liability provisions contained herein, the following shall occur, subject to Section 10.04(f)

:

    	102

    	 

    
Execution Copy

 

 

(i)if
the Indemnified Party is a Purchaser Indemnified Party, the Escrow Agent shall disburse to such Purchaser Indemnified Party
the Claimed Amount or the Agreed Amount (and in the event of cash amount, through the Purchaser’s Account, as defined
in the Escrow Agreement), as applicable, calculated pursuant Section 2.05(b) above, within five (5) Business Days following
the end of the Dispute Period, out of the relevant Selling Shareholder's part in the respective Escrowed Funds; provided that
with respect to any cash component that is deposited in the Escrowed Funds on behalf of a Selling Shareholder who is an
Indemnifying Party, the Purchaser may instruct the Escrow Agent to release to the Purchaser first the cash component and
then, if the cash component is lower than the Claimed Amount or the Agreed Amount, as applicable, the shares component of
such Indemnifying Party's respective Escrowed Funds.

 

(ii)In
the event of a Claimed Amount which was required due to a breach of a Sellers Fundamental Representation or due to willful
breach, intentional misrepresentation or fraud by a Selling Shareholder- if the respective Escrowed Funds disbursed to
Purchaser pursuant to Section 10.04(c)(i) shall not be sufficient to satisfy the Claimed Amount or the Agreed Amount, the
relevant Selling Shareholder shall pay the Purchaser its respective Participation Portion of the excess of the Agreed Amount
or Claimed Amount, as applicable, over the disbursed Escrowed Funds within three (3) calendar days following the end of the
Dispute Period.

 

(iii)if
the Indemnified Party is a Selling Shareholder Indemnified Party, the Purchaser shall pay such Indemnified Party the Agreed Amount
or Claimed Amount, as applicable, within three (3) calendar days following the end of the Dispute Period.

 

(d)Resolution
between the Parties. If the Addressee delivers a Response Notice indicating that there is a Contested Amount, the respective
Shareholder Representative, or, in case of a dispute between Purchaser and specific Selling Shareholders, such specific Selling
Shareholders, and the Purchaser shall attempt in good faith to resolve the dispute related to the Contested Amount. If the Purchaser
and the respective Shareholders Representative or such Selling Shareholder, as applicable, resolve such dispute, such resolution
shall be binding on the respective Shareholders Representative, the respective Selling Shareholders and the Purchaser and a settlement
agreement stipulating the amount owed to the Indemnified Parties (the "Stipulated Amount") shall be signed by
Purchaser and the respective Shareholders Representative or Selling Shareholder, as applicable, and the Stipulated Amount shall
be disbursed pursuant to the terms of Section 10.04(c)

as if such amount was an Agreed Amount.

 

(e)Dispute
Resolution. If the respective Shareholders Representative, or, in case of a dispute between Purchaser and a specific
Selling Shareholder, such specific Selling Shareholder, and the Purchaser are unable to resolve the dispute relating to any
Contested Amount within thirty (30) calendar days after the date that the Response Notice is given or is deemed duly given
pursuant to Section 12.08 to the Addressee, then either the Purchaser or the respective Shareholders Representative, or
specific Selling Shareholder, as applicable, may submit the claim described in the Officer’s Claim Certificate to
arbitration to be conducted by a sole arbitrator and in accordance with the rules of the Israeli Arbitration Law - 1968 (the
"Arbitration Law"), except as otherwise provided herein. The arbitration shall be conducted in Tel-Aviv,
Israel or such other place mutually acceptable to the Purchaser and the respective Shareholders Representative or specific
Selling Shareholder, as applicable. The arbitrator shall have the necessary expertise required in order to review the
materials provided by the parties and shall have the necessary expertise in arbitrating commercial matters underlying the
Contested Amount (the "Arbitrator") to be appointed by the respective Shareholders Representative, or
specific Selling Shareholder, as applicable, and the Purchaser, and if no agreement is reached on the identity of the
Arbitrator within ten (10) days following the submission of such dispute to arbitration, the identity of the Arbitrator will
be determined by the President of the Israeli Bar Association. The parties to such dispute agree to use all reasonable
efforts to cause the arbitration hearing to be conducted within sixty (60) days after the appointment of the Arbitrator and
to use all reasonable efforts to cause the decision of the Arbitrator to be furnished within fifteen (15) days after the
conclusion of the arbitration hearing. The Arbitrator’s authority shall be confined to: (i) deciding whether the
Indemnified Party is entitled to recover the Contested Amount (or a portion thereof), and the portion of the Contested Amount
the Indemnified Party is entitled to recover; and (ii) awarding expenses of the arbitration proceedings pursuant to this
Section. The Arbitrator shall not be bound by procedural law or rules of evidence and shall have no authority to issue any
injunctions, orders or other interlocutory remedies, but will rule consistent with the substantive law of the State of
Israel. Pending the Arbitrator’s award, the costs and expenses of the Arbitrator shall be borne equally by Purchaser
and the respective Shareholders Representative or specific Selling Shareholder, as applicable. The award of the Arbitrator
shall be in writing, state the reasons upon which it is based, and shall be final and binding upon the parties. Any
arbitration proceeding hereunder and the content of any discussions or communications with the Arbitrator shall be conducted
on a confidential basis, shall be subject to such disclosure restrictions imposed on the parties under any Applicable Law and
the Arbitrator shall be required to execute, prior to the commencement of its service, Purchaser’s standard
confidentiality agreement. Any amount payable to an Indemnified Party according to a written decision of the Arbitrator shall
be disbursed pursuant to the terms of Section 10.04(c) as if such amount was an Agreed Amount. Any ruling or decision of the
Arbitrator may be enforced in any court of competent jurisdiction. This Section constitutes an Arbitration Agreement in
accordance with the Arbitration Law. In the event of any contradiction between the provisions hereof and the Arbitration Law,
the provisions of this Agreement shall prevail.

 

    	103

    	 

    
Execution Copy

 

 

(f)Form
of Payment. Notwithstanding anything to the contrary herein, any amount payable under this Article X may be paid with
common shares of Parent (i.e., either (i) as forfeiture of such shares from the respective Escrowed Funds, with respect to an
indemnification of any Purchaser Indemnified Party, or (ii) through the issuance by Parent of additional shares, with respect
to an indemnification of any Selling Shareholders Indemnified Party) or, at the election of the Indemnifying Party, in cash;
provided that the value of each common share of Parent for the purpose of calculating the amount of shares payable as
indemnification in lieu of a cash payment shall be equal to the Parent Share Value and provided further that in the event
that a cash payment hereunder to Purchaser in lieu of release of common shares from the respective Escrowed Funds, an amount
of common shares of Parent equal to such cash payment calculated based on the Parent Share Value shall be released to the
respective Selling Shareholders by the Escrow Agent from the respective Escrowed Funds. In the event that any amount payable
by the Selling Shareholders under this Article X is paid with common shares of Parent released from the respective Escrowed
Funds, or in the event that any part of the Parent's common shares held in the respective Escrowed Funds is replaced with
cash, pursuant to this Agreement, the Parent shall deliver to the Transfer Agent, with a copy to the respective Shareholders
Representatives, irrevocable written instructions to (i) issue in the name of the respective Selling Shareholders new
certificates representing the new number of common shares of Parent to be held in escrow following such release or
replacement of shares and to deliver such certificates to the Escrow Agent upon surrender and cancellation of the
certificates held then by the Escrow Agent, and (ii) issue in the name of the Parent, or its designee, new certificates
representing such number of common shares of Parent so released or replaced.

 

(g)Each
indemnification claim made by an Indemnified Party shall be made only in accordance with this Article X and the respective
Escrow Agreement.

 

    	104

    	 

    
Execution Copy

 

 

Section
10.05Defense of Third-Party Claims.

 

In the event of the
assertion or commencement by any Person of any Proceeding (whether against any of the Companies, the Purchaser or any other Person)
with respect to which any Selling Shareholder may become obligated to hold harmless, indemnify, compensate or reimburse any Purchaser
Indemnified Party pursuant to this Article X, then Purchaser shall have the right, at its election, to proceed with the defense
of such Proceeding on its own. If Purchaser so proceeds with the defense of any such Proceeding:

 

(a)each
Selling Shareholder shall make available to Purchaser any documents, materials and other information in his possession or control
that may be necessary to the defense of such claim or Proceeding; and

 

(b)Purchaser
shall have the right to settle, adjust or compromise such Proceeding; provided, however, that if Purchaser settles, adjusts or
compromises any such Proceeding without the consent of the respective Shareholders Representative or specific Selling Shareholder,
as applicable, such settlement, adjustment or compromise shall not be conclusive evidence of the amount of Losses incurred by the
Purchaser Indemnified Party in connection with such Proceeding (it being understood that if Purchaser requests that such Shareholders
Representative or Selling Shareholder consent to a settlement, adjustment or compromise, such consent shall not be unreasonably
withheld, delayed or conditioned; provided that withholding, delaying or conditioning such consent will not be deemed to be unreasonable
if such settlement, adjustment or compromise does not provide full release of the claims raised against the respective Selling
Shareholders in such Proceeding).

 

Purchaser shall
give the respective Shareholders Representative or such specific Selling Shareholder, as applicable, prompt notice of the
commencement of any such Proceeding against Purchaser or any of the Companies and provide information reasonably requested by
such Shareholders Representative or Selling Shareholder, as applicable, and not subject to attorney-client privilege of
Purchaser or the Purchaser Indemnified Parties relating to such claim; provided, however, that any failure on the part of
Purchaser to so notify such Shareholders Representative or Selling Shareholder, as applicable, and provide such information
shall not limit any of the obligations of the respective Selling Shareholder(s) under Article X (except to the extent such
failure materially prejudices the defense of such Proceeding). If Purchaser does not elect to proceed with the defense of any
such claim or Proceeding, the respective Shareholders Representative or Selling Shareholder, as applicable, may proceed with
the defense of such claim or Proceeding with counsel reasonably satisfactory to Purchaser; provided, however, that such
Shareholders Representative or Selling Shareholder, as applicable, may not settle, adjust or compromise any such claim or
Proceeding without the prior written consent of Purchaser (which consent may not be unreasonably withheld, delayed or
conditioned, provided that withholding, delaying or conditioning such consent will not be
deemed to be unreasonable if such settlement, adjustment or compromise does not provide full release of the claims raised
against the Purchaser or the respective Company in such Proceeding).

 

    	105

    	 

    
 Execution Copy

 

 

Section
10.06No Contribution.

 

No Selling Shareholder
shall have, or be entitled to exercise or assert (or attempt to exercise or assert), any right of contribution, right of indemnity
or other right or remedy against the Companies in connection with any indemnification obligation or any other liability to which
he may become subject under or in connection with this Agreement.

 

Section
10.07Tax Impact.

 

The parties
hereto agree to treat any indemnity payment made pursuant to this Article X as an adjustment to the IDIT Purchase Price (with
respect to indemnification of any of IDIT's Selling Shareholders Indemnified Parties) or the FIS Purchase Price (with respect
to indemnification of any of FIS' Selling Shareholders Indemnified Parties), as the case may be, for Tax purposes.
Furthermore, the amount of any Losses claimed by an Indemnified Party pursuant to this Article X shall be reduced by (i) the
value of any net tax benefit resulting from such Loss to the extent such net tax benefit is actually realized by the
Indemnified Party or its Affiliates in or before the taxable year during which such indemnity payment is to be made and (ii)
the amount of any insurance proceeds (net of Taxes) actually received by Indemnified Party related to such Losses.

 

Section
10.08Additional Provisions.

 

(a)Effect
of Due Diligence. The representations, warranties, covenants and obligations of an Indemnifying Party, and the rights and remedies
that may be exercised by Indemnified Parties, shall not be limited or otherwise affected by or as a result of any information furnished
to, or any investigation made by or knowledge of, any of the Indemnified Parties or any of their Representatives.

 

(b)Effect
of Disclosure Schedules. For purposes of this Agreement, each statement or other item of information set forth in a Company
Disclosure Schedule or Selling Shareholder Disclosure Schedule or the Purchaser Disclosure Schedule shall be deemed to be a representation
and warranty made by such Company or Selling Shareholder or Purchaser or Parent, as applicable, in this Agreement.

 

Article
XI

Shareholders Representative

 

Section
11.01Appointment of Shareholders Representatives; Power and Authority.

 

(a)By
virtue of the execution of this Agreement, each IDIT Selling Shareholder hereby irrevocably agrees, constitutes and appoints the
IDIT Shareholders Representative and each FIS Selling Shareholder hereby irrevocably agrees, constitutes and appoints the FIS Shareholders
Representative (and by the execution of this Agreement as Shareholders Representatives, the Shareholders Representatives hereby
accepts their appointment) as the true, exclusive and lawful agent and attorney-in-fact of each of the respective Selling Shareholders
to act: (i) as a Shareholders Representative under this Agreement and to have the right, power and authority to perform all actions
(or refrain from taking any actions) the Shareholders Representatives shall be entitled to perform in accordance with this Agreement
and the Transactions.

 

(b)Without
derogating from the generality of the foregoing, as of the date hereof each Shareholders Representative shall have the right, power
and authority to (and such actions shall be binding and enforceable upon the Selling Shareholders):

 

    	106

    	 

    
Execution Copy

 

 

(i)act
for the respective Selling Shareholders represented by him with regard to all matters set forth in this Agreement;

 

(ii)execute
and deliver all amendments, waivers, ancillary agreements, share powers, certificates and documents such the Shareholders Representative
deems necessary or appropriate in connection with the consummation of the Transactions;

 

(iii)receive
funds for the payment of expenses of the respective Selling Shareholders represented thereby and apply such funds in payment for
such expenses;

 

(iv)do
or refrain from doing any further act or deed on behalf of the respective Selling Shareholders represented by him that such Shareholders
Representative deems necessary or appropriate in its sole discretion relating to the subject matter of this Agreement as fully
and completely as such Selling Shareholders could do if personally present;

 

(v)receive
all notices or other documents given or to be given to such Shareholders Representative by Purchaser pursuant to this Agreement;

 

(vi)
in the event of a claim against all the Company Selling Shareholders -negotiate, undertake, compromise, defend, resolve and settle
any suit, Proceeding, claim or dispute under this Agreement on behalf of the respective Selling Shareholders represented by him;

 

(vii)engage
special counsel, accountants and other advisors and incur such other expenses in connection with any of the transactions contemplated
by this Agreement;

 

(c)The
Shareholders Representatives may be removed or replaced only upon delivery of written notice to the Purchaser by the respective
Selling Shareholders holding at least a majority of the outstanding IDIT Shares or FIS Shares, as applicable, as of the respective
Closing. Upon the death, disability or incapacity of any Shareholders Representative, each of the respective Selling Shareholders
represented by him acknowledges and agrees that the new Shareholders Representative shall be appointed by the Selling Shareholders
who held a majority of the outstanding shares of the respective Company immediately prior to the respective Closing. Each Shareholders
Representative may resign at any time only upon a thirty (30) days’ prior written notice of such decision to resign and the
appointment of a successor Shareholders Representative as described above. The Shareholders Representatives shall not receive compensation
for serving in such capacity. Purchaser, the Companies and any other Person may conclusively and absolutely rely, without inquiry,
upon any action of the Shareholders Representatives in all matters referred to herein. The Purchaser and Parent are hereby relieved
from any liability to any Person for any acts done by the Shareholders Representatives and any acts done by Purchaser or Parent
in accordance with any decision, act, consent or instruction of the Shareholders Representatives.

 

Section
11.02Reimbursement.

 

The Selling
Shareholders shall be responsible for and shall, jointly and severally, reimburse the respective Shareholders Representatives upon
demand for all reasonable expenses, disbursements and advances incurred or made by such Shareholders Representative in accordance
with any of the provisions of this Agreement or any other documents executed in connection herewith or therewith, including the
costs and expense of receiving advice of counsel in relation to this Agreement.

 

Section
11.03Release from Liability; Indemnification.

 

    	107

    	 

    
Execution Copy

 

 

Each Selling Shareholder
hereby releases the respective Shareholders Representative and each Selling Shareholder agrees, jointly and severally with the
other respective Selling Shareholders holding the same Companies Shares, to indemnify, defend and hold harmless the respective
Shareholders Representative (including any Losses incurred, as such Losses are incurred) for, arising out of or in connection with
the acceptance or administration of the respective Shareholders Representative’s duties hereunder or any action taken or
not taken by him, her or it in his, her or its capacity as such agent (including the legal costs and expenses of defending such
Shareholders Representative against any claim or liability (and all actions, claims, proceedings and investigations in respect
thereof) in connection with, caused by or arising out of, directly or indirectly, the performance of such Shareholders Representative’s
duties hereunder), except for the liability of such Shareholders Representative, or any member thereof, to a Selling Shareholder
for Loss which such holder will suffer from the willful misconduct of such Shareholders Representative in carrying out his, her
or its duties hereunder. In all questions arising under this Agreement, the Shareholders Representatives may rely on the advice
of counsel, and the Shareholders Representatives will not be liable to the Selling Shareholders for anything done, omitted or suffered
by the Shareholders Representatives based on such advice.

 

Article
XII

Miscellaneous

 

Section
12.01Entire Agreement.

 

This Agreement (together
with its Exhibits and Schedules hereto), the Transaction Documents and the Nondisclosure Agreement constitute the entire agreement
between the parties with respect to the subject matter of this Agreement and supersede all prior agreements and understandings,
both oral and written, between the parties with respect to the subject matter of this Agreement (including without limitation any
prior proposal, term sheet or expression of interest).

 

Section
12.02Amendments and Waivers.

 

(a)This
Agreement may not be amended, modified, altered or supplemented other than by means of a written instrument duly executed and delivered
on behalf of Purchaser, Parent and each of the Companies that is affected thereby (or, if effected after the respective Closing,
(i) the Shareholder Representative of the Selling Shareholders of such affected Company (post-Closing) and (ii) Selling Shareholders
of such affected Company (pre-Closing) that held, as of the respective Closing, 70% of the voting rights in such affected Company;
provided, however, that any amendment, modification, alteration or supplement which amends the rights of and Selling Shareholder
adversely disproportionately compared to the
rights of the other Selling Shareholders of the same respective Company, shall require, in addition to the above, also the written
consent of such Selling Shareholder. Any amendment executed in accordance with the foregoing shall be binding upon all parties
(including the other, non-consenting Selling Shareholders) and their respective successors and assigns.

 

(b)No
failure on the part of any Person to exercise any power, right, privilege or remedy under this Agreement, and no delay on the part
of any Person in exercising any power, right, privilege or remedy under this Agreement, shall operate as a waiver of such power,
right, privilege or remedy; and no single or partial exercise of any such power, right, privilege or remedy shall preclude any
other or further exercise thereof or of any other power, right, privilege or remedy. No Person shall be deemed to have waived any
claim arising out of this Agreement, or any power, right, privilege or remedy under this Agreement, unless the waiver of such claim,
power, right, privilege or remedy is expressly set forth in a written instrument duly executed and delivered on behalf of such
Person; and any such waiver shall not be applicable or have any effect except in the specific instance in which it is given.

 

    	108

    	 

    
Execution Copy

 

 

Section
12.03Binding Effect; Benefit; Assignment.

 

(a)The
provisions of this Agreement shall be binding upon and shall inure to the benefit of the parties hereto and their respective successors
and assigns. This Agreement is not intended to confer any rights, benefits, remedies, obligations or liabilities hereunder upon
any Person, other than the parties hereto and their respective successors and assigns.

 

(b)No
party may assign, delegate or otherwise transfer any of its rights or obligations under this Agreement without the consent of each
other party hereto.

 

Section
12.04Construction. 

 

The parties have participated
jointly in the negotiation and drafting of this Agreement. In the event an ambiguity or question of intent or interpretation arises,
this Agreement will be construed as if drafted jointly by the parties and no presumption or burden of proof will arise favoring
or disfavoring any party by virtue of the authorship of any of the provisions of this Agreement. The parties intend that each representation,
warranty and covenant contained herein will have independent significance. If any party has breached or violated, or if there is
an inaccuracy in, any representation, warranty or covenant contained herein in any respect, the fact that there exists another
representation, warranty or covenant relating to the same subject matter (regardless of the relative levels of specificity) which
the party has not breached or violated, or in respect of which there is no inaccuracy, will not detract from or mitigate the fact
that the party has breached or violated, or there is an inaccuracy in, the first representation, warranty or covenant.

 

Section
12.05Headings. 

 

The headings contained
in this Agreement and in the schedules and exhibits hereto are for reference purposes only and shall not affect in any way the
meaning or interpretation of this Agreement.

 

Section
12.06Governing Law.

 

This Agreement shall
be governed by and construed in accordance with the laws of the State of Israel, without giving effect to principles of conflicts
of laws that would require the application of the laws of any other jurisdiction.

 

Section
12.07Jurisdiction.

 

Except with respect
to the proceedings referred in Section 10.04(e), the parties hereto agree that any Proceeding seeking to enforce any provision
of, or based on any matter arising out of or in connection with, this Agreement or the Transactions shall be brought before the
competent courts in Tel Aviv-Jaffa, Israel and each of the parties hereby irrevocably consents to the jurisdiction of such courts
(and of the appropriate appellate courts therefrom) in any such Proceeding and irrevocably waives, to the fullest extent permitted
by law, any objection that it may now or hereafter have to the laying of the venue of any such Proceeding in any such court or
that any such Proceeding brought in any such court has been brought in an inconvenient forum. Process in any such Proceeding may
be served on any party anywhere in the world, whether within or outside the jurisdiction of any such court. Without limiting the
foregoing, each party agrees that service of process to such party’s address set forth in Section
12.08 below shall be deemed effective service of process on such party.

 

    	109

    	 

    
 Execution Copy

 

 

Section
12.08Notices.

 

All notices, requests
and other communications required or permitted under, or otherwise made in connection with, this Agreement, shall be in writing
and shall be deemed to have been duly given (a) when delivered in person, (b) upon electronic confirmation of full receipt
when transmitted by facsimile transmission or by electronic mail (but, in the case of electronic mail, only if followed by transmittal
by national overnight courier or by hand for delivery on the next Business Day) or (if transmitted and received on a non-Business
Day) on the first Business Day following transmission and electronic confirmation of full receipt, (c) upon receipt after
dispatch by registered or certified mail, postage prepaid or (d) on the next Business Day if transmitted by national overnight
courier (with confirmation of delivery), in each case, addressed as follows:

 

if to Purchaser or
Parent, to:

 

Sapiens International Corporation N.V./Sapiens Technologies
(1982) Ltd.

Rabin Science Park

P.O. Box 4011

Nes Ziona 74140, Israel

Attention: CEO

Telephone No.:972 – 8 - 9382721

Facsimile No.: 972 – 8 -
9382730

E-mail: roni.g@sapiens.com
and roni.a@sapiens.com 

 

with a copy (which
shall not constitute notice) to:

 

Meitar, Liquornik, Geva & Leshem Brandwein

16 Abba Hillel Silver Rd., Ramat Gan 52506, Israel

Attention: Dan Shamgar, Advocate and Mike Rimon, Advocate

Telephone No.:+972-3-6103100

Facsimile No.: +972-3-6103111

E-mail: dshamgar@meitar.com; mrimon@meitar.com

 

if to IDIT prior to
the IDIT Closing Date, to:

 

IDIT I.D.I. Technologies Ltd.

Menachem Begin 5, Tel-Aviv, 50200

Attention: Mr. Yoel Amir

Telephone No.: 972 – 3 -6250922

Facsimile No.: 972 – 3 - 5621959

E-mail: yoela@idit.co.il

 

with a copy (which
shall not constitute notice) to:

 

Furth, Wilensky, Mizrachi, Knaani – Law Offices

1 Azrieli Tower (41st Floor), Tel –
Aviv, 67021

Attention: Udi Knaani, Advocate

Telephone No: +972 – 3 – 6070800

Fax No: +972 – 3 – 6097797

E-mail: udi@fwmk-law.co.il

 

 

    	110

    	 

    
Execution Copy

 

 

if to FIS prior to
the FIS Closing Date, to:

 

FIS Software Ltd.

Ha'Yarden 1 Air Port City, Lod, 70151

Attention: Mr. Shay Alon

Telephone No.: 972 – 73 - 2608200

Facsimile No.: 972 – 73 - 2608205

E-mail: SAlon@fis-software.com

 

with a copy (which
shall not constitute notice) to:

 

Prof. Yuval Levy & Co.

Attention: Tomer Maharshak, Advocate

Telephone No.: 972 – 3 - 5172303

Facsimile No.: 972 – 3 - 5164185

E-mail: tmaharshak@yuvalaw.co.il

And:

 

Furth, Wilensky, Mizrachi, Knaani – Law Offices

1 Azrieli Tower (41st Floor), Tel –
Aviv, 67021

Attention: Udi Knaani, Advocate

Telephone No: +972 – 3 – 6070800

Fax No: +972 – 3 – 6097797

E-mail: udi@fwmk-law.co.il

 

 

if to the IDIT Shareholders
Representative and to any IDIT Selling Shareholder, to:

 

Kardan Communications Ltd.

154 Menachem Begin Rd.

Tel Aviv, 64921

Attention: Mr. Amit Ben Yehuda

Telephone No.: 972 – 3 – 6083444

Facsimile No.: 972 – 3 - 6083434

E-mail: amit@kardan.com

 

with a copy (which
shall not constitute notice) to:

 

 

Furth, Wilensky, Mizrachi, Knaani – Law Offices

1 Azrieli Tower (41st Floor), Tel –
Aviv, 67021

Attention: Udi Knaani, Advocate

Telephone No: +972 – 3 – 6070800

Fax No: +972 – 3 – 6097797

E-mail: udi@fwmk-law.co.il

 

    	111

    	 

    
Execution Copy

 

if to the FIS Shareholders
Representative and to any FIS Selling Shareholder, to:

 

Dani Goldstein

Telephone No.: 972 - 3 - 7343100

Facsimile No.: 972-3 – 7367770

E-mail: danig@formulavision.com

 

With a copy (which
shall not constitute notice) to:

 

Prof. Yuval Levy & Co.

Attention: Tomer Maharshak, Advocate

Telephone No.: 972 – 3 - 5172303

Facsimile No.: 972 – 3 - 5164185

E-mail: tmaharshak@yuvalaw.co.il

And:

 

Furth, Wilensky, Mizrachi, Knaani – Law Offices

1 Azrieli Tower (41st Floor), Tel –
Aviv, 67021

Attention: Udi Knaani, Advocate

Telephone No: +972 – 3 – 6070800

Fax No: +972 – 3 – 6097797

E-mail: udi@fwmk-law.co.il

 

And:

 

Amit, Pollak, Matalon & Co.

Nitsba Tower, 19th Floor

17 Yitzhak Sade St.,

Tel Aviv 67775

Attention: Ian Rostowsky, Adv.

Facsimile No.: 972-3-5689001

E-mail: ian_ro@apm-law.com

 

or to such other address, facsimile number
or electronic mail as such party may hereafter specify for the purpose by notice to the other parties hereto in accordance with
this Section 12.08

.

 

Section
12.09Severability.

 

If any term, provision,
covenant or restriction of this Agreement is held by a court of competent jurisdiction or other Governmental Authority to be invalid,
void or unenforceable, the remainder of the terms, provisions, covenants and restrictions of this Agreement shall remain in full
force and effect and shall in no way be affected, impaired or invalidated so long as the economic or legal substance of the Transactions
is not affected in any manner materially adverse to any party. Upon such determination, the parties shall negotiate in good faith
to modify this Agreement so as to affect the original intent of the parties as closely as possible in an acceptable manner in order
that the Transactions be consummated as originally contemplated to the fullest extent possible.

 

    	112

    	 

    
Execution Copy

 

 

Section
12.10Specific Performance.

 

The parties hereto
agree that irreparable damage would occur if any provision of this Agreement were not performed in accordance with the terms hereof
and that the parties shall be entitled to an injunction or injunctions to prevent breaches of this Agreement or to enforce specifically
the performance of the terms and provisions of this Agreement in addition to any other remedy to which they are entitled under
this Agreement.

 

Section
12.11Expenses.

 

(a)In
the event that any of the Transactions is not consummated, each party to such respective Transaction shall bear its own respective
costs and expenses incurred in connection with this Agreement, including all third-party legal, accounting, financial advisory,
consulting or other fees and expenses incurred in connection with the respective Transaction.

 

(b)In
the event that a respective Transaction is consummated, and except as otherwise set forth in this Agreement, all costs and expenses
incurred by the parties to such Transaction in connection with this Agreement, including all third-party legal, accounting, financial
advisory, consulting or other fees and expenses incurred in connection with such Transaction, as set forth on Schedule D shall
be paid by the respective Companies and/or the Purchaser. The Purchaser shall also pay all costs and expenses associated with the
services of the Escrow Agent. Notwithstanding the above, any and all amounts payable to Companies' employees, consultants, or other
service providers in connection with the consummation of any of the Transactions will be paid solely by the respective Company.

 

Section
12.12Disclosure Schedule References.

 

The parties hereto
agree that any reference in a particular Section of any Company Disclosure Schedule or a Selling Shareholder Disclosure Schedule
or Purchaser Disclosure Schedule shall only be deemed to be an exception to (or, as applicable, a disclosure for purposes of) the
representations and warranties (or covenants, as applicable) of the relevant party that are contained in the corresponding Section
of this Agreement and any other section of this Agreement where such reference to such other section is reasonably apparent from
such reference.

 

Section
12.13Counterparts; Effectiveness.

 

This Agreement may
be signed in any number of counterparts, each of which shall be an original, with the same effect as if the signatures thereto
and hereto were upon the same instrument. This Agreement shall become effective when each party hereto shall have received a counterpart
hereof signed by all of the other parties hereto. Until and unless each party has received a counterpart hereof signed by the other
party hereto, this Agreement shall have no effect and no party shall have any right or obligation hereunder (whether by virtue
of any other oral or written agreement or other communication). The exchange of a fully executed Agreement (in counterparts or
otherwise) by electronic transmission in .PDF format or by facsimile shall be sufficient to bind the parties to the terms and conditions
of this Agreement.

 

[Signature Page Follows]

 

    	113

    	 

    
Execution Copy

 

 

IN WITNESS WHEREOF,
the parties hereto have executed this SHARE PURCHASE AGREEMENT as of the date first written above.

 

 

 

 

Sapiens
International Corporation N.V.

 

 

By:                                                                                  

Name:

Title:

 

 

 

SAPIENS
TECHNOLOGIES (1982) ltd.

 

 

By:                                                                                  

Name:

Title:

 

 

 

 

idit i.d.i.
technologies ltd.

 

 

By:                                                                                  

Name:

Title:

 

 

 

FIS SOFTWARE LTD.

 

 

By:                                                                                  

Name:

Title:

 

 

 

IDIT SHAREHOLDERS REPRESENTATIVE:

 

 

                                                                                          

Mr. Amit
Ben Yehuda

 

 

[Signature Page to Share Purchase Agreement]

    	 

    	 

    
Execution Copy

 

 

IN WITNESS WHEREOF, the parties hereto
have executed this SHARE PURCHASE AGREEMENT as of the date first written above.

 

 

                                                                              

Formula Vision Portfolio Holdings, Limited 

Partnership
(a partnership of Kardan and 

Formula Vision).

By: ________________________________

 

 

 

 

Please check one of the following two boxes:

 

 o
I am a Regulation D Investor (as referred to in Section 4.08 of the Agreement); or

 

o
I am a Regulation S Investor (as referred to in Section 4.08 of the Agreement).

 

o
I (i) am a U.S. Person (as referred to in Section 4.08 of the Agreement), (ii) am not a Regulation D Investor, (iii) meet the sophistication
requirements for a private placement under Regulation D or alternatively have obtained a purchaser representative that meets such
sophistication requirements and (iv) have been provided with offering materials that satisfy the informational requirements of
Regulation D.

 

Please check the following box if relevant to you:

 

		o	I am "investor" under Section 15(A)(b)(1) of the Israeli Securities Law.

 

 

[Signature Page to Share Purchase Agreement]

    	 

    	 

    
Execution Copy

 

 

IN WITNESS WHEREOF,
the parties hereto have executed this SHARE PURCHASE AGREEMENT as of the date first written above.

 

 

                                                                              

Formula Vision Technologies (F.V.T.)
Ltd.

By: ________________________________

 

 

Please check one of the following two boxes:

 

 o
I am a Regulation D Investor (as referred to in Section 4.08 of the Agreement); or

 

o
I am a Regulation S Investor (as referred to in Section 4.08 of the Agreement).

 

o
I (i) am a U.S. Person (as referred to in Section 4.08 of the Agreement), (ii) am not a Regulation D Investor, (iii) meet the sophistication
requirements for a private placement under Regulation D or alternatively have obtained a purchaser representative that meets such
sophistication requirements and (iv) have been provided with offering materials that satisfy the informational requirements of
Regulation D.

 

Please check the following box if relevant to you:

 

		o	I am "investor" under Section 15(A)(b)(1) of the Israeli Securities Law.

 

[Signature Page to Share Purchase Agreement]

    	 

    	 

    
Execution Copy

 

 

IN WITNESS WHEREOF,
the parties hereto have executed this SHARE PURCHASE AGREEMENT as of the date first written above.

 

 

                                                                              

Fahn Kanne Trust Ltd. (trustee for Sagi Schlisser).

By: ________________________________

 

 

Please check one of the following two boxes:

 

 o
I am a Regulation D Investor (as referred to in Section 4.08 of the Agreement); or

 

o
I am a Regulation S Investor (as referred to in Section 4.08 of the Agreement).

 

o
I (i) am a U.S. Person (as referred to in Section 4.08 of the Agreement), (ii) am not a Regulation D Investor, (iii) meet the sophistication
requirements for a private placement under Regulation D or alternatively have obtained a purchaser representative that meets such
sophistication requirements and (iv) have been provided with offering materials that satisfy the informational requirements of
Regulation D.

 

Please check the following box if relevant to you:

 

		o	I am "investor" under Section 15(A)(b)(1) of the Israeli Securities Law.

 

[Signature Page to Share Purchase Agreement]

    	 

    	 

    
Execution Copy

 

 

 

IN WITNESS WHEREOF,
the parties hereto have executed this SHARE PURCHASE AGREEMENT as of the date first written above.

 

 

                                                                              

GoldRock Israel Growth, L.P.

By: ________________________________

 

 

Please check one of the following two boxes:

 

 o
I am a Regulation D Investor (as referred to in Section 4.08 of the Agreement); or

 

o
I am a Regulation S Investor (as referred to in Section 4.08 of the Agreement).

 

o
I (i) am a U.S. Person (as referred to in Section 4.08 of the Agreement), (ii) am not a Regulation D Investor, (iii) meet the sophistication
requirements for a private placement under Regulation D or alternatively have obtained a purchaser representative that meets such
sophistication requirements and (iv) have been provided with offering materials that satisfy the informational requirements of
Regulation D.

 

Please check the following box if relevant to you:

 

		o	I am "investor" under Section 15(A)(b)(1) of the Israeli Securities Law.

 

[Signature Page to Share Purchase Agreement]

    	 

    	 

    
Execution Copy

 

 

IN WITNESS WHEREOF,
the parties hereto have executed this SHARE PURCHASE AGREEMENT as of the date first written above.

 

 

FIS SHAREHOLDERS REPRESENTATIVE:

 

 

                                                                              

Mr. Dani
Goldstien

 

 

[Signature Page to Share Purchase Agreement]

    	 

    	 

    
Execution Copy

 

 

IN WITNESS WHEREOF,
the parties hereto have executed this SHARE PURCHASE AGREEMENT as of the date first written above.

 

 

                                                                              

Eureka Ventures Partners I Ltd.

By: ________________________________

 

Please check one of the following two boxes:

 

 o
I am a Regulation D Investor (as referred to in Section 4.08 of the Agreement); or

 

o
I am a Regulation S Investor (as referred to in Section 4.08 of the Agreement).

 

o
I (i) am a U.S. Person (as referred to in Section 4.08 of the Agreement), (ii) am not a Regulation D Investor, (iii) meet the sophistication
requirements for a private placement under Regulation D or alternatively have obtained a purchaser representative that meets such
sophistication requirements and (iv) have been provided with offering materials that satisfy the informational requirements of
Regulation D.

 

Please check the following box if relevant to you:

 

		o	I am "investor" under Section 15(A)(b)(1) of the Israeli Securities Law.

 

 

 

[Signature Page to Share Purchase Agreement]

    	 

    	 

    
Execution Copy 

 

 

IN WITNESS WHEREOF,
the parties hereto have executed this SHARE PURCHASE AGREEMENT as of the date first written above.

 

 

                                                                              

Eyal Hakner

By: ________________________________

 

 

Please check one of the following two boxes:

 

 o
I am a Regulation D Investor (as referred to in Section 4.08 of the Agreement); or

 

o
I am a Regulation S Investor (as referred to in Section 4.08 of the Agreement).

 

o
I (i) am a U.S. Person (as referred to in Section 4.08 of the Agreement), (ii) am not a Regulation D Investor, (iii) meet the sophistication
requirements for a private placement under Regulation D or alternatively have obtained a purchaser representative that meets such
sophistication requirements and (iv) have been provided with offering materials that satisfy the informational requirements of
Regulation D.

 

Please check the following box if relevant to you:

 

		o	I am "investor" under Section 15(A)(b)(1) of the Israeli Securities Law.

 

[Signature Page to Share Purchase Agreement]

    	 

    	 

    
Execution Copy 

 

 

IN WITNESS WHEREOF,
the parties hereto have executed this SHARE PURCHASE AGREEMENT as of the date first written above.

 

 

                                                                              

Formula Ventures Ltd.

By: ________________________________

 

 

Please check one of the following two boxes:

 

 o
I am a Regulation D Investor (as referred to in Section 4.08 of the Agreement); or

 

o
I am a Regulation S Investor (as referred to in Section 4.08 of the Agreement).

 

o
I (i) am a U.S. Person (as referred to in Section 4.08 of the Agreement), (ii) am not a Regulation D Investor, (iii) meet the sophistication
requirements for a private placement under Regulation D or alternatively have obtained a purchaser representative that meets such
sophistication requirements and (iv) have been provided with offering materials that satisfy the informational requirements of
Regulation D.

 

Please check the following box if relevant to you:

 

		o	I am "investor" under Section 15(A)(b)(1) of the Israeli Securities Law.

 

 

[Signature Page to Share Purchase Agreement]

    	 

    	 

    
Execution Copy 

 

 

IN WITNESS WHEREOF,
the parties hereto have executed this SHARE PURCHASE AGREEMENT as of the date first written above.

 

 

                                                                              

Formula Vision Portfolio Holdings Limited Partnership

 

By: ________________________________

 

 

Please check one of the following two boxes:

 

o
I am a Regulation D Investor (as referred to in Section 4.08 of the Agreement); or

 

o
I am a Regulation S Investor (as referred to in Section 4.08 of the Agreement).

 

o
I (i) am a U.S. Person (as referred to in Section 4.08 of the Agreement), (ii) am not a Regulation D Investor, (iii) meet the sophistication
requirements for a private placement under Regulation D or alternatively have obtained a purchaser representative that meets such
sophistication requirements and (iv) have been provided with offering materials that satisfy the informational requirements of
Regulation D.

 

Please check the following box if relevant to you:

 

		o	I am "investor" under Section 15(A)(b)(1) of the Israeli Securities Law.

 

 

 

[Signature Page to Share Purchase Agreement]

    	 

    	 

    
Execution Copy 

 

 

IN WITNESS WHEREOF,
the parties hereto have executed this SHARE PURCHASE AGREEMENT as of the date first written above.

 

 

                                                                              

Genesis Partners II (Israel) L.P.

By: ________________________________

 

 

Please check one of the following two boxes:

 

 o
I am a Regulation D Investor (as referred to in Section 4.08 of the Agreement); or

 

o
I am a Regulation S Investor (as referred to in Section 4.08 of the Agreement).

 

o
I (i) am a U.S. Person (as referred to in Section 4.08 of the Agreement), (ii) am not a Regulation D Investor, (iii) meet the sophistication
requirements for a private placement under Regulation D or alternatively have obtained a purchaser representative that meets such
sophistication requirements and (iv) have been provided with offering materials that satisfy the informational requirements of
Regulation D.

 

Please check the following box if relevant to you:

 

		o	I am "investor" under Section 15(A)(b)(1) of the Israeli Securities Law.

 

 

 

 

[Signature Page to Share Purchase Agreement]

    	 

    	 

    
Execution Copy 

 

 

IN WITNESS WHEREOF,
the parties hereto have executed this SHARE PURCHASE AGREEMENT as of the date first written above.

 

 

                                                                              

Genesis Partners II, L.D.C.

By: ________________________________

 

 

Please check one of the following two boxes:

 

 o
I am a Regulation D Investor (as referred to in Section 4.08 of the Agreement); or

 

o
I am a Regulation S Investor (as referred to in Section 4.08 of the Agreement).

 

o
I (i) am a U.S. Person (as referred to in Section 4.08 of the Agreement), (ii) am not a Regulation D Investor, (iii) meet the sophistication
requirements for a private placement under Regulation D or alternatively have obtained a purchaser representative that meets such
sophistication requirements and (iv) have been provided with offering materials that satisfy the informational requirements of
Regulation D.

 

Please check the following box if relevant to you:

 

		o	I am "investor" under Section 15(A)(b)(1) of the Israeli Securities Law.

 

 

[Signature Page to Share Purchase Agreement]

    	 

    	 

    
Execution Copy 

 

 

IN WITNESS WHEREOF,
the parties hereto have executed this SHARE PURCHASE AGREEMENT as of the date first written above.

 

 

                                                                              

Giza Alpinvest Venture Fund III,
LLC.

By: ________________________________

 

 

Please check one of the following two boxes:

 

 o
I am a Regulation D Investor (as referred to in Section 4.08 of the Agreement); or

 

o
I am a Regulation S Investor (as referred to in Section 4.08 of the Agreement).

 

o
I (i) am a U.S. Person (as referred to in Section 4.08 of the Agreement), (ii) am not a Regulation D Investor, (iii) meet the sophistication
requirements for a private placement under Regulation D or alternatively have obtained a purchaser representative that meets such
sophistication requirements and (iv) have been provided with offering materials that satisfy the informational requirements of
Regulation D.

 

Please check the following box if relevant to you:

 

		o	I am "investor" under Section 15(A)(b)(1) of the Israeli Securities Law.

 

 

[Signature Page to Share Purchase Agreement]

    	 

    	 

    
Execution Copy

 

 

 

IN WITNESS WHEREOF,
the parties hereto have executed this SHARE PURCHASE AGREEMENT as of the date first written above.

 

 

                                                                              

Giza Executive Venture Fund III,
LLC.

By: ________________________________

 

 

Please check one of the following two boxes:

 

 o
I am a Regulation D Investor (as referred to in Section 4.08 of the Agreement); or

 

o
I am a Regulation S Investor (as referred to in Section 4.08 of the Agreement).

 

o
I (i) am a U.S. Person (as referred to in Section 4.08 of the Agreement), (ii) am not a Regulation D Investor, (iii) meet the sophistication
requirements for a private placement under Regulation D or alternatively have obtained a purchaser representative that meets such
sophistication requirements and (iv) have been provided with offering materials that satisfy the informational requirements of
Regulation D.

 

Please check the following box if relevant to you:

 

		o	I am "investor" under Section 15(A)(b)(1) of the Israeli Securities Law.

 

 

[Signature Page to Share Purchase Agreement]

    	 

    	 

    
Execution Copy

 

 

IN WITNESS WHEREOF,
the parties hereto have executed this SHARE PURCHASE AGREEMENT as of the date first written above.

 

 

                                                                              

Giza GE Venture Fund III, LLC.

By: ________________________________

 

 

Please check one of the following two boxes:

 

 o
I am a Regulation D Investor (as referred to in Section 4.08 of the Agreement); or

 

o
I am a Regulation S Investor (as referred to in Section 4.08 of the Agreement).

 

o
I (i) am a U.S. Person (as referred to in Section 4.08 of the Agreement), (ii) am not a Regulation D Investor, (iii) meet the sophistication
requirements for a private placement under Regulation D or alternatively have obtained a purchaser representative that meets such
sophistication requirements and (iv) have been provided with offering materials that satisfy the informational requirements of
Regulation D.

 

Please check the following box if relevant to you:

 

		o	I am "investor" under Section 15(A)(b)(1) of the Israeli Securities Law.

 

 

 [Signature Page to Share Purchase Agreement]

 

    	 

    	 

    

Execution Copy 

 

 

IN WITNESS WHEREOF,
the parties hereto have executed this SHARE PURCHASE AGREEMENT as of the date first written above.

 

 

                                                                              

Giza Gmulot Venture Fund III Limited Partnership.

By: ________________________________

 

 

Please check one of the following two boxes:

 

 o
I am a Regulation D Investor (as referred to in Section 4.08 of the Agreement); or

 

o
I am a Regulation S Investor (as referred to in Section 4.08 of the Agreement).

 

o
I (i) am a U.S. Person (as referred to in Section 4.08 of the Agreement), (ii) am not a Regulation D Investor, (iii) meet the sophistication
requirements for a private placement under Regulation D or alternatively have obtained a purchaser representative that meets such
sophistication requirements and (iv) have been provided with offering materials that satisfy the informational requirements of
Regulation D.

 

Please check the following box if relevant to you:

 

		o	I am "investor" under Section 15(A)(b)(1) of the Israeli Securities Law.

 

 

 

 [Signature Page to Share Purchase Agreement]

    	 

    	 

    

Execution Copy

 

 

IN WITNESS WHEREOF,
the parties hereto have executed this SHARE PURCHASE AGREEMENT as of the date first written above.

 

 

                                                                              

Giza Venture Fund III Limited Partnership.

By: ________________________________

 

 

Please check one of the following two boxes:

 

 o
I am a Regulation D Investor (as referred to in Section 4.08 of the Agreement); or

 

o
I am a Regulation S Investor (as referred to in Section 4.08 of the Agreement).

 

o
I (i) am a U.S. Person (as referred to in Section 4.08 of the Agreement), (ii) am not a Regulation D Investor, (iii) meet the sophistication
requirements for a private placement under Regulation D or alternatively have obtained a purchaser representative that meets such
sophistication requirements and (iv) have been provided with offering materials that satisfy the informational requirements of
Regulation D.

 

Please check the following box if relevant to you:

 

		o	I am "investor" under Section 15(A)(b)(1) of the Israeli Securities Law.

 

 

 [Signature Page to Share Purchase Agreement]

    	 

    	 

    
Execution Copy 

 

 

IN WITNESS WHEREOF,
the parties hereto have executed this SHARE PURCHASE AGREEMENT as of the date first written above.

 

 

                                                                              

Mizrahi Tefahot Trust Company Ltd (in trust).

By: ________________________________

 

 

Please check one of the following two boxes:

 

o
I am a Regulation D Investor (as referred to in Section 4.08 of the Agreement); or

 

o
I am a Regulation S Investor (as referred to in Section 4.08 of the Agreement).

 

o
I (i) am a U.S. Person (as referred to in Section 4.08 of the Agreement), (ii) am not a Regulation D Investor, (iii) meet the sophistication
requirements for a private placement under Regulation D or alternatively have obtained a purchaser representative that meets such
sophistication requirements and (iv) have been provided with offering materials that satisfy the informational requirements of
Regulation D.

 

Please check the following box if relevant to you:

 

		o	I am "investor" under Section 15(A)(b)(1) of the Israeli Securities Law.

 

 

 [Signature Page to Share Purchase Agreement]

    	 

    	 

    

Execution Copy 

 

 

IN WITNESS WHEREOF,
the parties hereto have executed this SHARE PURCHASE AGREEMENT as of the date first written above.

 

 

                                                                              

Schwartz, Lerner, Duvshani Trustees (2003).

By: ________________________________

 

 

Please check one of the following two boxes:

 

 o
I am a Regulation D Investor (as referred to in Section 4.08 of the Agreement); or

 

o
I am a Regulation S Investor (as referred to in Section 4.08 of the Agreement).

 

o
I (i) am a U.S. Person (as referred to in Section 4.08 of the Agreement), (ii) am not a Regulation D Investor, (iii) meet the sophistication
requirements for a private placement under Regulation D or alternatively have obtained a purchaser representative that meets such
sophistication requirements and (iv) have been provided with offering materials that satisfy the informational requirements of
Regulation D.

 

Please check the following box if relevant to you:

 

		o	I am "investor" under Section 15(A)(b)(1) of the Israeli Securities Law.

 

 

 

 [Signature Page to Share Purchase Agreement]

    	 

    	 

    

Execution Copy 

 

 

IN WITNESS WHEREOF,
the parties hereto have executed this SHARE PURCHASE AGREEMENT as of the date first written above.

 

 

                                                                              

Vintage Venture Partners (Israel)
LP.

By: ________________________________

 

 

Please check one of the following two boxes:

 

o
I am a Regulation D Investor (as referred to in Section 4.08 of the Agreement); or

 

o
I am a Regulation S Investor (as referred to in Section 4.08 of the Agreement).

 

o
I (i) am a U.S. Person (as referred to in Section 4.08 of the Agreement), (ii) am not a Regulation D Investor, (iii) meet the sophistication
requirements for a private placement under Regulation D or alternatively have obtained a purchaser representative that meets such
sophistication requirements and (iv) have been provided with offering materials that satisfy the informational requirements of
Regulation D.

 

Please check the following box if relevant to you:

 

		o	I am "investor" under Section 15(A)(b)(1) of the Israeli Securities Law.

 

 

 

 [Signature Page to Share Purchase Agreement]

    	 

    	 

    

Execution Copy

 

 

 

IN WITNESS WHEREOF,
the parties hereto have executed this SHARE PURCHASE AGREEMENT as of the date first written above.

 

 

                                                                              

Vintage Venture Partners (Parallel)
LP.

By: ________________________________

 

 

Please check one of the following two boxes:

 

o
I am a Regulation D Investor (as referred to in Section 4.08 of the Agreement); or

 

o
I am a Regulation S Investor (as referred to in Section 4.08 of the Agreement).

 

o
I (i) am a U.S. Person (as referred to in Section 4.08 of the Agreement), (ii) am not a Regulation D Investor, (iii) meet the sophistication
requirements for a private placement under Regulation D or alternatively have obtained a purchaser representative that meets such
sophistication requirements and (iv) have been provided with offering materials that satisfy the informational requirements of
Regulation D.

 

Please check the following box if relevant to you:

 

		o	I am "investor" under Section 15(A)(b)(1) of the Israeli Securities Law.

 

 

 

 [Signature Page to Share Purchase Agreement]

    	 

    	 

    

Execution Copy 

 

 

IN WITNESS WHEREOF,
the parties hereto have executed this SHARE PURCHASE AGREEMENT as of the date first written above.

 

 

                                                                              

Vintage Venture Partners III (Cayman)
LP.

By: ________________________________

 

 

Please check one of the following two boxes:

 

o
I am a Regulation D Investor (as referred to in Section 4.08 of the Agreement); or

 

o
I am a Regulation S Investor (as referred to in Section 4.08 of the Agreement).

 

o
I (i) am a U.S. Person (as referred to in Section 4.08 of the Agreement), (ii) am not a Regulation D Investor, (iii) meet the sophistication
requirements for a private placement under Regulation D or alternatively have obtained a purchaser representative that meets such
sophistication requirements and (iv) have been provided with offering materials that satisfy the informational requirements of
Regulation D.

 

Please check the following box if relevant to you:

 

		o	I am "investor" under Section 15(A)(b)(1) of the Israeli Securities Law.

 

 

 

 [Signature Page to Share Purchase Agreement]

    	 

    	 

    

Execution Copy 

 

 

IN WITNESS WHEREOF,
the parties hereto have executed this SHARE PURCHASE AGREEMENT as of the date first written above.

 

 

                                                                              

Vintage Venture Partners III (Israel)
LP.

By: ________________________________

 

 

Please check one of the following two boxes:

 

o
I am a Regulation D Investor (as referred to in Section 4.08 of the Agreement); or

 

o
I am a Regulation S Investor (as referred to in Section 4.08 of the Agreement).

 

o
I (i) am a U.S. Person (as referred to in Section 4.08 of the Agreement), (ii) am not a Regulation D Investor, (iii) meet the sophistication
requirements for a private placement under Regulation D or alternatively have obtained a purchaser representative that meets such
sophistication requirements and (iv) have been provided with offering materials that satisfy the informational requirements of
Regulation D.

 

Please check the following box if relevant to you:

 

		o	I am "investor" under Section 15(A)(b)(1) of the Israeli Securities Law.

 

 

 

 [Signature Page to Share Purchase Agreement]

    	 

    	 

    

Execution Copy 

 

 

IN WITNESS WHEREOF,
the parties hereto have executed this SHARE PURCHASE AGREEMENT as of the date first written above.

 

 

                                                                              

Vintage Venture Partners LP.

By: ________________________________

 

 

Please check one of the following two boxes:

 

o
I am a Regulation D Investor (as referred to in Section 4.08 of the Agreement); or

 

o
I am a Regulation S Investor (as referred to in Section 4.08 of the Agreement).

 

o
I (i) am a U.S. Person (as referred to in Section 4.08 of the Agreement), (ii) am not a Regulation D Investor, (iii) meet the sophistication
requirements for a private placement under Regulation D or alternatively have obtained a purchaser representative that meets such
sophistication requirements and (iv) have been provided with offering materials that satisfy the informational requirements of
Regulation D.

 

Please check the following box if relevant to you:

 

		o	I am "investor" under Section 15(A)(b)(1) of the Israeli Securities Law.

 

 

 

 

 

 [Signature Page to Share Purchase Agreement]

    	 

    	 

    

Execution Copy 

 

 

IN WITNESS WHEREOF,
the parties hereto have executed this SHARE PURCHASE AGREEMENT as of the date first written above.

 

 

                                                                              

Yehoshua Alon.

By: ________________________________

 

 

Please check one of the following two boxes:

 

o
I am a Regulation D Investor (as referred to in Section 4.08 of the Agreement); or

 

o
I am a Regulation S Investor (as referred to in Section 4.08 of the Agreement).

 

o
I (i) am a U.S. Person (as referred to in Section 4.08 of the Agreement), (ii) am not a Regulation D Investor, (iii) meet the sophistication
requirements for a private placement under Regulation D or alternatively have obtained a purchaser representative that meets such
sophistication requirements and (iv) have been provided with offering materials that satisfy the informational requirements of
Regulation D.

 

Please check the following box if relevant to you:

 

		o	I am "investor" under Section 15(A)(b)(1) of the Israeli Securities Law.

 

 

 

 

 [Signature Page to Share Purchase Agreement]

    	 

    	 

    

Execution Copy 

 

 

IN WITNESS WHEREOF,
the parties hereto have executed this SHARE PURCHASE AGREEMENT as of the date first written above.

 

 

                                                                              

Zeev Alon.

By: ________________________________

 

 

Please check one of the following two boxes:

 

o
I am a Regulation D Investor (as referred to in Section 4.08 of the Agreement); or

 

o
I am a Regulation S Investor (as referred to in Section 4.08 of the Agreement).

 

o
I (i) am a U.S. Person (as referred to in Section 4.08 of the Agreement), (ii) am not a Regulation D Investor, (iii) meet the sophistication
requirements for a private placement under Regulation D or alternatively have obtained a purchaser representative that meets such
sophistication requirements and (iv) have been provided with offering materials that satisfy the informational requirements of
Regulation D.

 

Please check the following box if relevant to you:

 

		o	I am "investor" under Section 15(A)(b)(1) of the Israeli Securities Law.

 

 

 

 

 [Signature Page to Share Purchase Agreement]

    	 

    	 

    

Execution Copy 

 

 

IN WITNESS WHEREOF,
the parties hereto have executed this SHARE PURCHASE AGREEMENT as of the date first written above.

 

 

                                                                              

Goodsmith Partners LLC.

By: ________________________________

 

 

Please check one of the following two boxes:

 

o
I am a Regulation D Investor (as referred to in Section 4.08 of the Agreement); or

 

o
I am a Regulation S Investor (as referred to in Section 4.08 of the Agreement).

 

o
I (i) am a U.S. Person (as referred to in Section 4.08 of the Agreement), (ii) am not a Regulation D Investor, (iii) meet the sophistication
requirements for a private placement under Regulation D or alternatively have obtained a purchaser representative that meets such
sophistication requirements and (iv) have been provided with offering materials that satisfy the informational requirements of
Regulation D.

 

Please check the following box if relevant to you:

 

		o	I am "investor" under Section 15(A)(b)(1) of the Israeli Securities Law.

 

 

 

 

 [Signature Page to Share Purchase Agreement]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00202-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00202-of-00352.parquet"}]]